10458613	Zinc (II) ion	Bell AC	The protein CTCF is required for the enhancer blocking activity of vertebrate insulators.	Cell	1999	357
12361782	Zinc (II) ion	Fang YZ	Free radicals, antioxidants, and nutrition.	Nutrition	2002	181
15331542	Zinc (II) ion	Chimienti F	Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules.	Diabetes	2004	105
15892631	Zinc (II) ion	Valko M	Metals, toxicity and oxidative stress.	Current medicinal chemistry	2005	464
17261637	Zinc (II) ion	Gromada J	Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.	Endocrine reviews	2007	158
17293876	Zinc (II) ion	Sladek R	A genome-wide association study identifies novel risk loci for type 2 diabetes.	Nature	2007	901
17928989	Zinc (II) ion	Horikoshi M	Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population.	Diabetologia	2007	63
17942684	Zinc (II) ion	Wenzlau JM	The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2007	237
17994216	Zinc (II) ion	Parnaud G	Proliferation of sorted human and rat beta cells.	Diabetologia	2008	86
18598350	Zinc (II) ion	Sanghera DK	Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk.	BMC medical genetics	2008	88
18622393	Zinc (II) ion	Mackay DJ	Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57.	Nature genetics	2008	126
19251047	Zinc (II) ion	Hou JC	Insulin granule biogenesis, trafficking and exocytosis.	Vitamins and hormones	2009	47
19400752	Zinc (II) ion	Lichten LA	Mammalian zinc transporters: nutritional and physiologic regulation.	Annual review of nutrition	2009	170
19566488	Zinc (II) ion	Niu J	Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.	Clinical science	2009	46
21067382	Zinc (II) ion	Knip M	Dietary intervention in infancy and later signs of beta-cell autoimmunity.	The New England journal of medicine	2010	61
21599891	Zinc (II) ion	Thirumoorthy N	A review of metallothionein isoforms and their role in pathophysiology.	World journal of surgical oncology	2011	39
21942864	Zinc (II) ion	Brender JR	Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.	Accounts of chemical research	2012	71
22223213	Zinc (II) ion	Kolattukudy PE	Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway.	Circulation research	2012	54
22332039	Zinc (II) ion	Kelleher SL	Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.	Advances in nutrition	2011	53
22355018	Zinc (II) ion	Wang L	Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay.	Diabetes care	2012	35
22485010	Zinc (II) ion	Jonassen I	Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.	Pharmaceutical research	2012	76
23059534	Zinc (II) ion	Liu Y	An atomic model of Zfp57 recognition of CpG methylation within a specific DNA sequence.	Genes & development	2012	44
23248199	Zinc (II) ion	Hawa MI	Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.	Diabetes care	2013	31
24051378	Zinc (II) ion	Tamaki M	The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance.	The Journal of clinical investigation	2013	51
24315485	Zinc (II) ion	Hu L	Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation.	Cell	2013	71
24584071	Zinc (II) ion	Flannick J	Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.	Nature genetics	2014	118
24603074	Zinc (II) ion	Kong SM	Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.	Human molecular genetics	2014	48
24751356	Zinc (II) ion	Davidson HW	Zinc transporter 8 (ZnT8) and β cell function.	Trends in endocrinology and metabolism	2014	20
25126789	Zinc (II) ion	Deng W	Reactivation of developmentally silenced globin genes by forced chromatin looping.	Cell	2014	82
25287711	Zinc (II) ion	Rutter GA	SLC30A8 mutations in type 2 diabetes.	Diabetologia	2015	19
25362967	Zinc (II) ion	Maret W	Analyzing free zinc(II) ion concentrations in cell biology with fluorescent chelating molecules.	Metallomics 	2015	21
25855295	Zinc (II) ion	Tanabe H	Crystal structures of the human adiponectin receptors.	Nature	2015	24
26025256	Zinc (II) ion	Strogantsev R	Allele-specific binding of ZFP57 in the epigenetic regulation of imprinted and non-imprinted monoallelic expression.	Genome biology	2015	22
26840484	Zinc (II) ion	Davies B	Re-engineering the zinc fingers of PRDM9 reverses hybrid sterility in mice.	Nature	2016	29
27083996	Zinc (II) ion	Ghirlando R	CTCF: making the right connections.	Genes & development	2016	39
27225690	Zinc (II) ion	Gerber PA	The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus.	Antioxidants & redox signaling	2017	7
27597529	Zinc (II) ion	Wolk A	Potential health hazards of eating red meat.	Journal of internal medicine	2017	7
10204114	ADP	Aguilar-Bryan L	Molecular biology of adenosine triphosphate-sensitive potassium channels.	Endocrine reviews	1999	151
12223530	ADP	Virág L	The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.	Pharmacological reviews	2002	280
12440774	ADP	Hassa PO	The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders.	Cellular and molecular life sciences 	2002	100
12469359	ADP	Straub SG	Glucose-stimulated signaling pathways in biphasic insulin secretion.	Diabetes/metabolism research and reviews	2002	86
12716823	ADP	Ceriello A	New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.	Diabetes care	2003	121
12960015	ADP	Hardie DG	Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.	Endocrinology	2003	219
15654602	ADP	Anello M	Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.	Diabetologia	2005	72
17167487	ADP	Hafner M	Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance.	Nature	2006	74
17310282	ADP	Roche TE	Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer.	Cellular and molecular life sciences 	2007	78
17334651	ADP	Boushel R	Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle.	Diabetologia	2007	118
17351150	ADP	Mogensen M	Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes.	Diabetes	2007	114
18678616	ADP	Phielix E	Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients.	Diabetes	2008	68
19168596	ADP	da Silva Xavier G	TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells.	Diabetes	2009	66
19220204	ADP	Vanhoutte PM	Endothelial dysfunction and vascular disease.	Acta physiologica	2009	134
19706858	ADP	Shuldiner AR	Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.	JAMA	2009	261
20011104	ADP	Richards JB	A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.	PLoS genetics	2009	62
20082095	ADP	Michel T	Cellular signaling and NO production.	Pflugers Archiv 	2010	53
21135052	ADP	Sumoza-Toledo A	TRPM2: a multifunctional ion channel for calcium signalling.	The Journal of physiology	2011	66
21265739	ADP	Hardie DG	AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer.	Biochemical Society transactions	2011	41
21646425	ADP	Pullen TJ	miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1).	Molecular and cellular biology	2011	75
21803289	ADP	Birkenfeld AL	Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice.	Cell metabolism	2011	54
21912398	ADP	Szendroedi J	The role of mitochondria in insulin resistance and type 2 diabetes mellitus.	Nature reviews. Endocrinology	2011	107
22702974	ADP	Carling D	AMP-activated protein kinase: new regulation, new roles?	The Biochemical journal	2012	94
23102217	ADP	Hardie DG	AMP-activated protein kinase: a target for drugs both ancient and modern.	Chemistry & biology	2012	99
23111421	ADP	Lewis JP	The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response.	Pharmacogenetics and genomics	2013	33
23747347	ADP	Russo GL	AMP-activated protein kinase: a target for old drugs against diabetes and cancer.	Biochemical pharmacology	2013	35
24395786	ADP	Vozza A	UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation.	Proceedings of the National Academy of Sciences of the United States of America	2014	64
24438746	ADP	Kugel S	Chromatin and beyond: the multitasking roles for SIRT6.	Trends in biochemical sciences	2014	56
24784220	ADP	Zhang J	Agonist-bound structure of the human P2Y12 receptor.	Nature	2014	42
24824502	ADP	Grahame Hardie D	AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease.	Journal of internal medicine	2014	39
25695398	ADP	Jensen TE	PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain.	The Biochemical journal	2015	15
26091340	ADP	Daniels CM	The Promise of Proteomics for the Study of ADP-Ribosylation.	Molecular cell	2015	34
26112889	ADP	Winnik S	Protective effects of sirtuins in cardiovascular diseases: from bench to bedside.	European heart journal	2015	42
26706498	ADP	Vanhoutte PM	Endothelial dysfunction and vascular disease - a 30th anniversary update.	Acta physiologica	2017	27
28232179	ADP	Carling D	AMPK signalling in health and disease.	Current opinion in cell biology	2017	15
9703762	Adenosine triphosphate	Szabó C	Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.	Trends in pharmacological sciences	1998	109
10346816	Adenosine triphosphate	Paull TT	Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex.	Genes & development	1999	172
10868964	Adenosine triphosphate	Hohmeier HE	Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.	Diabetes	2000	299
11033082	Adenosine triphosphate	Coghlan MP	Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.	Chemistry & biology	2000	240
11742413	Adenosine triphosphate	Maechler P	Mitochondrial function in normal and diabetic beta-cells.	Nature	2001	119
11756336	Adenosine triphosphate	Ido Y	Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.	Diabetes	2002	87
12540637	Adenosine triphosphate	Gloyn AL	Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.	Diabetes	2003	165
12676647	Adenosine triphosphate	Sugden MC	Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.	American journal of physiology. Endocrinology and metabolism	2003	108
12717402	Adenosine triphosphate	Neuschwander-Tetri BA	Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.	Hepatology	2003	371
12771873	Adenosine triphosphate	Furnary AP	Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.	The Journal of thoracic and cardiovascular surgery	2003	128
12808136	Adenosine triphosphate	Stump CS	Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts.	Proceedings of the National Academy of Sciences of the United States of America	2003	106
12928438	Adenosine triphosphate	Bhat R	Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.	The Journal of biological chemistry	2003	104
14693691	Adenosine triphosphate	Holz GG	Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell.	Diabetes	2004	94
14722619	Adenosine triphosphate	Scott JW	CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.	The Journal of clinical investigation	2004	228
14744259	Adenosine triphosphate	Pozuelo Rubio M	14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.	The Biochemical journal	2004	146
14749273	Adenosine triphosphate	Duchen MR	Roles of mitochondria in health and disease.	Diabetes	2004	75
14749278	Adenosine triphosphate	Rousset S	The biology of mitochondrial uncoupling proteins.	Diabetes	2004	101
14769489	Adenosine triphosphate	Veech RL	The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism.	Prostaglandins, leukotrienes, and essential fatty acids	2004	142
15109305	Adenosine triphosphate	Praskova M	Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.	The Biochemical journal	2004	114
15115830	Adenosine triphosphate	Gloyn AL	Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.	The New England journal of medicine	2004	248
15375023	Adenosine triphosphate	Huss JM	Nuclear receptor signaling and cardiac energetics.	Circulation research	2004	111
15448079	Adenosine triphosphate	Levin BE	Neuronal glucosensing: what do we know after 50 years?	Diabetes	2004	116
15504342	Adenosine triphosphate	Cacicedo JM	AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.	Biochemical and biophysical research communications	2004	83
15559249	Adenosine triphosphate	Meijer L	Pharmacological inhibitors of glycogen synthase kinase 3.	Trends in pharmacological sciences	2004	136
15883415	Adenosine triphosphate	Nair KS	Aging muscle.	The American journal of clinical nutrition	2005	89
16123337	Adenosine triphosphate	Hattersley AT	Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.	Diabetes	2005	95
16148943	Adenosine triphosphate	Koo SH	The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.	Nature	2005	306
16169595	Adenosine triphosphate	Inoue K	The function of microglia through purinergic receptors: neuropathic pain and cytokine release.	Pharmacology & therapeutics	2006	81
16183915	Adenosine triphosphate	Oram JF	ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.	Physiological reviews	2005	128
16246006	Adenosine triphosphate	Brand MD	The efficiency and plasticity of mitochondrial energy transduction.	Biochemical Society transactions	2005	87
16556766	Adenosine triphosphate	Wiederkehr A	Minireview: implication of mitochondria in insulin secretion and action.	Endocrinology	2006	70
16644800	Adenosine triphosphate	Hardie DG	AMP-activated protein kinase--development of the energy sensor concept.	The Journal of physiology	2006	210
16644802	Adenosine triphosphate	Viollet B	Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.	The Journal of physiology	2006	96
16822958	Adenosine triphosphate	Fujii N	AMP-activated protein kinase and the regulation of glucose transport.	American journal of physiology. Endocrinology and metabolism	2006	67
16879084	Adenosine triphosphate	Hardie DG	AMP-activated protein kinase as a drug target.	Annual review of pharmacology and toxicology	2007	135
16885549	Adenosine triphosphate	Babenko AP	Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.	The New England journal of medicine	2006	135
16885550	Adenosine triphosphate	Pearson ER	Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.	The New England journal of medicine	2006	214
17095732	Adenosine triphosphate	Oram JF	ATP-Binding cassette cholesterol transporters and cardiovascular disease.	Circulation research	2006	115
17287462	Adenosine triphosphate	Befroy DE	Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients.	Diabetes	2007	120
17307971	Adenosine triphosphate	Towler MC	AMP-activated protein kinase in metabolic control and insulin signaling.	Circulation research	2007	317
17332438	Adenosine triphosphate	Arad M	AMP-activated protein kinase in the heart: role during health and disease.	Circulation research	2007	92
17353295	Adenosine triphosphate	Wajchenberg BL	beta-cell failure in diabetes and preservation by clinical treatment.	Endocrine reviews	2007	147
17446535	Adenosine triphosphate	Flanagan SE	Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.	Diabetes	2007	76
17565987	Adenosine triphosphate	Zhang F	Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6.	The Journal of biological chemistry	2007	67
17567459	Adenosine triphosphate	Pessayre D	Role of mitochondria in non-alcoholic fatty liver disease.	Journal of gastroenterology and hepatology	2007	65
18025408	Adenosine triphosphate	Rafiq M	Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.	Diabetes care	2008	54
18048761	Adenosine triphosphate	Ferdinandy P	Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.	Pharmacological reviews	2007	157
18162506	Adenosine triphosphate	Edghill EL	Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.	Diabetes	2008	84
18270681	Adenosine triphosphate	Ling C	Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.	Diabetologia	2008	105
18285554	Adenosine triphosphate	Nair KS	Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance.	Diabetes	2008	60
18301398	Adenosine triphosphate	Murphy R	Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes.	Nature clinical practice. Endocrinology & metabolism	2008	95
18309108	Adenosine triphosphate	Kim JA	Role of mitochondrial dysfunction in insulin resistance.	Circulation research	2008	193
18321858	Adenosine triphosphate	Pang T	Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells.	The Journal of biological chemistry	2008	50
18395287	Adenosine triphosphate	Ouyang X	Fructose consumption as a risk factor for non-alcoholic fatty liver disease.	Journal of hepatology	2008	150
18521185	Adenosine triphosphate	Chen WM	Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.	The Journal of clinical investigation	2008	75
18716044	Adenosine triphosphate	Lanza IR	Endurance exercise as a countermeasure for aging.	Diabetes	2008	148
18719601	Adenosine triphosphate	Hardie DG	AMPK: a key regulator of energy balance in the single cell and the whole organism.	International journal of obesity	2008	153
18767144	Adenosine triphosphate	Flanagan SE	Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.	Human mutation	2009	71
19158351	Adenosine triphosphate	Cirillo P	Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells.	Journal of the American Society of Nephrology 	2009	59
19196246	Adenosine triphosphate	Richter EA	AMPK and the biochemistry of exercise: implications for human health and disease.	The Biochemical journal	2009	85
19231010	Adenosine triphosphate	Caballero F	Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH.	Journal of hepatology	2009	62
19243571	Adenosine triphosphate	Wang W	AMP-activated protein kinase and cancer.	Acta physiologica	2009	47
19245656	Adenosine triphosphate	Viollet B	AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.	Acta physiologica	2009	89
19778642	Adenosine triphosphate	Fogarty S	Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.	Biochimica et biophysica acta	2010	100
19805629	Adenosine triphosphate	Lamkanfi M	Glyburide inhibits the Cryopyrin/Nalp3 inflammasome.	The Journal of cell biology	2009	176
19833885	Adenosine triphosphate	Karakelides H	Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function.	Diabetes	2010	68
19887595	Adenosine triphosphate	Costford SR	Skeletal muscle NAMPT is induced by exercise in humans.	American journal of physiology. Endocrinology and metabolism	2010	49
19900593	Adenosine triphosphate	Bogoyevitch MA	c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges.	Biochimica et biophysica acta	2010	69
20032281	Adenosine triphosphate	Hernández-Alvarez MI	Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity.	Diabetes care	2010	48
20081827	Adenosine triphosphate	Berndt A	The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.	Nature chemical biology	2010	44
20103737	Adenosine triphosphate	Ruderman NB	AMPK and SIRT1: a long-standing partnership?	American journal of physiology. Endocrinology and metabolism	2010	145
20225132	Adenosine triphosphate	Jitrapakdee S	Regulation of insulin secretion: role of mitochondrial signalling.	Diabetologia	2010	70
20386866	Adenosine triphosphate	Ost A	Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes.	Molecular medicine	2010	65
20440072	Adenosine triphosphate	Cheng K	Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets.	The Journal of clinical investigation	2010	63
20444419	Adenosine triphosphate	Kalender A	Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.	Cell metabolism	2010	214
20466975	Adenosine triphosphate	Fryirs MA	Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion.	Arteriosclerosis, thrombosis, and vascular biology	2010	45
20585248	Adenosine triphosphate	Bournat JC	Mitochondrial dysfunction in obesity.	Current opinion in endocrinology, diabetes, and obesity	2010	54
20838378	Adenosine triphosphate	Piñeiro R	The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.	Oncogene	2011	48
21196229	Adenosine triphosphate	Richard D	Brown fat biology and thermogenesis.	Frontiers in bioscience	2011	60
21216854	Adenosine triphosphate	Schmid AI	Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.	Diabetes care	2011	39
21459328	Adenosine triphosphate	Porat S	Control of pancreatic β cell regeneration by glucose metabolism.	Cell metabolism	2011	112
21620960	Adenosine triphosphate	Hers I	Akt signalling in health and disease.	Cellular signalling	2011	223
21690355	Adenosine triphosphate	Forsyth AM	Multiscale approach to link red blood cell dynamics, shear viscosity, and ATP release.	Proceedings of the National Academy of Sciences of the United States of America	2011	38
21864748	Adenosine triphosphate	Henquin JC	The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells.	Diabetes research and clinical practice	2011	47
22110477	Adenosine triphosphate	Ma ZA	Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus.	Experimental diabetes research	2012	43
22156303	Adenosine triphosphate	Rottiers V	MicroRNAs in metabolism and metabolic diseases.	Cold Spring Harbor symposia on quantitative biology	2011	36
22179786	Adenosine triphosphate	Gupta S	Mechanism of mismatch recognition revealed by human MutSβ bound to unpaired DNA loops.	Nature structural & molecular biology	2011	50
22203527	Adenosine triphosphate	Del Barco S	Metformin: multi-faceted protection against cancer.	Oncotarget	2011	100
22446165	Adenosine triphosphate	Chowdhury SK	The role of aberrant mitochondrial bioenergetics in diabetic neuropathy.	Neurobiology of disease	2013	37
22798688	Adenosine triphosphate	Srivastava RA	AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.	Journal of lipid research	2012	33
22948162	Adenosine triphosphate	Juliana C	Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.	The Journal of biological chemistry	2012	116
23018146	Adenosine triphosphate	Huh JY	FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.	Metabolism	2012	140
23086037	Adenosine triphosphate	Lee HM	Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.	Diabetes	2013	96
23112875	Adenosine triphosphate	Lanaspa MA	Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.	PloS one	2012	43
23116613	Adenosine triphosphate	Miao XY	The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.	Peptides	2013	27
23298225	Adenosine triphosphate	Bijland S	Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation.	Clinical science	2013	39
23432475	Adenosine triphosphate	Cheng Z	Mitochondria and metabolic homeostasis.	Antioxidants & redox signaling	2013	34
23434541	Adenosine triphosphate	Chen K	ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.	The international journal of biochemistry & cell biology	2013	33
23471659	Adenosine triphosphate	Ye J	Mechanisms of insulin resistance in obesity.	Frontiers of medicine	2013	47
23852728	Adenosine triphosphate	Betz C	Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology.	Proceedings of the National Academy of Sciences of the United States of America	2013	77
23994581	Adenosine triphosphate	Rettberg JR	Estrogen: a master regulator of bioenergetic systems in the brain and body.	Frontiers in neuroendocrinology	2014	43
24042324	Adenosine triphosphate	Ashcroft FM	K(ATP) channels and islet hormone secretion: new insights and controversies.	Nature reviews. Endocrinology	2013	49
24206664	Adenosine triphosphate	Morita M	mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation.	Cell metabolism	2013	119
24265069	Adenosine triphosphate	Burnstock G	Purinergic signalling in the urinary tract in health and disease.	Purinergic signalling	2014	29
24332968	Adenosine triphosphate	Tornovsky-Babeay S	Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells.	Cell metabolism	2014	32
24337569	Adenosine triphosphate	Lai L	A role for peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis.	The Journal of biological chemistry	2014	20
24338270	Adenosine triphosphate	Singh P	Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.	Medical oncology	2014	45
24363178	Adenosine triphosphate	Gray LR	Regulation of pyruvate metabolism and human disease.	Cellular and molecular life sciences 	2014	42
24385509	Adenosine triphosphate	Westerterp M	ATP-binding cassette transporters, atherosclerosis, and inflammation.	Circulation research	2014	55
24606795	Adenosine triphosphate	Valero T	Mitochondrial biogenesis: pharmacological approaches.	Current pharmaceutical design	2014	29
24614098	Adenosine triphosphate	Huh JY	Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans.	International journal of obesity	2014	24
24647144	Adenosine triphosphate	Shao B	Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.	Circulation research	2014	45
24677093	Adenosine triphosphate	Rehman G	Role of AMP-activated protein kinase in cancer therapy.	Archiv der Pharmazie	2014	24
24692138	Adenosine triphosphate	Rui L	Energy metabolism in the liver.	Comprehensive Physiology	2014	103
24703697	Adenosine triphosphate	Prentice KJ	The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction.	Cell metabolism	2014	29
24740569	Adenosine triphosphate	Hodson DJ	ADCY5 couples glucose to insulin secretion in human islets.	Diabetes	2014	23
24746669	Adenosine triphosphate	Wang Z	Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.	Developmental cell	2014	37
24746806	Adenosine triphosphate	Wang Z	Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy.	Cell metabolism	2014	76
24770881	Adenosine triphosphate	Nelson PT	ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.	Acta neuropathologica	2014	23
24861084	Adenosine triphosphate	Fornoni A	Lipid biology of the podocyte--new perspectives offer new opportunities.	Nature reviews. Nephrology	2014	22
24949970	Adenosine triphosphate	Soleimanpour SA	The diabetes susceptibility gene Clec16a regulates mitophagy.	Cell	2014	34
24961373	Adenosine triphosphate	Chen L	OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.	Proceedings of the National Academy of Sciences of the United States of America	2014	33
24995977	Adenosine triphosphate	Lo JC	Adipsin is an adipokine that improves β cell function in diabetes.	Cell	2014	33
24998913	Adenosine triphosphate	Lee JV	Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.	Cell metabolism	2014	82
25263561	Adenosine triphosphate	Bensaad K	Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation.	Cell reports	2014	45
25475361	Adenosine triphosphate	Nigam SK	What do drug transporters really do?	Nature reviews. Drug discovery	2015	55
25590809	Adenosine triphosphate	Moore Z	NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone.	Cell death & disease	2015	18
25626736	Adenosine triphosphate	Finucane OM	Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesity.	Diabetes	2015	30
25686106	Adenosine triphosphate	Youm YH	The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.	Nature medicine	2015	105
25713188	Adenosine triphosphate	Sharma K	Mitochondrial hormesis and diabetic complications.	Diabetes	2015	25
25867026	Adenosine triphosphate	Sesen J	Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.	PloS one	2015	25
25879284	Adenosine triphosphate	Goldberg EL	Drivers of age-related inflammation and strategies for healthspan extension.	Immunological reviews	2015	18
25904599	Adenosine triphosphate	Zhang H	Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.	Circulation research	2015	18
26002551	Adenosine triphosphate	Loubière C	Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.	Oncotarget	2015	15
26159692	Adenosine triphosphate	Dibble CC	Regulation of mTORC1 by PI3K signaling.	Trends in cell biology	2015	103
26322680	Adenosine triphosphate	Doménech E	AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest.	Nature cell biology	2015	29
26323267	Adenosine triphosphate	Rosenson RS	Dysfunctional HDL and atherosclerotic cardiovascular disease.	Nature reviews. Cardiology	2016	51
26389676	Adenosine triphosphate	Ferdaoussi M	Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.	The Journal of clinical investigation	2015	24
26404370	Adenosine triphosphate	Gröber U	Magnesium in Prevention and Therapy.	Nutrients	2015	18
26808348	Adenosine triphosphate	Min SY	Human 'brite/beige' adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice.	Nature medicine	2016	21
26818947	Adenosine triphosphate	Imamura M	Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.	Nature communications	2016	13
27076077	Adenosine triphosphate	Yoshihara E	ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β Cells.	Cell metabolism	2016	14
27230643	Adenosine triphosphate	Shah MS	Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.	Circulation research	2016	24
27350397	Adenosine triphosphate	Daulatzai MA	Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.	Journal of neuroscience research	2017	14
28011087	Adenosine triphosphate	Mansueto G	Transcription Factor EB Controls Metabolic Flexibility during Exercise.	Cell metabolism	2017	17
28057794	Adenosine triphosphate	Burnstock G	Purinergic Signaling in the Cardiovascular System.	Circulation research	2017	17
28131082	Adenosine triphosphate	Rovira-Llopis S	Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications.	Redox biology	2017	7
28239646	Adenosine triphosphate	Wang YY	Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells.	JCI insight	2017	12
28437620	Adenosine triphosphate	Jellinger PS	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.	Endocrine practice 	2017	14
11588148	Guanosine triphosphate	Weinstein LS	Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.	Endocrine reviews	2001	99
15854902	Guanosine triphosphate	Long X	Rheb binds and regulates the mTOR kinase.	Current biology 	2005	279
15878852	Guanosine triphosphate	Long X	Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.	The Journal of biological chemistry	2005	112
17679617	Guanosine triphosphate	Xu J	Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus.	Circulation	2007	62
18765678	Guanosine triphosphate	Avruch J	Amino acid regulation of TOR complex 1.	American journal of physiology. Endocrinology and metabolism	2009	146
19890090	Guanosine triphosphate	Kowluru A	Small G proteins in islet beta-cell function.	Endocrine reviews	2010	46
20428113	Guanosine triphosphate	Chappie JS	G domain dimerization controls dynamin's assembly-stimulated GTPase activity.	Nature	2010	98
21867484	Guanosine triphosphate	Werner ER	Tetrahydrobiopterin: biochemistry and pathophysiology.	The Biochemical journal	2011	60
22745122	Guanosine triphosphate	Gawlowski T	Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes.	The Journal of biological chemistry	2012	47
24337580	Guanosine triphosphate	Oshiro N	Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.	The Journal of biological chemistry	2014	24
26123023	Guanosine triphosphate	Mattila JP	A hemi-fission intermediate links two mechanistically distinct stages of membrane fission.	Nature	2015	18
11961019	Urea	Paniagua R	Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.	Journal of the American Society of Nephrology 	2002	103
17645639	Urea	Durante W	Arginase: a critical regulator of nitric oxide synthesis and vascular function.	Clinical and experimental pharmacology & physiology	2007	107
18682704	Urea	Shaham O	Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity.	Molecular systems biology	2008	122
19214027	Urea	Hsu HJ	Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.	The American journal of the medical sciences	2009	45
19240267	Urea	Møller N	Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.	Endocrine reviews	2009	147
19926893	Urea	Mehdi UF	Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.	Journal of the American Society of Nephrology 	2009	72
20686651	Urea	Gudbjartsson DF	Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.	PLoS genetics	2010	50
21527736	Urea	Wright EM	Biology of human sodium glucose transporters.	Physiological reviews	2011	183
22869039	Urea	Tong L	Structure and function of biotin-dependent carboxylases.	Cellular and molecular life sciences 	2013	47
26867814	Urea	Obi Y	Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.	American journal of kidney diseases 	2016	24
28262773	Urea	Hocher B	Metabolomics for clinical use and research in chronic kidney disease.	Nature reviews. Nephrology	2017	13
7649494	Iron	Packer L	alpha-Lipoic acid as a biological antioxidant.	Free radical biology & medicine	1995	171
10573511	Iron	Angulo P	Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.	Hepatology	1999	237
10756000	Iron	Ribes JA	Zygomycetes in human disease.	Clinical microbiology reviews	2000	214
11175786	Iron	Puccio H	Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.	Nature genetics	2001	159
11296694	Iron	Chitturi S	Etiopathogenesis of nonalcoholic steatohepatitis.	Seminars in liver disease	2001	93
11473047	Iron	Marchesini G	Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.	Diabetes	2001	400
11563810	Iron	Whitfield JB	Gamma glutamyl transferase.	Critical reviews in clinical laboratory sciences	2001	138
11812557	Iron	Beutler E	Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.	Lancet	2002	119
12105842	Iron	Bugianesi E	Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.	Gastroenterology	2002	260
12512031	Iron	Ruhl CE	Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.	Gastroenterology	2003	120
12809815	Iron	Clark JM	The prevalence and etiology of elevated aminotransferase levels in the United States.	The American journal of gastroenterology	2003	274
14647275	Iron	Papanikolaou G	Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.	Nature genetics	2004	207
14871914	Iron	Jiang R	Body iron stores in relation to risk of type 2 diabetes in apparently healthy women.	JAMA	2004	102
15451911	Iron	Jehn M	Serum ferritin and risk of the metabolic syndrome in U.S. adults.	Diabetes care	2004	74
15625418	Iron	Hill ID	Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.	Journal of pediatric gastroenterology and nutrition	2005	145
15925276	Iron	Abraham NG	Heme oxygenase and the cardiovascular-renal system.	Free radical biology & medicine	2005	89
16775600	Iron	Nath KA	Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues.	Kidney international	2006	111
16952548	Iron	Bekri S	Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.	Gastroenterology	2006	92
17721544	Iron	Tanno T	High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.	Nature medicine	2007	193
17891154	Iron	Hierro A	Functional architecture of the retromer cargo-recognition complex.	Nature	2007	85
18323402	Iron	Abraham NG	Pharmacological and clinical aspects of heme oxygenase.	Pharmacological reviews	2008	289
18576916	Iron	Loboda A	Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities.	Antioxidants & redox signaling	2008	66
19414861	Iron	Tanno T	Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.	Blood	2009	109
20156111	Iron	Santos R	Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.	Antioxidants & redox signaling	2010	51
20484814	Iron	Liu M	The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.	The Journal of clinical investigation	2010	42
20492708	Iron	Galanello R	Beta-thalassemia.	Orphanet journal of rare diseases	2010	107
20542038	Iron	Pietrangelo A	Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.	Gastroenterology	2010	87
20704546	Iron	Was H	Heme oxygenase-1 in tumor biology and therapy.	Current drug targets	2010	65
20858683	Iron	Soranzo N	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Diabetes	2010	130
21788481	Iron	Zuris JA	Facile transfer of 2Fe-2S clusters from the diabetes drug target mitoNEET to an apo-acceptor protein.	Proceedings of the National Academy of Sciences of the United States of America	2011	37
21904647	Iron	Lipinski B	Hydroxyl radical and its scavengers in health and disease.	Oxidative medicine and cellular longevity	2011	38
22055506	Iron	Nandal A	Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2.	Cell metabolism	2011	43
22286106	Iron	Ray PD	Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.	Cellular signalling	2012	451
22306201	Iron	Poulsen HE	RNA modifications by oxidation: a novel disease mechanism?	Free radical biology & medicine	2012	39
22327295	Iron	Noinaj N	Structural basis for iron piracy by pathogenic Neisseria.	Nature	2012	58
24158761	Iron	Bachman E	Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.	The journals of gerontology. Series A, Biological sciences and medical sciences	2014	32
24180257	Iron	Wegiel B	Heme oxygenase-1: a metabolic nike.	Antioxidants & redox signaling	2014	27
24359125	Iron	Lang F	Oxidative stress and suicidal erythrocyte death.	Antioxidants & redox signaling	2014	24
24705334	Iron	Perdomini M	Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.	Nature medicine	2014	32
25838035	Iron	Kim Y	A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus.	Metabolism	2015	16
26098370	Iron	Bai Y	X-ray structure of a mammalian stearoyl-CoA desaturase.	Nature	2015	21
26827289	Iron	Brigandi RA	A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.	American journal of kidney diseases 	2016	13
27887750	Iron	Webster AC	Chronic Kidney Disease.	Lancet	2017	16
28060743	Iron	González N	2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.	Oncotarget	2017	5
10869423	Heme	Geiszt M	Identification of renox, an NAD(P)H oxidase in kidney.	Proceedings of the National Academy of Sciences of the United States of America	2000	215
16955146	Heme	Stasch JP	Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.	The Journal of clinical investigation	2006	123
18195184	Heme	Dulak J	Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.	Circulation	2008	75
21091076	Heme	Wu ML	A central role of heme oxygenase-1 in cardiovascular protection.	Antioxidants & redox signaling	2011	39
21198553	Heme	Förstermann U	Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.	British journal of pharmacology	2011	45
21947364	Heme	Lehr S	Identification and validation of novel adipokines released from primary human adipocytes.	Molecular & cellular proteomics 	2012	35
23615880	Heme	Wang W	Glycine metabolism in animals and humans: implications for nutrition and health.	Amino acids	2013	45
24843120	Heme	Frey AG	Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
24995976	Heme	Jais A	Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man.	Cell	2014	50
12377295	Gonadotropin releasing hormone	Tsigos C	Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.	Journal of psychosomatic research	2002	306
23738509	Gonadotropin releasing hormone	Abreu AP	Central precocious puberty caused by mutations in the imprinted gene MKRN3.	The New England journal of medicine	2013	52
24056171	Gonadotropin releasing hormone	Thompson IR	GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression.	Molecular and cellular endocrinology	2014	20
24615662	Gonadotropin releasing hormone	Skorupskaite K	The kisspeptin-GnRH pathway in human reproductive health and disease.	Human reproduction update	2014	26
1944469	Cyclic AMP	Weinstein LS	Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.	The New England journal of medicine	1991	221
11342529	Cyclic AMP	Yamagishi SI	Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A.	The Journal of biological chemistry	2001	104
12496249	Cyclic AMP	Kang G	Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells.	The Journal of biological chemistry	2003	89
12588810	Cyclic AMP	Puigserver P	Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.	Endocrine reviews	2003	480
12606503	Cyclic AMP	Daitoku H	Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.	Diabetes	2003	84
15044356	Cyclic AMP	Brubaker PL	Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.	Endocrinology	2004	104
15331566	Cyclic AMP	Baggio LL	A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.	Diabetes	2004	74
16177793	Cyclic AMP	Zhang J	Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes.	Nature	2005	101
16563471	Cyclic AMP	Lips P	Vitamin D physiology.	Progress in biophysics and molecular biology	2006	173
16966319	Cyclic AMP	Wang J	Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84.	The Journal of biological chemistry	2006	72
16980408	Cyclic AMP	Wu Z	Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells.	Proceedings of the National Academy of Sciences of the United States of America	2006	91
17068144	Cyclic AMP	Granata R	Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling.	Endocrinology	2007	58
17306374	Cyclic AMP	Doyle ME	Mechanisms of action of glucagon-like peptide 1 in the pancreas.	Pharmacology & therapeutics	2007	129
18078445	Cyclic AMP	Peschke E	Melatonin, endocrine pancreas and diabetes.	Journal of pineal research	2008	51
18216022	Cyclic AMP	Liu Z	Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.	The Journal of biological chemistry	2008	71
18565824	Cyclic AMP	Dejana E	The role of adherens junctions and VE-cadherin in the control of vascular permeability.	Journal of cell science	2008	245
18604457	Cyclic AMP	Cheng X	Epac and PKA: a tale of two intracellular cAMP receptors.	Acta biochimica et biophysica Sinica	2008	97
19151200	Cyclic AMP	Noyan-Ashraf MH	GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.	Diabetes	2009	116
19164583	Cyclic AMP	Li Y	GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.	Proceedings of the National Academy of Sciences of the United States of America	2009	109
19386626	Cyclic AMP	Shu L	Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.	Human molecular genetics	2009	76
19742322	Cyclic AMP	Kuroda A	Insulin gene expression is regulated by DNA methylation.	PloS one	2009	69
20068138	Cyclic AMP	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	102
20448207	Cyclic AMP	Oeseburg H	Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.	Arteriosclerosis, thrombosis, and vascular biology	2010	61
20592469	Cyclic AMP	Liew CW	The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells.	The Journal of clinical investigation	2010	49
21209017	Cyclic AMP	Tolhurst G	Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP.	Endocrinology	2011	44
21356520	Cyclic AMP	Song WJ	Snapin mediates incretin action and augments glucose-dependent insulin secretion.	Cell metabolism	2011	35
21454562	Cyclic AMP	Miller LJ	Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.	The Journal of biological chemistry	2011	35
22147710	Cyclic AMP	Koole C	Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.	The Journal of biological chemistry	2012	32
22266668	Cyclic AMP	Gier B	Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.	Diabetes	2012	49
22553202	Cyclic AMP	Nin V	Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.	The Journal of biological chemistry	2012	40
22778400	Cyclic AMP	Narasimamurthy R	Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines.	Proceedings of the National Academy of Sciences of the United States of America	2012	75
22885100	Cyclic AMP	Chung JH	Resveratrol as a calorie restriction mimetic: therapeutic implications.	Trends in cell biology	2012	44
22974359	Cyclic AMP	Fu Z	Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.	Current diabetes reviews	2013	46
23035207	Cyclic AMP	Shigeta T	Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions.	Circulation	2012	40
23349487	Cyclic AMP	Kimple ME	Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion.	Diabetes	2013	26
23447132	Cyclic AMP	Schmidt M	Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions.	Pharmacological reviews	2013	57
24225429	Cyclic AMP	Fujita H	DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1α in type 2 diabetic patients with incipient nephropathy.	Endocrine journal	2014	25
24393785	Cyclic AMP	Pernicova I	Metformin--mode of action and clinical implications for diabetes and cancer.	Nature reviews. Endocrinology	2014	151
24606903	Cyclic AMP	Lee S	Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes.	Cell metabolism	2014	29
24703698	Cyclic AMP	Song WJ	Glucagon regulates hepatic kisspeptin to impair insulin secretion.	Cell metabolism	2014	35
24885604	Cyclic AMP	Edlund A	CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells.	BMC medicine	2014	21
24995979	Cyclic AMP	Kong X	IRF4 is a key thermogenic transcriptional partner of PGC-1α.	Cell	2014	48
25150496	Cyclic AMP	He X	The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma.	Nature medicine	2014	32
25565142	Cyclic AMP	Modali SD	Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.	Molecular endocrinology	2015	25
26211738	Cyclic AMP	Xu H	The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells.	Scientific reports	2015	59
26644581	Cyclic AMP	Luan B	CREB pathway links PGE2 signaling with macrophage polarization.	Proceedings of the National Academy of Sciences of the United States of America	2015	21
26700562	Cyclic AMP	Wootten D	A Hydrogen-Bonded Polar Network in the Core of the Glucagon-Like Peptide-1 Receptor Is a Fulcrum for Biased Agonism: Lessons from Class B Crystal Structures.	Molecular pharmacology	2016	12
26706021	Cyclic AMP	Diaz-Gerevini GT	Beneficial action of resveratrol: How and why?	Nutrition	2016	22
27185156	Cyclic AMP	Tuomi T	Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes.	Cell metabolism	2016	20
27692610	Cyclic AMP	Guo C	Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.	Immunity	2016	17
28462931	Cyclic AMP	Hasel P	Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism.	Nature communications	2017	9
14988435	Oxidized glutathione	Wu G	Glutathione metabolism and its implications for health.	The Journal of nutrition	2004	361
18781224	Oxidized glutathione	Jacobs KM	SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression.	International journal of biological sciences	2008	74
22186191	Oxidized glutathione	Calabrese V	Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes.	Biochimica et biophysica acta	2012	36
22530666	Oxidized glutathione	Allen EM	Protein-thiol oxidation and cell death: regulatory role of glutaredoxins.	Antioxidants & redox signaling	2012	39
26950115	Oxidized glutathione	Zeeshan HM	Endoplasmic Reticulum Stress and Associated ROS.	International journal of molecular sciences	2016	26
11744348	Serotonin	Das UN	Is obesity an inflammatory condition?	Nutrition	2001	128
15927394	Serotonin	Goldstein DJ	Duloxetine vs. placebo in patients with painful diabetic neuropathy.	Pain	2005	104
16266355	Serotonin	Raskin J	A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.	Pain medicine	2005	76
17060567	Serotonin	Wernicke JF	A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.	Neurology	2006	73
20189712	Serotonin	Hatzimouratidis K	Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.	European urology	2010	118
20633104	Serotonin	Oxenkrug GF	Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism.	Annals of the New York Academy of Sciences	2010	44
23165769	Serotonin	Rosario FJ	Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells.	The Journal of physiology	2013	39
25002497	Serotonin	Davies SK	Effect of sleep deprivation on the human metabolome.	Proceedings of the National Academy of Sciences of the United States of America	2014	56
25392241	Serotonin	Riley KG	Connective tissue growth factor modulates adult β-cell maturity and proliferation to promote β-cell regeneration in mice.	Diabetes	2015	19
25433637	Serotonin	Su P	A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.	Neuron	2014	23
25563903	Serotonin	Han TK	Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.	The Journal of pharmacology and experimental therapeutics	2015	18
27349436	Serotonin	Morris G	The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease.	Molecular neurobiology	2017	8
27390338	Serotonin	Vanhoutte PM	Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator.	Circulation research	2016	29
10409121	Adenosine monophosphate	Winder WW	AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.	The American journal of physiology	1999	165
10818001	Adenosine monophosphate	Milan D	A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle.	Science	2000	104
11797013	Adenosine monophosphate	Minokoshi Y	Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.	Nature	2002	369
12747837	Adenosine monophosphate	Polekhina G	AMPK beta subunit targets metabolic stress sensing to glycogen.	Current biology 	2003	95
12847291	Adenosine monophosphate	Hong SP	Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases.	Proceedings of the National Academy of Sciences of the United States of America	2003	180
12878598	Adenosine monophosphate	Waki H	Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.	The Journal of biological chemistry	2003	180
12960011	Adenosine monophosphate	Unger RH	Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome.	Endocrinology	2003	141
14614828	Adenosine monophosphate	Woods A	LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.	Current biology 	2003	431
14729328	Adenosine monophosphate	Carling D	The AMP-activated protein kinase cascade--a unifying system for energy control.	Trends in biochemical sciences	2004	232
14749280	Adenosine monophosphate	Havel PJ	Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism.	Diabetes	2004	107
14749508	Adenosine monophosphate	Bjørbaek C	Leptin signaling in the central nervous system and the periphery.	Recent progress in hormone research	2004	97
15358229	Adenosine monophosphate	Xiang X	AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.	Biochemical and biophysical research communications	2004	75
15681023	Adenosine monophosphate	Luo Z	AMPK, the metabolic syndrome and cancer.	Trends in pharmacological sciences	2005	114
15734849	Adenosine monophosphate	Del Guerra S	Functional and molecular defects of pancreatic islets in human type 2 diabetes.	Diabetes	2005	99
16054041	Adenosine monophosphate	Kahn BB	AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.	Cell metabolism	2005	696
16380484	Adenosine monophosphate	Kukidome D	Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.	Diabetes	2006	140
16407220	Adenosine monophosphate	Xie Z	Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells.	The Journal of biological chemistry	2006	64
16443786	Adenosine monophosphate	Davis BJ	Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase.	Diabetes	2006	114
16634986	Adenosine monophosphate	Whitehead JP	Adiponectin--a key adipokine in the metabolic syndrome.	Diabetes, obesity & metabolism	2006	100
16709629	Adenosine monophosphate	Xue B	AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.	The Journal of physiology	2006	78
16823475	Adenosine monophosphate	Long YC	AMP-activated protein kinase signaling in metabolic regulation.	The Journal of clinical investigation	2006	179
16873691	Adenosine monophosphate	Bandyopadhyay GK	Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.	Diabetes	2006	75
16936205	Adenosine monophosphate	Yoon MJ	Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.	Diabetes	2006	99
17003332	Adenosine monophosphate	Carey AL	Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.	Diabetes	2006	143
17021375	Adenosine monophosphate	Ahima RS	Adipose tissue as an endocrine organ.	Obesity	2006	127
17130640	Adenosine monophosphate	Nolan CJ	Fatty acid signaling in the beta-cell and insulin secretion.	Diabetes	2006	96
17192291	Adenosine monophosphate	Körner A	Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies.	The Journal of clinical endocrinology and metabolism	2007	60
17287464	Adenosine monophosphate	Cheng KK	Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells.	Diabetes	2007	78
17327455	Adenosine monophosphate	Sriwijitkamol A	Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study.	Diabetes	2007	85
17476361	Adenosine monophosphate	Shu Y	Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.	The Journal of clinical investigation	2007	182
17560826	Adenosine monophosphate	Burns KA	Modulation of PPAR activity via phosphorylation.	Biochimica et biophysica acta	2007	112
17638885	Adenosine monophosphate	Buzzai M	Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.	Cancer research	2007	307
17855357	Adenosine monophosphate	Göransson O	Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase.	The Journal of biological chemistry	2007	124
18006825	Adenosine monophosphate	Dowling RJ	Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.	Cancer research	2007	269
18022388	Adenosine monophosphate	Hardie DG	Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease.	FEBS letters	2008	64
18054335	Adenosine monophosphate	Kadowaki T	The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.	FEBS letters	2008	63
18171435	Adenosine monophosphate	Hawley JA	Exercise training-induced improvements in insulin action.	Acta physiologica	2008	73
18184930	Adenosine monophosphate	McGee SL	AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5.	Diabetes	2008	96
18202144	Adenosine monophosphate	Ahima RS	Adipokines and the peripheral and neural control of energy balance.	Molecular endocrinology	2008	56
18250273	Adenosine monophosphate	Xie Z	Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.	Circulation	2008	87
18256928	Adenosine monophosphate	Phoenix KN	Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	Breast cancer research and treatment	2009	47
18387000	Adenosine monophosphate	Huang X	Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.	The Biochemical journal	2008	133
18390897	Adenosine monophosphate	Bertrand L	Insulin signalling in the heart.	Cardiovascular research	2008	51
18482975	Adenosine monophosphate	Hou X	SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.	The Journal of biological chemistry	2008	218
18687677	Adenosine monophosphate	Lan F	SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation.	The Journal of biological chemistry	2008	202
18810325	Adenosine monophosphate	Witczak CA	AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism.	Cellular and molecular life sciences 	2008	70
19029992	Adenosine monophosphate	Goldstein BJ	Protective vascular and myocardial effects of adiponectin.	Nature clinical practice. Cardiovascular medicine	2009	75
19136996	Adenosine monophosphate	Villanueva EC	Leptin receptor signaling and the regulation of mammalian physiology.	International journal of obesity	2008	55
19273282	Adenosine monophosphate	Viollet B	Targeting the AMPK pathway for the treatment of Type 2 diabetes.	Frontiers in bioscience	2009	52
19276888	Adenosine monophosphate	Cantó C	PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.	Current opinion in lipidology	2009	261
19276890	Adenosine monophosphate	Gong J	CIDE proteins and metabolic disorders.	Current opinion in lipidology	2009	60
19387610	Adenosine monophosphate	Matthews VB	Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase.	Diabetologia	2009	72
19416711	Adenosine monophosphate	Zhang BB	AMPK: an emerging drug target for diabetes and the metabolic syndrome.	Cell metabolism	2009	206
19442239	Adenosine monophosphate	Colombo SL	AMPKalpha1 regulates the antioxidant status of vascular endothelial cells.	The Biochemical journal	2009	61
19468337	Adenosine monophosphate	Dzeja P	Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.	International journal of molecular sciences	2009	59
19592618	Adenosine monophosphate	Li XN	Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.	Diabetes	2009	53
19679549	Adenosine monophosphate	Kisfalvi K	Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.	Cancer research	2009	109
20080987	Adenosine monophosphate	Lu H	MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.	Cardiovascular research	2010	68
20167927	Adenosine monophosphate	Wang S	AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.	Circulation research	2010	109
20181668	Adenosine monophosphate	Hallows KR	Role of the energy sensor AMP-activated protein kinase in renal physiology and disease.	American journal of physiology. Renal physiology	2010	43
20299473	Adenosine monophosphate	An D	TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle.	Diabetes	2010	44
20371735	Adenosine monophosphate	Lira VA	PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.	American journal of physiology. Endocrinology and metabolism	2010	67
20388847	Adenosine monophosphate	Rozengurt E	Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.	Clinical cancer research 	2010	80
20442309	Adenosine monophosphate	Ben Sahra I	Metformin in cancer therapy: a new perspective for an old antidiabetic drug?	Molecular cancer therapeutics	2010	145
20444885	Adenosine monophosphate	Kim AY	Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation.	Molecular endocrinology	2010	52
20534540	Adenosine monophosphate	Mankouri J	Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
20656475	Adenosine monophosphate	Jalving M	Metformin: taking away the candy for cancer?	European journal of cancer	2010	99
20682687	Adenosine monophosphate	Jablonski KA	Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program.	Diabetes	2010	70
20810672	Adenosine monophosphate	Memmott RM	Metformin prevents tobacco carcinogen--induced lung tumorigenesis.	Cancer prevention research	2010	142
21035759	Adenosine monophosphate	Misu H	A liver-derived secretory protein, selenoprotein P, causes insulin resistance.	Cell metabolism	2010	69
21130749	Adenosine monophosphate	Gauthier MS	Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans.	Biochemical and biophysical research communications	2011	48
21186369	Adenosine monophosphate	Holland WL	Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.	Nature medicine	2011	232
21282364	Adenosine monophosphate	Xiao F	Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways.	Diabetes	2011	67
21295072	Adenosine monophosphate	Cani PD	The gut microbiome as therapeutic target.	Pharmacology & therapeutics	2011	56
21309058	Adenosine monophosphate	Mashili FL	Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity.	Diabetes/metabolism research and reviews	2011	40
21540236	Adenosine monophosphate	Ben Sahra I	Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.	Cancer research	2011	162
21840335	Adenosine monophosphate	Speakman JR	Caloric restriction.	Molecular aspects of medicine	2011	152
22017684	Adenosine monophosphate	Inoki K	AMPK and mTOR in cellular energy homeostasis and drug targets.	Annual review of pharmacology and toxicology	2012	149
22271188	Adenosine monophosphate	Drew BG	The emerging role of HDL in glucose metabolism.	Nature reviews. Endocrinology	2012	35
22315316	Adenosine monophosphate	Martínez de Morentin PB	Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase.	Diabetes	2012	40
22323564	Adenosine monophosphate	Xu XJ	Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue.	Journal of lipid research	2012	45
22750049	Adenosine monophosphate	O'Neill HM	AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity.	Molecular and cellular endocrinology	2013	45
22773548	Adenosine monophosphate	Chen HP	Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.	Gut	2013	68
23028138	Adenosine monophosphate	Nitert MD	Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes.	Diabetes	2012	69
23104101	Adenosine monophosphate	Morris BJ	Seven sirtuins for seven deadly diseases of aging.	Free radical biology & medicine	2013	72
23274900	Adenosine monophosphate	Sylow L	Rac1 is a novel regulator of contraction-stimulated glucose uptake in skeletal muscle.	Diabetes	2013	25
23460021	Adenosine monophosphate	Salvadó L	Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.	Diabetologia	2013	28
23562077	Adenosine monophosphate	Mansuy-Aubert V	Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure.	Cell metabolism	2013	39
23663483	Adenosine monophosphate	Karnevi E	Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.	BMC cancer	2013	31
23801715	Adenosine monophosphate	Hardie DG	AMPK: a target for drugs and natural products with effects on both diabetes and cancer.	Diabetes	2013	77
23863634	Adenosine monophosphate	Ruderman NB	AMPK, insulin resistance, and the metabolic syndrome.	The Journal of clinical investigation	2013	141
23932046	Adenosine monophosphate	Palomer X	An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.	International journal of cardiology	2013	35
24026768	Adenosine monophosphate	Matsuda M	Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	20
24055102	Adenosine monophosphate	Lee JH	Sestrins orchestrate cellular metabolism to attenuate aging.	Cell metabolism	2013	61
24419232	Adenosine monophosphate	Dallaglio K	Paradoxic effects of metformin on endothelial cells and angiogenesis.	Carcinogenesis	2014	26
24583766	Adenosine monophosphate	Hardie DG	AMPK: regulating energy balance at the cellular and whole body levels.	Physiology	2014	43
24857548	Adenosine monophosphate	Zhou G	Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.	Molecular cell	2014	50
24957699	Adenosine monophosphate	Fisman EZ	Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?	Cardiovascular diabetology	2014	38
24988476	Adenosine monophosphate	Napolitano A	Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.	PloS one	2014	33
25018645	Adenosine monophosphate	Coughlan KA	AMPK activation: a therapeutic target for type 2 diabetes?	Diabetes, metabolic syndrome and obesity 	2014	43
25345753	Adenosine monophosphate	Esser N	Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.	Expert opinion on investigational drugs	2015	29
25647160	Adenosine monophosphate	Ido Y	Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes.	PloS one	2015	25
25742316	Adenosine monophosphate	Ford RJ	Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity.	The Biochemical journal	2015	19
25794703	Adenosine monophosphate	Scheen AJ	Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control.	Diabetes & metabolism	2015	17
25849721	Adenosine monophosphate	Dowling RJ	Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.	Breast cancer research 	2015	17
25862373	Adenosine monophosphate	Kato H	Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.	Biochemical and biophysical research communications	2015	17
25940306	Adenosine monophosphate	O'Brien AJ	Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.	The Biochemical journal	2015	17
26147760	Adenosine monophosphate	Hanssen MJ	Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus.	Nature medicine	2015	48
26160707	Adenosine monophosphate	Qi D	AMPK: energy sensor and survival mechanism in the ischemic heart.	Trends in endocrinology and metabolism	2015	24
26360050	Adenosine monophosphate	Lee SY	Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance.	PloS one	2015	22
26625127	Adenosine monophosphate	Griss T	Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.	PLoS biology	2015	32
26643070	Adenosine monophosphate	Osman I	Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.	Biochemical pharmacology	2016	13
26711141	Adenosine monophosphate	Dasgupta B	Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.	Trends in pharmacological sciences	2016	20
26742071	Adenosine monophosphate	Kim Y	Polyphenols and Glycemic Control.	Nutrients	2016	19
26772531	Adenosine monophosphate	Daskalopoulos EP	AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.	Journal of molecular and cellular cardiology	2016	10
26813102	Adenosine monophosphate	Lai YC	SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.	Circulation	2016	23
26931135	Adenosine monophosphate	Cleasby ME	Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.	The Journal of endocrinology	2016	15
27199291	Adenosine monophosphate	López M	Hypothalamic AMPK: a canonical regulator of whole-body energy balance.	Nature reviews. Endocrinology	2016	15
27362768	Adenosine monophosphate	Sośnicki S	Molecular targets of metformin antitumor action.	Pharmacological reports 	2016	12
27378194	Adenosine monophosphate	Gadducci A	Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.	Critical reviews in oncology/hematology	2016	11
27416781	Adenosine monophosphate	Jeon SM	Regulation and function of AMPK in physiology and diseases.	Experimental & molecular medicine	2016	30
27418629	Adenosine monophosphate	Cameron AR	Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.	Circulation research	2016	20
27577854	Adenosine monophosphate	Smith BK	Treatment of nonalcoholic fatty liver disease: role of AMPK.	American journal of physiology. Endocrinology and metabolism	2016	15
28089566	Adenosine monophosphate	Howell JJ	Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.	Cell metabolism	2017	14
28467931	Adenosine monophosphate	Cokorinos EC	Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.	Cell metabolism	2017	9
15879305	NAD	Münzel T	Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase.	Arteriosclerosis, thrombosis, and vascular biology	2005	72
17694090	NAD	Vaquero A	NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.	Oncogene	2007	93
19107194	NAD	Sasaki T	Phosphorylation regulates SIRT1 function.	PloS one	2008	103
20226541	NAD	Imai S	Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases.	Trends in pharmacological sciences	2010	137
20409078	NAD	Donmez G	Aging and disease: connections to sirtuins.	Aging cell	2010	119
21288303	NAD	Ramachandran D	Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic β-islets.	The FEBS journal	2011	35
21709297	NAD	Uribarri J	Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.	Diabetes care	2011	58
22479251	NAD	Yamakuchi M	MicroRNA Regulation of SIRT1.	Frontiers in physiology	2012	42
22575091	NAD	Chapple SJ	Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging.	The international journal of biochemistry & cell biology	2012	45
22863012	NAD	Qiang L	Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ.	Cell	2012	148
23075334	NAD	Kitada M	Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.	Clinical science	2013	40
23374890	NAD	Wickman C	Obesity and kidney disease: potential mechanisms.	Seminars in nephrology	2013	36
23417962	NAD	Donmez G	SIRT1 and SIRT2: emerging targets in neurodegeneration.	EMBO molecular medicine	2013	58
24184811	NAD	Li Y	Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.	Gastroenterology	2014	44
24439680	NAD	Hubbard BP	Small molecule SIRT1 activators for the treatment of aging and age-related diseases.	Trends in pharmacological sciences	2014	89
27821631	NAD	Ma L	APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction.	Journal of the American Society of Nephrology 	2017	10
28380384	NAD	Krishnaiah SY	Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism.	Cell metabolism	2017	9
19302590	Prostaglandin I2	Grgic I	Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.	British journal of pharmacology	2009	55
21838680	Prostaglandin I2	Folli F	The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.	Current diabetes reviews	2011	44
17244779	Cervonoyl ethanolamide	Golden SH	Endogenous sex hormones and glucose tolerance status in postmenopausal women.	The Journal of clinical endocrinology and metabolism	2007	58
12136128	Uridine 5'-diphosphate	McClain DA	Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.	Proceedings of the National Academy of Sciences of the United States of America	2002	86
16317114	Uridine 5'-diphosphate	Love DC	The hexosamine signaling pathway: deciphering the "O-GlcNAc code".	Science's STKE 	2005	176
17906960	Uridine 5'-diphosphate	Marchetti P	The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients.	Diabetologia	2007	110
19647043	Uridine 5'-diphosphate	Hanover JA	The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine.	Biochimica et biophysica acta	2010	110
24287310	Uridine 5'-diphosphate	Dassanayaka S	O-GlcNAc and the cardiovascular system.	Pharmacology & therapeutics	2014	24
24630721	Uridine 5'-diphosphate	Wang ZV	Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway.	Cell	2014	55
24759912	Uridine 5'-diphosphate	Yuzwa SA	O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.	Chemical Society reviews	2014	25
28178330	4,4'-Methylenedianiline	Rasool M	Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distress.	PloS one	2017	5
9531176	Calcium	Block GA	Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.	American journal of kidney diseases 	1998	283
10814708	Calcium	Luthi-Carter R	Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.	Human molecular genetics	2000	137
11726533	Calcium	Deluca HF	Vitamin D: its role and uses in immunology.	FASEB journal 	2001	138
12093242	Calcium	Kirpichnikov D	Metformin: an update.	Annals of internal medicine	2002	188
12205025	Calcium	Febbraio MA	Muscle-derived interleukin-6: mechanisms for activation and possible biological roles.	FASEB journal 	2002	126
12520530	Calcium	Holick MF	Vitamin D: A millenium perspective.	Journal of cellular biochemistry	2003	207
14976002	Calcium	Ceriello A	Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.	Arteriosclerosis, thrombosis, and vascular biology	2004	198
15031312	Calcium	Tilvis RS	Predictors of cognitive decline and mortality of aged people over a 10-year period.	The journals of gerontology. Series A, Biological sciences and medical sciences	2004	100
15102615	Calcium	Vattikuti R	Osteogenic regulation of vascular calcification: an early perspective.	American journal of physiology. Endocrinology and metabolism	2004	76
15294881	Calcium	Fang ZY	Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.	Endocrine reviews	2004	175
15561405	Calcium	Simard M	The neurobiology of glia in the context of water and ion homeostasis.	Neuroscience	2004	120
15798098	Calcium	Nagpal S	Noncalcemic actions of vitamin D receptor ligands.	Endocrine reviews	2005	154
16306347	Calcium	Cnop M	Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.	Diabetes	2005	320
16601233	Calcium	Shao JS	Molecular mechanisms of vascular calcification: lessons learned from the aorta.	Arteriosclerosis, thrombosis, and vascular biology	2006	83
16618821	Calcium	Wallace TW	Prevalence and determinants of troponin T elevation in the general population.	Circulation	2006	68
17091124	Calcium	Levin A	Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.	Kidney international	2007	262
17095733	Calcium	Johnson RC	Vascular calcification: pathobiological mechanisms and clinical implications.	Circulation research	2006	152
17127183	Calcium	Shaffer EA	Gallstone disease: Epidemiology of gallbladder stone disease.	Best practice & research. Clinical gastroenterology	2006	94
17205962	Calcium	Craver L	Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.	Nephrology, dialysis, transplantation 	2007	55
17240286	Calcium	Elliott WJ	Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.	Lancet	2007	152
17277040	Calcium	Pittas AG	The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.	Diabetes care	2007	149
17557889	Calcium	Arnson Y	Vitamin D and autoimmunity: new aetiological and therapeutic considerations.	Annals of the rheumatic diseases	2007	99
17804441	Calcium	Scirica BM	Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.	Circulation	2007	91
17984482	Calcium	Kunz R	Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.	Annals of internal medicine	2008	98
18048764	Calcium	Eizirik DL	The role for endoplasmic reticulum stress in diabetes mellitus.	Endocrine reviews	2008	306
18202126	Calcium	Schraw T	Plasma adiponectin complexes have distinct biochemical characteristics.	Endocrinology	2008	55
18269634	Calcium	Palomer X	Role of vitamin D in the pathogenesis of type 2 diabetes mellitus.	Diabetes, obesity & metabolism	2008	74
18332897	Calcium	Yan SF	Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.	Nature clinical practice. Endocrinology & metabolism	2008	92
18390794	Calcium	Braun M	Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion.	Diabetes	2008	104
18393659	Calcium	Kellett GL	Sugar absorption in the intestine: the role of GLUT2.	Annual review of nutrition	2008	76
18426812	Calcium	Reis JP	Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults.	European journal of endocrinology	2008	53
18559892	Calcium	Cunha DA	Initiation and execution of lipotoxic ER stress in pancreatic beta-cells.	Journal of cell science	2008	157
18579197	Calcium	Buell JS	Vitamin D and neurocognitive dysfunction: preventing "D"ecline?	Molecular aspects of medicine	2008	59
18591391	Calcium	Forouhi NG	Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000.	Diabetes	2008	140
18694980	Calcium	Bouillon R	Vitamin D and human health: lessons from vitamin D receptor null mice.	Endocrine reviews	2008	262
18777097	Calcium	Chang-Chen KJ	Beta-cell failure as a complication of diabetes.	Reviews in endocrine & metabolic disorders	2008	50
18801384	Calcium	Holick MF	The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.	Molecular aspects of medicine	2008	61
18952609	Calcium	Zhang L	Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.	The Journal of biological chemistry	2008	63
19451355	Calcium	Hagström E	Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.	Circulation	2009	86
19520338	Calcium	Blaha M	Absence of coronary artery calcification and all-cause mortality.	JACC. Cardiovascular imaging	2009	72
19563700	Calcium	Kumar P	Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.	Expert reviews in molecular medicine	2009	97
19877084	Calcium	Rho YH	Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.	Arthritis and rheumatism	2009	49
20176609	Calcium	Nasrallah MM	Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.	Nephrology, dialysis, transplantation 	2010	46
20346437	Calcium	Zhong H	Integrating pathway analysis and genetics of gene expression for genome-wide association studies.	American journal of human genetics	2010	127
20466670	Calcium	Floege J	Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.	Nephrology, dialysis, transplantation 	2011	70
20668910	Calcium	Nunes KP	RhoA/Rho-kinase and vascular diseases: what is the link?	Cellular and molecular life sciences 	2010	41
20736230	Calcium	Ramagopalan SV	A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.	Genome research	2010	222
20795941	Calcium	Holick MF	Vitamin D: evolutionary, physiological and health perspectives.	Current drug targets	2011	67
20863562	Calcium	Shin JS	Vitamin D effects on pregnancy and the placenta.	Placenta	2010	48
21067953	Calcium	Guillot X	Vitamin D and inflammation.	Joint, bone, spine 	2010	78
21193740	Calcium	Boström KI	Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.	Circulation research	2011	57
21323907	Calcium	Félétou M	Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.	British journal of pharmacology	2011	65
21485744	Calcium	Wolkowitz OM	Of sound mind and body: depression, disease, and accelerated aging.	Dialogues in clinical neuroscience	2011	56
21544514	Calcium	Tseng CH	Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.	Diabetologia	2011	38
21640757	Calcium	Jorde R	Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.	Progress in lipid research	2011	57
21676245	Calcium	Cao JJ	Effects of obesity on bone metabolism.	Journal of orthopaedic surgery and research	2011	97
21792295	Calcium	Kones R	Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.	Drug design, development and therapy	2011	42
21872797	Calcium	Haussler MR	Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.	Best practice & research. Clinical endocrinology & metabolism	2011	91
22088239	Calcium	Liu LS	2010 Chinese guidelines for the management of hypertension.	Zhonghua xin xue guan bing za zhi	2011	115
22112350	Calcium	Tousoulis D	The role of nitric oxide on endothelial function.	Current vascular pharmacology	2012	78
22157397	Calcium	Dockray GJ	Cholecystokinin.	Current opinion in endocrinology, diabetes, and obesity	2012	31
22189484	Calcium	Vejakama P	Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.	Diabetologia	2012	32
22217880	Calcium	Asai O	Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion.	Kidney international	2012	33
22315413	Calcium	Kyriazis GA	Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion.	Proceedings of the National Academy of Sciences of the United States of America	2012	52
22364157	Calcium	Rosanoff A	Suboptimal magnesium status in the United States: are the health consequences underestimated?	Nutrition reviews	2012	31
22431676	Calcium	Kavousi M	Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.	Annals of internal medicine	2012	65
22442301	Calcium	Xu G	Preventing β-cell loss and diabetes with calcium channel blockers.	Diabetes	2012	33
22444631	Calcium	Gross O	Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1.	Immunity	2012	131
22473330	Calcium	Thompson B	Arterial calcification and bone physiology: role of the bone-vascular axis.	Nature reviews. Endocrinology	2012	47
22492527	Calcium	Rosengren AH	Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes.	Diabetes	2012	70
22782502	Calcium	Haussler MR	Molecular mechanisms of vitamin D action.	Calcified tissue international	2013	118
22871241	Calcium	Carnicer R	Nitric oxide synthases in heart failure.	Antioxidants & redox signaling	2013	36
22885925	Calcium	Shi Y	Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.	Nature genetics	2012	77
22910756	Calcium	Yeboah J	Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.	JAMA	2012	163
23169676	Calcium	Girgis CM	The roles of vitamin D in skeletal muscle: form, function, and metabolism.	Endocrine reviews	2013	62
23238772	Calcium	Agmon-Levin N	Vitamin D in systemic and organ-specific autoimmune diseases.	Clinical reviews in allergy & immunology	2013	27
23305783	Calcium	Haneklaus M	Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments.	Current opinion in immunology	2013	35
23506867	Calcium	Khananshvili D	The SLC8 gene family of sodium-calcium exchangers (NCX) - structure, function, and regulation in health and disease.	Molecular aspects of medicine	2013	32
23687099	Calcium	Neeland IJ	Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.	Obesity	2013	55
23856263	Calcium	Brown EM	Role of the calcium-sensing receptor in extracellular calcium homeostasis.	Best practice & research. Clinical endocrinology & metabolism	2013	32
23994495	Calcium	Lawlor KE	Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria?	Biochimica et biophysica acta	2014	29
24157497	Calcium	Wu HY	Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.	BMJ	2013	32
24180474	Calcium	Konior A	NADPH oxidases in vascular pathology.	Antioxidants & redox signaling	2014	52
24284821	Calcium	Andrukhova O	Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.	Molecular endocrinology	2014	31
24621794	Calcium	Braunwald E	Heart failure.	JACC. Heart failure	2013	96
24641882	Calcium	Brault M	Statin treatment and new-onset diabetes: a review of proposed mechanisms.	Metabolism	2014	28
24928681	Calcium	Montaigne D	Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients.	Circulation	2014	33
24997452	Calcium	Varga ZV	Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.	Biochimica et biophysica acta	2015	38
25239387	Calcium	Gilon P	Calcium signaling in pancreatic β-cells in health and in Type 2 diabetes.	Cell calcium	2014	23
25308530	Calcium	D'Aurizio F	Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases?	Autoimmunity reviews	2015	18
25422446	Calcium	Lu S	A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2014	23
25448035	Calcium	Tamir S	Structure-function analysis of NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health and disease.	Biochimica et biophysica acta	2015	23
25682935	Calcium	Saccone D	Regulation of the vitamin D receptor gene by environment, genetics and epigenetics.	Gene	2015	23
25834230	Calcium	Carlström M	Renal autoregulation in health and disease.	Physiological reviews	2015	44
25844899	Calcium	Santulli G	Calcium release channel RyR2 regulates insulin release and glucose homeostasis.	The Journal of clinical investigation	2015	52
25913633	Calcium	Meier C	Effects of diabetes drugs on the skeleton.	Bone	2016	17
25916871	Calcium	Schlieper G	Vascular calcification in chronic kidney disease: an update.	Nephrology, dialysis, transplantation 	2016	11
25999530	Calcium	Stewart AF	Human β-cell proliferation and intracellular signaling: part 3.	Diabetes	2015	26
26153245	Calcium	Ding J	Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease.	Diabetes	2015	19
26178670	Calcium	Fetahu IS	miR-135b- and miR-146b-dependent silencing of calcium-sensing receptor expression in colorectal tumors.	International journal of cancer	2016	11
26262795	Calcium	Basaria S	Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.	JAMA	2015	19
26620248	Calcium	Weber MA	Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study.	The lancet. Diabetes & endocrinology	2016	17
26678809	Calcium	Jia G	Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.	Nature reviews. Endocrinology	2016	42
27062145	Calcium	Ou HT	Recent trends in the use of antidiabetic medications from 2008 to 2013: A nation-wide population-based study from Taiwan.	Journal of diabetes	2017	5
27662816	Calcium	Wimalawansa SJ	Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome.	The Journal of steroid biochemistry and molecular biology	2018	5
27864307	Calcium	Dahan T	Pancreatic β-Cells Express the Fetal Islet Hormone Gastrin in Rodent and Human Diabetes.	Diabetes	2017	5
28209843	Calcium	Lees JA	Lipid transport by TMEM24 at ER-plasma membrane contacts regulates pulsatile insulin secretion.	Science	2017	9
28409320	Calcium	Garbossa SG	Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.	Reviews in endocrine & metabolic disorders	2017	6
28504650	Calcium	Kraakman MJ	Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.	The Journal of clinical investigation	2017	10
10385608	Glutathione	Lu SC	Regulation of hepatic glutathione synthesis: current concepts and controversies.	FASEB journal 	1999	121
12379575	Glutathione	Esposito K	Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.	Circulation	2002	278
12606496	Glutathione	Robertson RP	Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection.	Diabetes	2003	133
12808161	Glutathione	Locatelli F	Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.	Nephrology, dialysis, transplantation 	2003	93
12881453	Glutathione	Lee DH	Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.	Clinical chemistry	2003	77
14641060	Glutathione	Thornalley PJ	Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation.	Biochemical Society transactions	2003	117
16127462	Glutathione	Vikramadithyan RK	Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.	The Journal of clinical investigation	2005	68
16678271	Glutathione	Kühn H	Inflammation and immune regulation by 12/15-lipoxygenases.	Progress in lipid research	2006	122
16765337	Glutathione	Paravicini TM	Redox signaling in hypertension.	Cardiovascular research	2006	120
18158646	Glutathione	Franco R	The central role of glutathione in the pathophysiology of human diseases.	Archives of physiology and biochemistry	2007	86
18567819	Glutathione	Boden G	Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals.	Diabetes	2008	119
18601945	Glutathione	Lu SC	Regulation of glutathione synthesis.	Molecular aspects of medicine	2009	216
18633117	Glutathione	Xue M	Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease.	Diabetes	2008	58
19433800	Glutathione	Ristow M	Antioxidants prevent health-promoting effects of physical exercise in humans.	Proceedings of the National Academy of Sciences of the United States of America	2009	320
19664690	Glutathione	Shay KP	Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.	Biochimica et biophysica acta	2009	95
19749157	Glutathione	Ungvari Z	Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells.	American journal of physiology. Heart and circulatory physiology	2009	95
20524845	Glutathione	Cheng X	Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway.	Antioxidants & redox signaling	2011	43
20876676	Glutathione	Yu M	Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress.	Clinical journal of the American Society of Nephrology 	2011	47
20939847	Glutathione	Chandrasekharan B	Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress.	Neurogastroenterology and motility 	2011	38
21029308	Glutathione	Jones DP	Redox compartmentalization and cellular stress.	Diabetes, obesity & metabolism	2010	59
21087145	Glutathione	Lubos E	Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities.	Antioxidants & redox signaling	2011	86
21129940	Glutathione	Guerrero-Beltrán CE	Protective effect of sulforaphane against oxidative stress: recent advances.	Experimental and toxicologic pathology 	2012	49
21554949	Glutathione	Flora SJ	Arsenic-induced oxidative stress and its reversibility.	Free radical biology & medicine	2011	88
22001757	Glutathione	Chambers JC	Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.	Nature genetics	2011	141
22228760	Glutathione	Vladykovskaya E	Lipid peroxidation product 4-hydroxy-trans-2-nonenal causes endothelial activation by inducing endoplasmic reticulum stress.	The Journal of biological chemistry	2012	33
22375253	Glutathione	Matough FA	The role of oxidative stress and antioxidants in diabetic complications.	Sultan Qaboos University medical journal	2012	36
22525041	Glutathione	Crawford A	Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease.	Gene	2012	31
22995213	Glutathione	Lu SC	Glutathione synthesis.	Biochimica et biophysica acta	2013	154
23633659	Glutathione	Zhong Q	Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy.	Investigative ophthalmology & visual science	2013	27
23863625	Glutathione	Guo S	Inactivation of specific β cell transcription factors in type 2 diabetes.	The Journal of clinical investigation	2013	114
24102912	Glutathione	Mitranun W	Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients.	Scandinavian journal of medicine & science in sports	2014	30
24186494	Glutathione	Xu Z	NRF2 plays a protective role in diabetic retinopathy in mice.	Diabetologia	2014	31
25244505	Glutathione	Li H	Vascular oxidative stress, nitric oxide and atherosclerosis.	Atherosclerosis	2014	76
25364233	Glutathione	Wang YY	Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.	Drug design, development and therapy	2014	24
27245224	Glutathione	Peiró C	Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway.	Cardiovascular diabetology	2016	11
1778354	Oxygen	Eriksson KF	Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study.	Diabetologia	1991	138
8144582	Oxygen	Yan SD	Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.	The Journal of biological chemistry	1994	170
8790408	Oxygen	Lebovitz RM	Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1996	226
9054939	Oxygen	Fleury C	Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia.	Nature genetics	1997	199
10688666	Oxygen	Liu H	Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin.	Molecular and cellular biology	2000	121
10946914	Oxygen	Mohanty P	Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes.	The Journal of clinical endocrinology and metabolism	2000	92
11287350	Oxygen	Wautier MP	Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.	American journal of physiology. Endocrinology and metabolism	2001	161
11424232	Oxygen	Rösen P	The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society.	Diabetes/metabolism research and reviews	2001	115
11874812	Oxygen	Ip MS	Obstructive sleep apnea is independently associated with insulin resistance.	American journal of respiratory and critical care medicine	2002	207
11874813	Oxygen	Punjabi NM	Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.	American journal of respiratory and critical care medicine	2002	166
12829641	Oxygen	Basu R	Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance.	Diabetes	2003	87
12855411	Oxygen	Lassègue B	Vascular NAD(P)H oxidases: specific features, expression, and regulation.	American journal of physiology. Regulatory, integrative and comparative physiology	2003	201
12874436	Oxygen	Inoguchi T	Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase.	Journal of the American Society of Nephrology 	2003	80
12874439	Oxygen	Lee HB	Reactive oxygen species-regulated signaling pathways in diabetic nephropathy.	Journal of the American Society of Nephrology 	2003	89
12882902	Oxygen	Short KR	Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity.	Diabetes	2003	136
14578299	Oxygen	Quagliaro L	Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.	Diabetes	2003	134
14604834	Oxygen	Delafontaine P	Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.	Arteriosclerosis, thrombosis, and vascular biology	2004	100
14633847	Oxygen	Tripathy D	Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects.	Diabetes	2003	124
14656731	Oxygen	Alp NJ	Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.	Arteriosclerosis, thrombosis, and vascular biology	2004	115
14990351	Oxygen	Gladwin MT	The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation.	Free radical biology & medicine	2004	76
15128745	Oxygen	Schulze PC	Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.	The Journal of biological chemistry	2004	95
15173060	Oxygen	Landmesser U	Endothelial function: a critical determinant in atherosclerosis?	Circulation	2004	119
15353412	Oxygen	Punjabi NM	Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study.	American journal of epidemiology	2004	217
15475499	Oxygen	Li JM	Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology.	American journal of physiology. Regulatory, integrative and comparative physiology	2004	172
15555528	Oxygen	SanGiovanni JP	The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina.	Progress in retinal and eye research	2005	126
15677487	Oxygen	Goldstein BJ	Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets.	Diabetes	2005	81
15738989	Oxygen	Krauss S	The mitochondrial uncoupling-protein homologues.	Nature reviews. Molecular cell biology	2005	145
15914121	Oxygen	Valle I	PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells.	Cardiovascular research	2005	123
15998257	Oxygen	Goldstein BJ	Role of insulin-induced reactive oxygen species in the insulin signaling pathway.	Antioxidants & redox signaling	2005	65
15998259	Oxygen	Evans JL	The molecular basis for oxidative stress-induced insulin resistance.	Antioxidants & redox signaling	2005	87
16141358	Oxygen	Hunyady L	Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.	Molecular endocrinology	2006	121
16394109	Oxygen	Galkina E	Leukocyte recruitment and vascular injury in diabetic nephropathy.	Journal of the American Society of Nephrology 	2006	73
16506274	Oxygen	Cersosimo E	Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.	Diabetes/metabolism research and reviews	2006	64
16585403	Oxygen	Förstermann U	Endothelial nitric oxide synthase in vascular disease: from marvel to menace.	Circulation	2006	344
16704347	Oxygen	King JC	Maternal obesity, metabolism, and pregnancy outcomes.	Annual review of nutrition	2006	67
16771662	Oxygen	Cave AC	NADPH oxidases in cardiovascular health and disease.	Antioxidants & redox signaling	2006	164
16894049	Oxygen	Goldin A	Advanced glycation end products: sparking the development of diabetic vascular injury.	Circulation	2006	336
17115886	Oxygen	Lillig CH	Thioredoxin and related molecules--from biology to health and disease.	Antioxidants & redox signaling	2007	174
17174230	Oxygen	Sokos GG	Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.	Journal of cardiac failure	2006	133
17311546	Oxygen	Maiese K	Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus.	Current neurovascular research	2007	62
17494630	Oxygen	Schoner W	Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.	American journal of physiology. Cell physiology	2007	123
17555404	Oxygen	Schmidt TS	Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.	Clinical science	2007	58
17557769	Oxygen	West SD	Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes.	Thorax	2007	87
17584843	Oxygen	Newsholme P	Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity.	The Journal of physiology	2007	114
17586614	Oxygen	Cooper SA	Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.	American journal of physiology. Heart and circulatory physiology	2007	67
18048767	Oxygen	Fan Y	Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells.	Arteriosclerosis, thrombosis, and vascular biology	2008	51
18094066	Oxygen	Wei Y	Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.	American journal of physiology. Regulatory, integrative and comparative physiology	2008	52
18227481	Oxygen	Paravicini TM	NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.	Diabetes care	2008	159
18323464	Oxygen	Solomon TP	Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults.	Journal of applied physiology	2008	52
18382884	Oxygen	Münzel T	Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.	Annals of medicine	2008	78
18420487	Oxygen	Busik JV	Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators.	Diabetes	2008	80
18420577	Oxygen	Housley MP	O-GlcNAc regulates FoxO activation in response to glucose.	The Journal of biological chemistry	2008	101
18783313	Oxygen	Frey RS	NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.	Antioxidants & redox signaling	2009	128
19074987	Oxygen	Pasarica M	Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response.	Diabetes	2009	172
19118493	Oxygen	Zhang H	Role of TNF-alpha in vascular dysfunction.	Clinical science	2009	108
19135149	Oxygen	S Roriz-Filho J	(Pre)diabetes, brain aging, and cognition.	Biochimica et biophysica acta	2009	68
19149564	Oxygen	Potenza MA	Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.	Current medicinal chemistry	2009	66
19179352	Oxygen	Gao L	Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.	Cardiovascular research	2009	91
19255424	Oxygen	Scheer FA	Adverse metabolic and cardiovascular consequences of circadian misalignment.	Proceedings of the National Academy of Sciences of the United States of America	2009	384
19281826	Oxygen	Roberts CK	Oxidative stress and metabolic syndrome.	Life sciences	2009	114
19455179	Oxygen	Liang F	SIRT1 and insulin resistance.	Nature reviews. Endocrinology	2009	71
19471024	Oxygen	Silverstein RL	CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.	Science signaling	2009	218
19501608	Oxygen	Pi J	ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function.	Toxicology and applied pharmacology	2010	65
19505186	Oxygen	Sarsour EH	Redox control of the cell cycle in health and disease.	Antioxidants & redox signaling	2009	79
19584191	Oxygen	Nadeau KJ	Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.	The Journal of clinical endocrinology and metabolism	2009	51
19706525	Oxygen	Block K	Subcellular localization of Nox4 and regulation in diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2009	144
19755625	Oxygen	Ghanim H	Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance.	Diabetes care	2009	106
19782153	Oxygen	Schrauwen P	Mitochondrial dysfunction and lipotoxicity.	Biochimica et biophysica acta	2010	47
19833897	Oxygen	Yao D	Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands.	Diabetes	2010	99
19889414	Oxygen	Salpea KD	Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation.	Atherosclerosis	2010	75
19893025	Oxygen	Chen Y	Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.	The American journal of pathology	2009	57
19910640	Oxygen	Lassègue B	NADPH oxidases: functions and pathologies in the vasculature.	Arteriosclerosis, thrombosis, and vascular biology	2010	180
19915016	Oxygen	Nadeau KJ	Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.	The Journal of clinical endocrinology and metabolism	2010	82
20051526	Oxygen	Manolagas SC	From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis.	Endocrine reviews	2010	176
20075245	Oxygen	Schroder K	The NLRP3 inflammasome: a sensor for metabolic danger?	Science	2010	238
20103708	Oxygen	Jiang T	The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy.	Diabetes	2010	78
20110125	Oxygen	Myatt L	Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta.	Placenta	2010	65
20150287	Oxygen	Curtis JM	Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction.	Diabetes	2010	69
20299674	Oxygen	Yan SF	The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.	Circulation research	2010	98
20388123	Oxygen	Warner MJ	Mechanisms involved in the developmental programming of adulthood disease.	The Biochemical journal	2010	72
20534755	Oxygen	Ghanim H	An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol.	The Journal of clinical endocrinology and metabolism	2010	47
20718759	Oxygen	Elmarakby AA	Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.	Cardiovascular therapeutics	2012	65
20819950	Oxygen	de Cavanagh EM	Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?	Cardiovascular research	2011	37
20939814	Oxygen	Kashihara N	Oxidative stress in diabetic nephropathy.	Current medicinal chemistry	2010	68
20959532	Oxygen	Dasu MR	Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors.	American journal of physiology. Endocrinology and metabolism	2011	54
20965424	Oxygen	Sengupta S	Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.	Molecular cell	2010	422
21144973	Oxygen	Rajesh M	Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.	Journal of the American College of Cardiology	2010	61
21145849	Oxygen	Begriche K	Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.	Journal of hepatology	2011	48
21167901	Oxygen	Rondeau P	The glycation of albumin: structural and functional impacts.	Biochimie	2011	49
21196259	Oxygen	Chrissobolis S	Oxidative stress and endothelial dysfunction in cerebrovascular disease.	Frontiers in bioscience	2011	41
21335095	Oxygen	Rabbani N	Glyoxalase in diabetes, obesity and related disorders.	Seminars in cell & developmental biology	2011	63
21350183	Oxygen	Chiang DJ	Obesity, diabetes mellitus, and liver fibrosis.	American journal of physiology. Gastrointestinal and liver physiology	2011	42
21497090	Oxygen	Bosch M	Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility.	Current biology 	2011	52
21616142	Oxygen	Batinic-Haberle I	Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.	Free radical biology & medicine	2011	50
21629295	Oxygen	Drummond GR	Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.	Nature reviews. Drug discovery	2011	207
21664213	Oxygen	Aubert J	Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.	Clinics and research in hepatology and gastroenterology	2011	51
21670228	Oxygen	Goossens GH	Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation.	Circulation	2011	61
21747057	Oxygen	Shenouda SM	Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus.	Circulation	2011	105
21878340	Oxygen	Darley-Usmar VM	Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.	Journal of molecular and cellular cardiology	2012	31
21885599	Oxygen	Giarratana MC	Proof of principle for transfusion of in vitro-generated red blood cells.	Blood	2011	80
21916837	Oxygen	Arden GB	Hypoxia and oxidative stress in the causation of diabetic retinopathy.	Current diabetes reviews	2011	38
21962515	Oxygen	Haque A	Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity.	Cell	2011	42
22013105	Oxygen	Chaudhuri A	Exenatide exerts a potent antiinflammatory effect.	The Journal of clinical endocrinology and metabolism	2012	36
22068265	Oxygen	Simonson TS	Genetic determinants of Tibetan high-altitude adaptation.	Human genetics	2012	31
22278288	Oxygen	Menu P	ER stress activates the NLRP3 inflammasome via an UPR-independent pathway.	Cell death & disease	2012	73
22350585	Oxygen	Hulsmans M	Mitochondrial reactive oxygen species and risk of atherosclerosis.	Current atherosclerosis reports	2012	30
22411934	Oxygen	Salminen A	Inflammaging: disturbed interplay between autophagy and inflammasomes.	Aging	2012	79
22443458	Oxygen	Dikalov SI	Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease.	Antioxidants & redox signaling	2013	40
22454632	Oxygen	Ponugoti B	Role of forkhead transcription factors in diabetes-induced oxidative stress.	Experimental diabetes research	2012	51
22502743	Oxygen	Weaver JR	Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction.	Molecular and cellular endocrinology	2012	33
22632748	Oxygen	Vendramini-Costa DB	Molecular link mechanisms between inflammation and cancer.	Current pharmaceutical design	2012	101
22645602	Oxygen	Li B	Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.	Experimental diabetes research	2012	33
22693349	Oxygen	Paneni F	Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes.	Circulation research	2012	38
22701472	Oxygen	Arcidiacono B	Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.	Experimental diabetes research	2012	74
22766318	Oxygen	Supale S	Mitochondrial dysfunction in pancreatic β cells.	Trends in endocrinology and metabolism	2012	48
22843705	Oxygen	Kröller-Schön S	Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.	Cardiovascular research	2012	42
22940046	Oxygen	Leung TM	CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.	Journal of hepatology	2013	65
23085514	Oxygen	Urao N	Redox regulation of stem/progenitor cells and bone marrow niche.	Free radical biology & medicine	2013	44
23152680	Oxygen	Pasquale MK	Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.	International journal of chronic obstructive pulmonary disease	2012	39
23181220	Oxygen	Kongara S	The interplay between autophagy and ROS in tumorigenesis.	Frontiers in oncology	2012	40
23181475	Oxygen	Hansell P	Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension.	Clinical and experimental pharmacology & physiology	2013	28
23276949	Oxygen	Yin Y	Inflammasomes: sensors of metabolic stresses for vascular inflammation.	Frontiers in bioscience	2013	37
23323860	Oxygen	Padgett LE	The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.	Annals of the New York Academy of Sciences	2013	61
23325084	Oxygen	Ruiz S	Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.	Kidney international	2013	78
23341580	Oxygen	Jansen F	High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.	Cardiovascular research	2013	35
23349484	Oxygen	Sukumar P	Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction.	Diabetes	2013	35
23379642	Oxygen	Wilkinson-Berka JL	Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.	Clinical science	2013	32
23436141	Oxygen	Lucas K	Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.	Molecular neurobiology	2013	51
23472786	Oxygen	Santos CX	Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension.	Antioxidants & redox signaling	2014	25
23564668	Oxygen	Gray SP	NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.	Circulation	2013	86
23603815	Oxygen	Cypess AM	Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat.	Nature medicine	2013	170
23702245	Oxygen	Dodson M	Cellular metabolic and autophagic pathways: traffic control by redox signaling.	Free radical biology & medicine	2013	81
23736373	Oxygen	Lee P	Functional thermogenic beige adipogenesis is inducible in human neck fat.	International journal of obesity	2014	47
23767990	Oxygen	Gorin Y	Nox as a target for diabetic complications.	Clinical science	2013	30
23859953	Oxygen	Rochette L	Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?	Pharmacology & therapeutics	2013	46
23959876	Oxygen	Xin X	Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.	Proceedings of the National Academy of Sciences of the United States of America	2013	30
23975169	Oxygen	Magenta A	Oxidative stress and microRNAs in vascular diseases.	International journal of molecular sciences	2013	40
23984879	Oxygen	Ishibashi Y	Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.	Cardiovascular diabetology	2013	35
24084731	Oxygen	Daffu G	Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond.	International journal of molecular sciences	2013	37
24217221	Oxygen	Kim S	Endoplasmic reticulum stress is sufficient for the induction of IL-1β production via activation of the NF-κB and inflammasome pathways.	Innate immunity	2014	25
24462787	Oxygen	Huynh K	Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.	Pharmacology & therapeutics	2014	72
24511132	Oxygen	Jha JC	Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	51
24608041	Oxygen	Wang H	Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210.	Nature immunology	2014	54
24687582	Oxygen	Fry CS	Fibre type-specific satellite cell response to aerobic training in sedentary adults.	The Journal of physiology	2014	25
24786789	Oxygen	Xu Y	Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase.	Cancer research	2014	23
24918289	Oxygen	Zhang Y	Erythropoietin action in stress response, tissue maintenance and metabolism.	International journal of molecular sciences	2014	26
25066192	Oxygen	Drummond GR	Endothelial NADPH oxidases: which NOX to target in vascular disease?	Trends in endocrinology and metabolism	2014	48
25355928	Oxygen	Javeed N	Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-cell Dysfunction.	Clinical cancer research 	2015	16
25409149	Oxygen	Venkatanarayan A	IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.	Nature	2015	29
25434839	Oxygen	Yang P	Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling.	American journal of obstetrics and gynecology	2015	22
25440060	Oxygen	Walter KM	Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy.	Cell metabolism	2014	20
25497209	Oxygen	Diakopoulos KN	Impaired autophagy induces chronic atrophic pancreatitis in mice via sex- and nutrition-dependent processes.	Gastroenterology	2015	21
25595581	Oxygen	Wang F	Advances in revealing the molecular targets downstream of oxidative stress-induced proapoptotic kinase signaling in diabetic embryopathy.	American journal of obstetrics and gynecology	2015	20
25617478	Oxygen	Cashman CR	Mechanisms of distal axonal degeneration in peripheral neuropathies.	Neuroscience letters	2015	28
25689954	Oxygen	Courtnay R	Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.	Molecular biology reports	2015	36
25699252	Oxygen	Bocci V	Nrf2 activation as target to implement therapeutic treatments.	Frontiers in chemistry	2015	16
25782072	Oxygen	Zeng H	High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss.	Journal of cellular and molecular medicine	2015	17
25814684	Oxygen	Eelen G	Endothelial cell metabolism in normal and diseased vasculature.	Circulation research	2015	52
26184557	Oxygen	Klotz LO	Redox regulation of FoxO transcription factors.	Redox biology	2015	45
26210446	Oxygen	O'Neill S	Genetic disorders coupled to ROS deficiency.	Redox biology	2015	19
26246395	Oxygen	Rainsford KD	Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.	Inflammopharmacology	2015	23
26335400	Oxygen	Richter K	Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences.	Redox biology	2015	25
26612684	Oxygen	Kim H	Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains.	Nature communications	2015	21
26649319	Oxygen	Akter R	Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.	Journal of diabetes research	2016	11
26705059	Oxygen	Russo I	Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.	Journal of molecular and cellular cardiology	2016	22
26715682	Oxygen	Gray SP	Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.	Arteriosclerosis, thrombosis, and vascular biology	2016	25
26801191	Oxygen	Patching SG	Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.	Molecular neurobiology	2017	7
26910598	Oxygen	Martínez-Cerón E	Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial.	American journal of respiratory and critical care medicine	2016	18
26990284	Oxygen	Di Lisa F	New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases.	British journal of pharmacology	2017	8
26998193	Oxygen	Zhang J	ROS and ROS-Mediated Cellular Signaling.	Oxidative medicine and cellular longevity	2016	40
27027295	Oxygen	Chouchani ET	Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1.	Nature	2016	36
27049945	Oxygen	Jiang L	Reductive carboxylation supports redox homeostasis during anchorage-independent growth.	Nature	2016	56
27075628	Oxygen	Ribas V	Skeletal muscle action of estrogen receptor α is critical for the maintenance of mitochondrial function and metabolic homeostasis in females.	Science translational medicine	2016	15
27240461	Oxygen	Zhu H	The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways.	Scientific reports	2016	15
27356044	Oxygen	Panigrahy SK	Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes.	Journal of drug targeting	2017	8
27426517	Oxygen	Fiorese CJ	The Transcription Factor ATF5 Mediates a Mammalian Mitochondrial UPR.	Current biology 	2016	28
27540856	Oxygen	Hourihan JM	Cysteine Sulfenylation Directs IRE-1 to Activate the SKN-1/Nrf2 Antioxidant Response.	Molecular cell	2016	14
27826011	Oxygen	Qiu YY	Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.	Pharmacological research	2016	11
27878313	Oxygen	Vallon V	Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.	Diabetologia	2017	15
27892954	Oxygen	Plovier H	A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.	Nature medicine	2017	36
27899487	Oxygen	Qi H	Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.	Diabetes	2017	7
28089725	Oxygen	Zhenyukh O	High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation.	Free radical biology & medicine	2017	7
28209797	Oxygen	Förstermann U	Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.	Circulation research	2017	25
28288320	Oxygen	Dinda B	Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders.	European journal of medicinal chemistry	2017	7
15094069	Dexamethasone	Banks WA	The source of cerebral insulin.	European journal of pharmacology	2004	90
18172311	Dexamethasone	Matsui W	Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.	Cancer research	2008	174
20693346	Dexamethasone	Aveleira CA	TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability.	Diabetes	2010	80
22056147	Dexamethasone	Kunisada Y	Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.	Stem cell research	2012	51
25573908	Dexamethasone	Kopp JB	Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.	Journal of the American Society of Nephrology 	2015	26
26622051	Dexamethasone	Dhindsa S	Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.	Diabetes care	2016	16
12454321	Folic acid	Timms PM	Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?	QJM 	2002	86
14704320	Folic acid	Yajnik CS	Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries.	The Journal of nutrition	2004	84
16401840	Folic acid	Gurol ME	Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.	Neurology	2006	123
17851649	Folic acid	Yajnik CS	Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study.	Diabetologia	2008	98
19131384	Folic acid	de Ruijter W	Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.	BMJ	2009	78
20223594	Folic acid	Eden T	Aetiology of childhood leukaemia.	Cancer treatment reviews	2010	48
22949852	Folic acid	Singh S	Epigenetic effects of environmental chemicals bisphenol A and phthalates.	International journal of molecular sciences	2012	52
26418287	Folic acid	Nilsson E	Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.	The Journal of clinical endocrinology and metabolism	2015	19
17224929	Imidazoleacetic acid	Côté M	Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.	International journal of obesity	2007	71
22124462	Imidazoleacetic acid	Yu L	Distinguishing persistent insulin autoantibodies with differential risk: nonradioactive bivalent proinsulin/insulin autoantibody assay.	Diabetes	2012	36
25660258	Imidazoleacetic acid	Krischer JP	The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.	Diabetologia	2015	39
15536109	Hydrochlorothiazide	Bakris GL	Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.	JAMA	2004	72
27217403	Hydrochlorothiazide	Itani HA	Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans.	Hypertension	2016	18
20678967	Vitamin D3	Hardy OT	Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity.	Surgery for obesity and related diseases 	2011	45
23407306	Vitamin D3	Belenchia AM	Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial.	The American journal of clinical nutrition	2013	52
24477043	Vitamin D3	Daly RM	Protein-enriched diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass and muscle strength and reduces circulating IL-6 concentrations in elderly women: a cluster randomized controlled trial.	The American journal of clinical nutrition	2014	29
25801871	Vitamin D3	Pilz S	Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.	Hypertension	2015	24
26944421	Vitamin D3	Cooper C	Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial.	The lancet. Diabetes & endocrinology	2016	26
12959935	Phosphoenolpyruvic acid	Barthel A	Novel concepts in insulin regulation of hepatic gluconeogenesis.	American journal of physiology. Endocrinology and metabolism	2003	85
16034410	Phosphoenolpyruvic acid	Yang Q	Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.	Nature	2005	450
19587243	Phosphoenolpyruvic acid	Samuel VT	Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2009	54
20736318	Phosphoenolpyruvic acid	Nagashima T	Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice.	Molecular pharmacology	2010	45
21726808	Phosphoenolpyruvic acid	Jiang W	Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.	Molecular cell	2011	107
21965330	Phosphoenolpyruvic acid	Wang RH	Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.	The Journal of clinical investigation	2011	91
25009184	Phosphoenolpyruvic acid	Zhang P	Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.	Proceedings of the National Academy of Sciences of the United States of America	2014	42
10788730	Potassium	Block G	A rapid food screener to assess fat and fruit and vegetable intake.	American journal of preventive medicine	2000	109
14981009	Potassium	Nikolaidis LA	Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.	Circulation	2004	184
15823385	Potassium	Stumvoll M	Type 2 diabetes: principles of pathogenesis and therapy.	Lancet	2005	356
16258232	Potassium	Miyata N	Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.	Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi	2005	74
16412224	Potassium	Baker AR	Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.	Cardiovascular diabetology	2006	129
17066486	Potassium	Lewis JD	Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research.	Pharmacoepidemiology and drug safety	2007	148
17088564	Potassium	Beeton C	Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.	Proceedings of the National Academy of Sciences of the United States of America	2006	148
18711366	Potassium	Unoki H	SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations.	Nature genetics	2008	237
21051417	Potassium	Yu Q	Insulin says NO to cardiovascular disease.	Cardiovascular research	2011	39
21967988	Potassium	Arnoux JB	Congenital hyperinsulinism: current trends in diagnosis and therapy.	Orphanet journal of rare diseases	2011	39
22466348	Potassium	Fleseriu M	Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.	The Journal of clinical endocrinology and metabolism	2012	57
23121378	Potassium	Parving HH	Cardiorenal end points in a trial of aliskiren for type 2 diabetes.	The New England journal of medicine	2012	152
24866132	Potassium	Fernandes-Rosa FL	Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.	Hypertension	2014	42
25035150	Potassium	Vausort M	Long noncoding RNAs in patients with acute myocardial infarction.	Circulation research	2014	51
25774848	Potassium	Shinoda K	Genetic and functional characterization of clonally derived adult human brown adipocytes.	Nature medicine	2015	82
26414968	Potassium	Williams B	Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.	Lancet	2015	53
26553871	Potassium	Schmid-Burgk JL	A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation.	The Journal of biological chemistry	2016	42
27043774	Potassium	McMurray JJ	Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.	The New England journal of medicine	2016	19
19502414	L-Glutamic acid	Stancáková A	Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men.	Diabetes	2009	55
17277784	L-Phenylalanine	Lee S	Structural basis for viral late-domain binding to Alix.	Nature structural & molecular biology	2007	61
20076942	L-Phenylalanine	Tai ES	Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men.	Diabetologia	2010	110
22332087	L-Phenylalanine	Adams SH	Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.	Advances in nutrition	2011	85
22511205	L-Phenylalanine	Würtz P	Metabolic signatures of insulin resistance in 7,098 young adults.	Diabetes	2012	69
22718433	L-Phenylalanine	Friedrich N	Metabolomics in diabetes research.	The Journal of endocrinology	2012	36
23129134	L-Phenylalanine	Würtz P	Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults.	Diabetes care	2013	79
17222166	D-Galactose	Wright EM	Active sugar transport in health and disease.	Journal of internal medicine	2007	97
18327256	D-Galactose	Döring A	SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.	Nature genetics	2008	136
19965550	D-Galactose	Santer R	Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target.	Clinical journal of the American Society of Nephrology 	2010	51
20980548	D-Galactose	Hummel CS	Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2.	American journal of physiology. Cell physiology	2011	49
25193531	D-Galactose	Yki-Järvinen H	New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).	Diabetes care	2014	38
26662838	D-Galactose	Terauchi Y	New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).	Diabetes, obesity & metabolism	2016	13
27434045	D-Galactose	Forouhi NG	Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.	PLoS medicine	2016	11
15123604	L-Methionine	Bohren KM	A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.	The Journal of biological chemistry	2004	86
19853062	L-Methionine	Spindler SR	Caloric restriction: from soup to nuts.	Ageing research reviews	2010	59
20373368	L-Methionine	Valenti L	Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.	Hepatology	2010	120
24743734	L-Methionine	González-Rodríguez A	Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.	Cell death & disease	2014	60
25533952	L-Methionine	Brestoff JR	Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity.	Nature	2015	129
27778219	L-Methionine	Morris AA	Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency.	Journal of inherited metabolic disease	2017	8
28167322	L-Methionine	Mridha AR	NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.	Journal of hepatology	2017	12
9839517	Progesterone	Risch HA	Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.	Journal of the National Cancer Institute	1998	141
12086951	Progesterone	Kirwan JP	TNF-alpha is a predictor of insulin resistance in human pregnancy.	Diabetes	2002	101
19440038	Progesterone	Liu B	Metformin induces unique biological and molecular responses in triple negative breast cancer cells.	Cell cycle	2009	123
22112968	Progesterone	He X	Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.	Annals of oncology 	2012	54
22689798	Progesterone	Chlebowski RT	Diabetes, metformin, and breast cancer in postmenopausal women.	Journal of clinical oncology 	2012	49
24556859	Progesterone	Bernal-Mizrachi E	Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map.	Diabetes	2014	48
26053034	Progesterone	Hait NC	The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.	Oncogenesis	2015	23
19037880	Eicosapentaenoic acid	Flachs P	Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.	Clinical science	2009	55
19202385	Eicosapentaenoic acid	Fedor D	Prevention of insulin resistance by n-3 polyunsaturated fatty acids.	Current opinion in clinical nutrition and metabolic care	2009	64
21349231	Eicosapentaenoic acid	Cottin SC	The differential effects of EPA and DHA on cardiovascular risk factors.	The Proceedings of the Nutrition Society	2011	37
21733300	Eicosapentaenoic acid	Sergeant S	Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome.	The British journal of nutrition	2012	38
21762726	Eicosapentaenoic acid	Poudyal H	Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action.	Progress in lipid research	2011	46
22315394	Eicosapentaenoic acid	Rockett BD	Fish oil increases raft size and membrane order of B cells accompanied by differential effects on function.	Journal of lipid research	2012	39
22591895	Eicosapentaenoic acid	Wu JH	Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis.	The British journal of nutrition	2012	61
23034965	Eicosapentaenoic acid	Itariu BK	Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.	The American journal of clinical nutrition	2012	43
23498665	Eicosapentaenoic acid	Siriwardhana N	Modulation of adipose tissue inflammation by bioactive food compounds.	The Journal of nutritional biochemistry	2013	35
23809162	Eicosapentaenoic acid	Yan Y	Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.	Immunity	2013	86
25841249	Eicosapentaenoic acid	Bhaswant M	Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids.	The Journal of nutritional biochemistry	2015	17
26597785	Eicosapentaenoic acid	Park HG	Palmitic acid (16:0) competes with omega-6 linoleic and omega-3 ɑ-linolenic acids for FADS2 mediated Δ6-desaturation.	Biochimica et biophysica acta	2016	11
27565734	Eicosapentaenoic acid	Sawada T	Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.	Cardiovascular diabetology	2016	10
11818477	Ceramide (d18:1/12:0)	Unger RH	Lipotoxic diseases.	Annual review of medicine	2002	179
11978640	Ceramide (d18:1/12:0)	Lupi R	Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.	Diabetes	2002	121
12086926	Ceramide (d18:1/12:0)	Itani SI	Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha.	Diabetes	2002	295
14693694	Ceramide (d18:1/12:0)	Adams JM 2nd	Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.	Diabetes	2004	152
16445986	Ceramide (d18:1/12:0)	Summers SA	Ceramides in insulin resistance and lipotoxicity.	Progress in lipid research	2006	209
16464906	Ceramide (d18:1/12:0)	Bruce CR	Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.	American journal of physiology. Endocrinology and metabolism	2006	67
17339025	Ceramide (d18:1/12:0)	Holland WL	Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.	Cell metabolism	2007	330
17620421	Ceramide (d18:1/12:0)	Kolak M	Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.	Diabetes	2007	79
18451260	Ceramide (d18:1/12:0)	Holland WL	Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.	Endocrine reviews	2008	147
18567738	Ceramide (d18:1/12:0)	Smith EL	The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.	FASEB journal 	2008	67
19008343	Ceramide (d18:1/12:0)	Haus JM	Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.	Diabetes	2009	120
19777393	Ceramide (d18:1/12:0)	de la Monte SM	Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.	Current opinion in investigational drugs	2009	47
19798445	Ceramide (d18:1/12:0)	Hicks AA	Genetic determinants of circulating sphingolipid concentrations in European populations.	PLoS genetics	2009	54
19833891	Ceramide (d18:1/12:0)	Coen PM	Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content.	Diabetes	2010	58
20110572	Ceramide (d18:1/12:0)	Schwartz EA	Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2010	46
20361178	Ceramide (d18:1/12:0)	DeFronzo RA	Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.	Diabetologia	2010	140
20712405	Ceramide (d18:1/12:0)	Tanida I	Autophagosome formation and molecular mechanism of autophagy.	Antioxidants & redox signaling	2011	111
21336841	Ceramide (d18:1/12:0)	Eckardt K	Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity.	Reviews in endocrine & metabolic disorders	2011	36
21498783	Ceramide (d18:1/12:0)	Badin PM	Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans.	Diabetes	2011	39
21873552	Ceramide (d18:1/12:0)	Amati F	Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?	Diabetes	2011	107
22359512	Ceramide (d18:1/12:0)	Demirkan A	Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.	PLoS genetics	2012	68
22619219	Ceramide (d18:1/12:0)	Takahashi T	Role of sulfatide in normal and pathological cells and tissues.	Journal of lipid research	2012	37
22807032	Ceramide (d18:1/12:0)	Bosma M	Perilipin 2 improves insulin sensitivity in skeletal muscle despite elevated intramuscular lipid levels.	Diabetes	2012	33
23139352	Ceramide (d18:1/12:0)	Boon J	Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.	Diabetes	2013	45
23612696	Ceramide (d18:1/12:0)	Lopez X	Plasma ceramides are elevated in female children and adolescents with type 2 diabetes.	Journal of pediatric endocrinology & metabolism 	2013	26
24422572	Ceramide (d18:1/12:0)	Jesus AA	IL-1 blockade in autoinflammatory syndromes.	Annual review of medicine	2014	41
24430435	Ceramide (d18:1/12:0)	Henstridge DC	Activating HSP72 in rodent skeletal muscle increases mitochondrial number and oxidative capacity and decreases insulin resistance.	Diabetes	2014	32
24979806	Ceramide (d18:1/12:0)	Szendroedi J	Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans.	Proceedings of the National Academy of Sciences of the United States of America	2014	44
25295788	Ceramide (d18:1/12:0)	Turpin SM	Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.	Cell metabolism	2014	80
25295789	Ceramide (d18:1/12:0)	Raichur S	CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.	Cell metabolism	2014	56
26412155	Ceramide (d18:1/12:0)	Chaurasia B	Ceramides - Lipotoxic Inducers of Metabolic Disorders.	Trends in endocrinology and metabolism	2015	50
26670557	Ceramide (d18:1/12:0)	Jiang C	Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.	Nature communications	2015	37
26676316	Ceramide (d18:1/12:0)	Chakravarthy H	Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy.	Stem cells	2016	10
26739815	Ceramide (d18:1/12:0)	Bergman BC	Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans.	Diabetologia	2016	14
26780287	Ceramide (d18:1/12:0)	Luukkonen PK	Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.	Journal of hepatology	2016	20
9525995	L-Leucine	Patti ME	Bidirectional modulation of insulin action by amino acids.	The Journal of clinical investigation	1998	104
11120765	L-Leucine	Chatila TA	JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.	The Journal of clinical investigation	2000	199
12368292	L-Leucine	Kataoka K	MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene.	The Journal of biological chemistry	2002	82
16043704	L-Leucine	Bell JK	The molecular structure of the Toll-like receptor 3 ligand-binding domain.	Proceedings of the National Academy of Sciences of the United States of America	2005	80
16365106	L-Leucine	Layman DK	Potential importance of leucine in treatment of obesity and the metabolic syndrome.	The Journal of nutrition	2006	73
17377159	L-Leucine	Jin Y	NALP1 in vitiligo-associated multiple autoimmune disease.	The New England journal of medicine	2007	123
17463046	L-Leucine	Roos S	Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth.	The Journal of physiology	2007	72
18511290	L-Leucine	Brognard J	PHLiPPing the switch on Akt and protein kinase C signaling.	Trends in endocrinology and metabolism	2008	72
18946481	L-Leucine	Magitta NF	A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes.	Genes and immunity	2009	48
20182580	L-Leucine	Liao Y	Physiological regulation of Akt activity and stability.	American journal of translational research	2010	103
21811631	L-Leucine	Jeong YS	Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression.	PloS one	2011	41
21885739	L-Leucine	Schlessinger A	Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET.	Proceedings of the National Academy of Sciences of the United States of America	2011	44
21982649	L-Leucine	Ridker PM	Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).	American heart journal	2011	184
22553379	L-Leucine	Stancáková A	Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men.	Diabetes	2012	60
23302862	L-Leucine	Menting JG	How insulin engages its primary binding site on the insulin receptor.	Nature	2013	67
23382179	L-Leucine	Levandowski CB	NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome.	Proceedings of the National Academy of Sciences of the United States of America	2013	35
23385611	L-Leucine	Lu J	Insulin resistance and the metabolism of branched-chain amino acids.	Frontiers of medicine	2013	26
23471228	L-Leucine	Shimabukuro M	Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2013	25
23473037	L-Leucine	Biason-Lauber A	Identification of a SIRT1 mutation in a family with type 1 diabetes.	Cell metabolism	2013	28
23645676	L-Leucine	Krokowski D	A self-defeating anabolic program leads to β-cell apoptosis in endoplasmic reticulum stress-induced diabetes via regulation of amino acid flux.	The Journal of biological chemistry	2013	35
24392697	L-Leucine	Newton AC	Turning off AKT: PHLPP as a drug target.	Annual review of pharmacology and toxicology	2014	31
25733449	L-Leucine	Rahman SA	Molecular mechanisms of congenital hyperinsulinism.	Journal of molecular endocrinology	2015	17
26895884	L-Leucine	Lee CC	Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS).	Diabetes care	2016	11
27455510	L-Leucine	Moon JS	NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages.	Nature medicine	2016	21
27898682	L-Leucine	Lotta LA	Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.	PLoS medicine	2016	13
28436964	L-Leucine	Zhang Y	SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.	Nature cell biology	2017	6
12186805	Asymmetric dimethylarginine	Lin KY	Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.	Circulation	2002	106
17273169	Asymmetric dimethylarginine	Leiper J	Disruption of methylarginine metabolism impairs vascular homeostasis.	Nature medicine	2007	97
17933965	Asymmetric dimethylarginine	Palm F	Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.	American journal of physiology. Heart and circulatory physiology	2007	75
19289633	Asymmetric dimethylarginine	Böger RH	Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.	Circulation	2009	67
22001186	Sphing-4-enine-1-phosphate	Maceyka M	Sphingosine-1-phosphate signaling and its role in disease.	Trends in cell biology	2012	208
26268607	Sphing-4-enine-1-phosphate	Galvani S	HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.	Science signaling	2015	34
26970273	Sphing-4-enine-1-phosphate	Pyne S	Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances.	Progress in lipid research	2016	15
11438497	L-Alanine	Dixon JB	Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.	Gastroenterology	2001	185
12774006	L-Alanine	Mofrad P	Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.	Hepatology	2003	184
12892317	L-Alanine	Lambeir AM	Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.	Critical reviews in clinical laboratory sciences	2003	118
14512888	L-Alanine	Neuschwander-Tetri BA	Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.	Hepatology	2003	101
14752837	L-Alanine	Promrat K	A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.	Hepatology	2004	114
16249437	L-Alanine	Hanley AJ	Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.	Diabetes	2005	85
16682043	L-Alanine	Schindhelm RK	Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.	Atherosclerosis	2007	76
16832839	L-Alanine	Schindhelm RK	Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.	Diabetes/metabolism research and reviews	2006	69
17595248	L-Alanine	Kotronen A	Liver fat in the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2007	80
18053320	L-Alanine	Klonoff DC	Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.	Current medical research and opinion	2008	153
18346983	L-Alanine	Freathy RM	Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI.	Diabetes	2008	106
18384521	L-Alanine	Leite NC	Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.	Liver international 	2009	88
18390575	L-Alanine	Harrison SA	Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.	Gut	2008	97
18752331	L-Alanine	Fracanzani AL	Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.	Hepatology	2008	105
18945255	L-Alanine	Loomba R	Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.	Alimentary pharmacology & therapeutics	2009	54
19010326	L-Alanine	Goessling W	Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.	Gastroenterology	2008	66
19100265	L-Alanine	Ruhl CE	Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.	Gastroenterology	2009	66
19131466	L-Alanine	Fraser A	Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.	Diabetes care	2009	77
19291789	L-Alanine	Gastaldelli A	Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.	Hepatology	2009	64
19523535	L-Alanine	Shah AG	Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.	Clinical gastroenterology and hepatology 	2009	95
19524579	L-Alanine	Kotronen A	Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.	Gastroenterology	2009	77
19747917	L-Alanine	Ahlenstiel G	Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.	Gastroenterology	2010	98
20648476	L-Alanine	Neuschwander-Tetri BA	Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.	Hepatology	2010	98
20658466	L-Alanine	Ghouri N	Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.	Hepatology	2010	47
20664019	L-Alanine	Lazo M	Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.	Diabetes care	2010	54
20708005	L-Alanine	Chalasani N	Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.	Gastroenterology	2010	76
20858492	L-Alanine	Williams CD	Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.	Gastroenterology	2011	398
21195350	L-Alanine	Chen S	Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking.	Cell metabolism	2011	42
21319195	L-Alanine	Valenti L	Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.	Hepatology	2011	65
21525259	L-Alanine	Azadbakht L	The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients.	The Journal of nutrition	2011	42
21540183	L-Alanine	Gao Z	Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity.	The Journal of biological chemistry	2011	51
21741920	L-Alanine	Ahlenstiel G	Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.	Gastroenterology	2011	58
21987488	L-Alanine	Bambha K	Ethnicity and nonalcoholic fatty liver disease.	Hepatology	2012	40
22183689	L-Alanine	Lomonaco R	Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.	Hepatology	2012	56
22271511	L-Alanine	Kim D	Nonalcoholic fatty liver disease is associated with coronary artery calcification.	Hepatology	2012	59
22426755	L-Alanine	Montonen J	Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress.	European journal of nutrition	2013	29
23355498	L-Alanine	Loomba R	Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.	American journal of epidemiology	2013	28
23444397	L-Alanine	HPS2-THRIVE Collaborative Group.	HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.	European heart journal	2013	104
23539735	L-Alanine	Lee SA	CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2013	28
23703931	L-Alanine	Noureddin M	Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis.	Hepatology	2013	36
23715754	L-Alanine	Cariou B	Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.	Diabetes care	2013	30
23718573	L-Alanine	Hoofnagle JH	Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.	Alimentary pharmacology & therapeutics	2013	29
23727264	L-Alanine	Mudaliar S	Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.	Gastroenterology	2013	102
23824655	L-Alanine	Fall T	The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis.	PLoS medicine	2013	53
23991091	L-Alanine	Miller AM	MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.	PloS one	2013	35
24090188	L-Alanine	Rao H	Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection.	Journal of gastroenterology and hepatology	2014	24
24316260	L-Alanine	Lambert JE	Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.	Gastroenterology	2014	78
24436062	L-Alanine	Konerman MA	Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.	Hepatology	2014	23
24681128	L-Alanine	Fontana RJ	Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.	Gastroenterology	2014	26
24947364	L-Alanine	Scott RA	Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity.	Diabetes	2014	32
25019921	L-Alanine	Weiß J	Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.	Deutsches Arzteblatt international	2014	22
25216328	L-Alanine	Mulvihill EE	Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.	Endocrine reviews	2014	37
25449138	L-Alanine	Liew SC	Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases.	European journal of medical genetics	2015	20
25468160	L-Alanine	Neuschwander-Tetri BA	Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.	Lancet	2015	205
25645567	L-Alanine	Blonde L	Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes.	Cardiovascular diabetology	2015	17
25776943	L-Alanine	Guo K	Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals.	Obesity	2015	18
25873639	L-Alanine	Kwok R	Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.	Gut	2016	18
26171685	L-Alanine	Koehler EM	Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.	Hepatology	2016	15
26234526	L-Alanine	Faghihzadeh F	The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.	The British journal of nutrition	2015	19
26667191	L-Alanine	Ballestri S	Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.	Journal of gastroenterology and hepatology	2016	33
26919392	L-Alanine	Klemann C	Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.	Clinical and experimental immunology	2016	12
27002799	L-Alanine	Nelson JE	Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?	The American journal of gastroenterology	2016	15
27075625	L-Alanine	Wang H	NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis.	Science translational medicine	2016	21
27151177	L-Alanine	Cui J	Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.	Journal of hepatology	2016	15
28119464	L-Alanine	Nystoriak MA	Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes.	Science signaling	2017	9
11071182	Homocysteine	Anand SS	Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)	Lancet	2000	188
16551713	Homocysteine	Mora S	Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.	JAMA	2006	77
16723443	Homocysteine	Wong TY	Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA).	Investigative ophthalmology & visual science	2006	100
17101823	Homocysteine	Akomolafe A	Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.	Archives of neurology	2006	68
17200940	Homocysteine	Greenwald SE	Ageing of the conduit arteries.	The Journal of pathology	2007	113
17428730	Homocysteine	Rubenstrunk A	Safety issues and prospects for future generations of PPAR modulators.	Biochimica et biophysica acta	2007	70
17962588	Homocysteine	Khatri M	Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS).	Stroke	2007	60
17967770	Homocysteine	Mora S	Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms.	Circulation	2007	150
18048406	Homocysteine	Broadbent HM	Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.	Human molecular genetics	2008	151
18703981	Homocysteine	Purnell C	Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature.	Alzheimer disease and associated disorders	2009	47
20100888	Homocysteine	Roy B	Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA).	Psychosomatic medicine	2010	51
21680719	Homocysteine	Tan ZS	Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study.	Diabetes care	2011	46
23704675	Homocysteine	TODAY Study Group.	Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial.	Diabetes care	2013	28
24706014	Homocysteine	Westwood AJ	Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.	Neurology	2014	22
11773613	Vasopressin	Nielsen S	Aquaporins in the kidney: from molecules to medicine.	Physiological reviews	2002	213
26794439	Vasopressin	Christ-Crain M	Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.	Nature reviews. Endocrinology	2016	12
11052966	Palmitic acid	Belke DD	Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.	American journal of physiology. Endocrinology and metabolism	2000	94
18633101	Palmitic acid	Reyna SM	Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects.	Diabetes	2008	95
19141690	Palmitic acid	Gwiazda KS	Effects of palmitate on ER and cytosolic Ca2+ homeostasis in beta-cells.	American journal of physiology. Endocrinology and metabolism	2009	54
19401434	Palmitic acid	Nagasumi K	Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice.	Diabetes	2009	50
19723495	Palmitic acid	Barrès R	Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density.	Cell metabolism	2009	152
20068143	Palmitic acid	de Kreutzenberg SV	Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms.	Diabetes	2010	64
20369226	Palmitic acid	Igoillo-Esteve M	Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes.	Diabetologia	2010	54
21659500	Palmitic acid	Koutsari C	Storage of circulating free fatty acid in adipose tissue of postabsorptive humans: quantitative measures and implications for body fat distribution.	Diabetes	2011	38
22408252	Palmitic acid	Tan SH	Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin).	The Journal of biological chemistry	2012	47
22563482	Palmitic acid	Martino L	Palmitate activates autophagy in INS-1E β-cells and in isolated rat and human pancreatic islets.	PloS one	2012	37
22753171	Palmitic acid	Matsuzaka T	Elovl6 promotes nonalcoholic steatohepatitis.	Hepatology	2012	37
23737756	Palmitic acid	Nogueira TC	GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim.	PLoS genetics	2013	39
24297848	Palmitic acid	Kurdiova T	Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.	The Journal of physiology	2014	50
24379348	Palmitic acid	Cnop M	RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate.	Diabetes	2014	44
24424032	Palmitic acid	Hara T	Calcium efflux from the endoplasmic reticulum leads to β-cell death.	Endocrinology	2014	22
24947355	Palmitic acid	Tubbs E	Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.	Diabetes	2014	36
26408801	Palmitic acid	Khodabandehloo H	Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction.	Translational research 	2016	32
28323973	Palmitic acid	Søndergaard E	How to Measure Adipose Tissue Insulin Sensitivity.	The Journal of clinical endocrinology and metabolism	2017	5
19079713	Liothyronine	Turyk ME	Hormone disruption by PBDEs in adult male sport fish consumers.	Environmental health perspectives	2008	64
26187233	Liothyronine	Ravussin E	A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity.	The journals of gerontology. Series A, Biological sciences and medical sciences	2015	50
9593791	17a-Ethynylestradiol	Redelmeier DA	The treatment of unrelated disorders in patients with chronic medical diseases.	The New England journal of medicine	1998	138
10591334	17a-Ethynylestradiol	Visser M	Elevated C-reactive protein levels in overweight and obese adults.	JAMA	1999	351
12540596	17a-Ethynylestradiol	Combs TP	Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin.	Diabetes	2003	89
15087503	17a-Ethynylestradiol	Schreiber SN	The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2004	158
15100410	17a-Ethynylestradiol	Mootha VK	Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle.	Proceedings of the National Academy of Sciences of the United States of America	2004	224
15136311	17a-Ethynylestradiol	Ford DE	Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey.	Archives of internal medicine	2004	102
16731843	17a-Ethynylestradiol	Soriano FX	Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2.	Diabetes	2006	87
17981890	17a-Ethynylestradiol	Rose DP	Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.	Endocrine reviews	2007	71
18281716	17a-Ethynylestradiol	Hotchkiss AK	Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.	Toxicological sciences 	2008	57
20031276	17a-Ethynylestradiol	Rasgon NL	Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.	Neurobiology of aging	2011	48
20484465	17a-Ethynylestradiol	Fu Z	Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice.	Endocrinology	2010	42
21109497	17a-Ethynylestradiol	Mauvais-Jarvis F	Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity.	Trends in endocrinology and metabolism	2011	53
21245576	17a-Ethynylestradiol	Park CJ	Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice.	The Journal of clinical investigation	2011	52
21689398	17a-Ethynylestradiol	Patnaik JL	Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.	Breast cancer research 	2011	87
21747171	17a-Ethynylestradiol	Tiano JP	Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes.	The Journal of clinical investigation	2011	50
22438791	17a-Ethynylestradiol	Anbalagan M	Post-translational modifications of nuclear receptors and human disease.	Nuclear receptor signaling	2012	51
22829776	17a-Ethynylestradiol	Coviello AD	A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation.	PLoS genetics	2012	35
23676496	17a-Ethynylestradiol	Gan Z	Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism.	The Journal of clinical investigation	2013	52
26919573	17a-Ethynylestradiol	Klair JS	A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.	Hepatology	2016	12
27914795	17a-Ethynylestradiol	Wintrob ZA	Insulin use, adipokine profiles and breast cancer prognosis.	Cytokine	2017	11
3056758	D-Fructose	Reaven GM	Banting lecture 1988. Role of insulin resistance in human disease.	Diabetes	1988	1244
8112322	D-Fructose	Mueckler M	Facilitative glucose transporters.	European journal of biochemistry	1994	135
15723702	D-Fructose	Basciano H	Fructose, insulin resistance, and metabolic dyslipidemia.	Nutrition & metabolism	2005	138
18224243	D-Fructose	Lorenzi M	The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.	Experimental diabetes research	2007	59
18842065	D-Fructose	Caulfield MJ	SLC2A9 is a high-capacity urate transporter in humans.	PLoS medicine	2008	89
20029377	D-Fructose	Perez-Pozo SE	Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response.	International journal of obesity	2010	60
20130660	D-Fructose	Tarini J	The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects.	Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme	2010	47
21389266	D-Fructose	Wu M	Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2011	44
21677052	D-Fructose	Aeberli I	Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial.	The American journal of clinical nutrition	2011	51
21875310	D-Fructose	Smith BW	Non-alcoholic fatty liver disease.	Critical reviews in clinical laboratory sciences	2011	65
24652725	D-Fructose	Bray GA	Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar.	Diabetes care	2014	62
26416735	D-Fructose	Nomura N	Structure and mechanism of the mammalian fructose transporter GLUT5.	Nature	2015	34
1532777	L-Tyrosine	DeFronzo RA	Pathogenesis of NIDDM. A balanced overview.	Diabetes care	1992	218
7926300	L-Tyrosine	Hotamisligil GS	Tumor necrosis factor alpha: a key component of the obesity-diabetes link.	Diabetes	1994	161
7997262	L-Tyrosine	Hubbard SR	Crystal structure of the tyrosine kinase domain of the human insulin receptor.	Nature	1994	188
8599760	L-Tyrosine	Grzesiek S	The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase.	Nature structural biology	1996	117
8756680	L-Tyrosine	Grzesiek S	The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR.	Biochemistry	1996	137
9054945	L-Tyrosine	Pugliese A	The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.	Nature genetics	1997	173
9491886	L-Tyrosine	Hof P	Crystal structure of the tyrosine phosphatase SHP-2.	Cell	1998	160
9603962	L-Tyrosine	Hara K	Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.	The Journal of biological chemistry	1998	332
9609109	L-Tyrosine	White MF	The IRS-signalling system: a network of docking proteins that mediate insulin action.	Molecular and cellular biochemistry	1998	120
10395191	L-Tyrosine	Hotamisligil GS	The role of TNFalpha and TNF receptors in obesity and insulin resistance.	Journal of internal medicine	1999	97
11163213	L-Tyrosine	Salmeen A	Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.	Molecular cell	2000	105
11345501	L-Tyrosine	Shibuya M	Structure and function of VEGF/VEGF-receptor system involved in angiogenesis.	Cell structure and function	2001	88
12417588	L-Tyrosine	Lee YH	c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade.	The Journal of biological chemistry	2003	96
12453891	L-Tyrosine	Senn JJ	Interleukin-6 induces cellular insulin resistance in hepatocytes.	Diabetes	2002	131
12502502	L-Tyrosine	Buteau J	Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor.	Diabetes	2003	97
12765939	L-Tyrosine	Bouzakri K	Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.	Diabetes	2003	82
14749507	L-Tyrosine	Myers MG Jr	Leptin receptor signaling and the regulation of mammalian physiology.	Recent progress in hormone research	2004	115
14988838	L-Tyrosine	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	133
15004560	L-Tyrosine	Bottini N	A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.	Nature genetics	2004	314
15208781	L-Tyrosine	Begovich AB	A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.	American journal of human genetics	2004	363
15273934	L-Tyrosine	Kyogoku C	Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.	American journal of human genetics	2004	161
15531553	L-Tyrosine	Velaga MR	The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease.	The Journal of clinical endocrinology and metabolism	2004	84
15567406	L-Tyrosine	Uhlik MT	Structural and evolutionary division of phosphotyrosine binding (PTB) domains.	Journal of molecular biology	2005	81
15719322	L-Tyrosine	Criswell LA	Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.	American journal of human genetics	2005	158
15768830	L-Tyrosine	Williams TM	The Caveolin genes: from cell biology to medicine.	Annals of medicine	2004	121
16186396	L-Tyrosine	Plomgaard P	Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.	Diabetes	2005	96
16828580	L-Tyrosine	Borzychowski AM	Inflammation and pre-eclampsia.	Seminars in fetal & neonatal medicine	2006	93
17038556	L-Tyrosine	Jager J	Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.	Endocrinology	2007	134
17315038	L-Tyrosine	LeRoith D	Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1.	Nature clinical practice. Endocrinology & metabolism	2007	69
17467573	L-Tyrosine	Zhang S	PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.	Drug discovery today	2007	77
17627510	L-Tyrosine	Maiese K	Mechanistic insights into diabetes mellitus and oxidative stress.	Current medicinal chemistry	2007	63
17647198	L-Tyrosine	Chong ZZ	The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.	Histology and histopathology	2007	80
18056643	L-Tyrosine	Yu X	Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.	Proceedings of the National Academy of Sciences of the United States of America	2007	59
18234883	L-Tyrosine	Alessandri-Haber N	Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia.	The Journal of neuroscience 	2008	61
18281274	L-Tyrosine	Zabolotny JM	Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.	The Journal of biological chemistry	2008	91
18285558	L-Tyrosine	Ali TK	Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.	Diabetes	2008	63
18776148	L-Tyrosine	Huber A	Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.	Endocrine reviews	2008	52
18984735	L-Tyrosine	Regazzetti C	Hypoxia decreases insulin signaling pathways in adipocytes.	Diabetes	2009	57
19188609	L-Tyrosine	De Felice FG	Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers.	Proceedings of the National Academy of Sciences of the United States of America	2009	144
19875613	L-Tyrosine	Long SA	Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.	Diabetes	2010	80
20068149	L-Tyrosine	Novosyadlyy R	Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.	Cancer research	2010	96
20174558	L-Tyrosine	Tsai FJ	A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese.	PLoS genetics	2010	119
20457905	L-Tyrosine	Ulanet DB	Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy.	Proceedings of the National Academy of Sciences of the United States of America	2010	86
20716670	L-Tyrosine	Mimeault M	Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.	Pharmacological reviews	2010	48
21062898	L-Tyrosine	Amasheh M	TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling.	Journal of cell science	2010	50
21426149	L-Tyrosine	Barr AJ	Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.	Future medicinal chemistry	2010	50
21515266	L-Tyrosine	Burn GL	Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?	FEBS letters	2011	39
21777652	L-Tyrosine	Wright JW	Brain renin-angiotensin--a new look at an old system.	Progress in neurobiology	2011	46
21906675	L-Tyrosine	Wang H	Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.	Cellular signalling	2012	37
21989056	L-Tyrosine	Davison LJ	Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene.	Human molecular genetics	2012	38
22219194	L-Tyrosine	Shao B	Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.	The Journal of biological chemistry	2012	48
22337149	L-Tyrosine	Pollak M	The insulin and insulin-like growth factor receptor family in neoplasia: an update.	Nature reviews. Cancer	2012	276
22426112	L-Tyrosine	Vang T	LYP inhibits T-cell activation when dissociated from CSK.	Nature chemical biology	2012	41
22609131	L-Tyrosine	Capurso C	From excess adiposity to insulin resistance: the role of free fatty acids.	Vascular pharmacology	2012	41
22688339	L-Tyrosine	Dinh T	Mechanisms involved in the development and healing of diabetic foot ulceration.	Diabetes	2012	38
22869320	L-Tyrosine	Copps KD	Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2.	Diabetologia	2012	121
23209344	L-Tyrosine	Byeon SE	The role of Src kinase in macrophage-mediated inflammatory responses.	Mediators of inflammation	2012	48
23619366	L-Tyrosine	Dai X	A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.	The Journal of clinical investigation	2013	58
23770288	L-Tyrosine	Kamato D	Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.	Cellular signalling	2013	47
23933118	L-Tyrosine	Thakker RV	Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).	Molecular and cellular endocrinology	2014	46
24662820	L-Tyrosine	Beristain AG	PKA signaling drives mammary tumorigenesis through Src.	Oncogene	2015	17
25151409	L-Tyrosine	Bach LA	Insulin-like growth factors and kidney disease.	American journal of kidney diseases 	2015	16
25220640	L-Tyrosine	He RJ	Protein tyrosine phosphatases as potential therapeutic targets.	Acta pharmacologica Sinica	2014	30
25551525	L-Tyrosine	Wabitsch M	Biologically inactive leptin and early-onset extreme obesity.	The New England journal of medicine	2015	19
25573003	L-Tyrosine	Burke JE	Synergy in activating class I PI3Ks.	Trends in biochemical sciences	2015	20
25751815	L-Tyrosine	Wang P	A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication.	Nature medicine	2015	37
25913680	L-Tyrosine	Cabanillas ME	A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.	Cancer	2015	15
26953159	L-Tyrosine	Dirice E	Inhibition of DYRK1A Stimulates Human β-Cell Proliferation.	Diabetes	2016	15
27091649	L-Tyrosine	Burton GJ	Mitochondrial - Endoplasmic reticulum interactions in the trophoblast: Stress and senescence.	Placenta	2017	9
27977138	L-Tyrosine	Zhang ZY	Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.	Accounts of chemical research	2017	9
19897683	Thyroxine	Skarulis MC	Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance.	The Journal of clinical endocrinology and metabolism	2010	43
25743335	Thyroxine	Taylor PN	Whole-genome sequence-based analysis of thyroid function.	Nature communications	2015	18
26837268	Thyroxine	Maraka S	Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis.	Thyroid 	2016	14
14976218	L-Lysine	Miao F	In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions.	The Journal of biological chemistry	2004	82
17478498	L-Lysine	Greene E	Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia.	Nucleic acids research	2007	70
17500065	L-Lysine	Cho YW	PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.	The Journal of biological chemistry	2007	217
18003914	L-Lysine	Hong S	Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.	Proceedings of the National Academy of Sciences of the United States of America	2007	175
18177270	L-Lysine	Wang Y	Post-translational modifications of adiponectin: mechanisms and functional implications.	The Biochemical journal	2008	94
18579779	L-Lysine	Villeneuve LM	Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2008	106
18776137	L-Lysine	Miao F	Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.	Diabetes	2008	55
19208907	L-Lysine	Brasacchio D	Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail.	Diabetes	2009	113
19903865	L-Lysine	Chen S	Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells.	American journal of physiology. Endocrinology and metabolism	2010	50
21035756	L-Lysine	Stitzel ML	Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci.	Cell metabolism	2010	74
23221071	L-Lysine	Zhong Q	Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation.	Investigative ophthalmology & visual science	2013	28
23273980	L-Lysine	Chocarro-Calvo A	Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer.	Molecular cell	2013	32
23423566	L-Lysine	Zhong Q	Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.	Diabetes	2013	31
24049067	L-Lysine	García-Jiménez C	A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose.	Journal of molecular endocrinology	2014	27
24160699	L-Lysine	Sinclair DA	Small-molecule allosteric activators of sirtuins.	Annual review of pharmacology and toxicology	2014	54
24196706	L-Lysine	Ohno H	EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex.	Nature	2013	83
24458354	L-Lysine	Miao F	Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes.	Diabetes	2014	39
25472959	L-Lysine	Paneni F	Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus.	Circulation. Cardiovascular genetics	2015	20
27698142	L-Lysine	Wang C	Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.	Proceedings of the National Academy of Sciences of the United States of America	2016	15
17132539	Pyruvic acid	Sugden MC	Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases.	Archives of physiology and biochemistry	2006	65
19553674	Pyruvic acid	Noland RC	Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control.	The Journal of biological chemistry	2009	93
23121289	Pyruvic acid	Pullen TJ	When less is more: the forbidden fruits of gene repression in the adult β-cell.	Diabetes, obesity & metabolism	2013	26
24395925	Pyruvic acid	Seiler SE	Obesity and lipid stress inhibit carnitine acetyltransferase activity.	Journal of lipid research	2014	24
25187364	Pyruvic acid	Albers PH	Human muscle fiber type-specific insulin signaling: impact of obesity and type 2 diabetes.	Diabetes	2015	16
25662011	Pyruvic acid	Perry RJ	Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.	Cell	2015	96
26727229	Pyruvic acid	Samuel VT	The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.	The Journal of clinical investigation	2016	78
28196866	Pyruvic acid	Wang XX	SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.	The Journal of biological chemistry	2017	9
11430833	Phosphate	Frame S	A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.	Molecular cell	2001	169
15161630	Phosphate	Galiano RD	Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.	The American journal of pathology	2004	144
16037577	Phosphate	Hruska KA	Bone morphogenetic proteins in vascular calcification.	Circulation research	2005	82
17460662	Phosphate	Hart GW	Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.	Nature	2007	371
17964265	Phosphate	Nowotny M	Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription.	Molecular cell	2007	107
20628650	Phosphate	Padayatty SJ	Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.	PloS one	2010	51
23217254	Phosphate	Angelin B	Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.	Cell metabolism	2012	55
26567701	Phosphate	Degirolamo C	Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.	Nature reviews. Drug discovery	2016	29
12734147	Ribavirin	Booth CM	Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.	JAMA	2003	134
16107837	Ribavirin	Feld JJ	Mechanism of action of interferon and ribavirin in treatment of hepatitis C.	Nature	2005	240
25754160	Ribavirin	Serti E	Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.	Gastroenterology	2015	30
25920094	Ribavirin	Pawlotsky JM	From non-A, non-B hepatitis to hepatitis C virus cure.	Journal of hepatology	2015	44
26319013	Ribavirin	Negro F	Extrahepatic morbidity and mortality of chronic hepatitis C.	Gastroenterology	2015	28
26733671	Ribavirin	Serti E	Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα.	Gut	2017	12
17426693	Niacinamide	Jiang W	In vitro derivation of functional insulin-producing cells from human embryonic stem cells.	Cell research	2007	89
17510217	Niacinamide	Jiang J	Generation of insulin-producing islet-like clusters from human embryonic stem cells.	Stem cells	2007	124
19897059	Niacinamide	Baur JA	Biochemical effects of SIRT1 activators.	Biochimica et biophysica acta	2010	40
21855631	Niacinamide	Xu X	Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells.	Mechanisms of development	2011	37
24003918	Niacinamide	Imai S	The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing.	Diabetes, obesity & metabolism	2013	38
24567379	Niacinamide	Cai W	Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
25596852	Niacinamide	Kannt A	Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.	Diabetologia	2015	17
25843049	Niacinamide	Nostro MC	Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines.	Stem cell reports	2015	27
25967123	Niacinamide	Isakova T	Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.	Journal of the American Society of Nephrology 	2015	25
26215259	Niacinamide	Garten A	Physiological and pathophysiological roles of NAMPT and NAD metabolism.	Nature reviews. Endocrinology	2015	36
28291578	Niacinamide	Pissios P	Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme.	Trends in endocrinology and metabolism	2017	6
15817606	Warfarin	Wannamethee SG	Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.	European heart journal	2005	75
19683639	Warfarin	Holmes DR	Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.	Lancet	2009	179
20435227	Warfarin	Ashley EA	Clinical assessment incorporating a personal genome.	Lancet	2010	234
23184840	Warfarin	Gomes T	Rates of hemorrhage during warfarin therapy for atrial fibrillation.	CMAJ 	2013	31
23583249	Warfarin	Reddy VY	Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).	Journal of the American College of Cardiology	2013	64
27893129	Warfarin	Shehab N	US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014.	JAMA	2016	19
7694152	D-Glutamic acid	Kaufman DL	Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.	Nature	1993	184
17563060	D-Glutamic acid	In't Veld P	Screening for insulitis in adult autoantibody-positive organ donors.	Diabetes	2007	59
18192540	D-Glutamic acid	Molven A	Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.	Diabetes	2008	50
21829393	D-Glutamic acid	Plagnol V	Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.	PLoS genetics	2011	82
25362113	D-Glutamic acid	Villapol S	Neuroprotective effects of angiotensin receptor blockers.	American journal of hypertension	2015	18
25646370	D-Glutamic acid	Matsuo H	Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.	Annals of the rheumatic diseases	2016	22
25673413	D-Glutamic acid	Locke AE	Genetic studies of body mass index yield new insights for obesity biology.	Nature	2015	564
26384381	D-Glutamic acid	Hernández C	Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.	Diabetes	2016	10
27059127	D-Glutamic acid	Velasco M	Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.	Neuropharmacology	2017	6
9655393	Fenofibrate	Staels B	Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.	Nature	1998	149
17599422	Fenofibrate	ACCORD Study Group.	Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.	The American journal of cardiology	2007	113
19702724	Fenofibrate	Mraz M	Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.	Clinical endocrinology	2009	61
25471221	Fenofibrate	Tenenbaum A	Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.	Cardiovascular diabetology	2014	23
28043905	Fenofibrate	Nicoletti P	Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.	Gastroenterology	2017	10
14769680	Sodium	Wang TJ	Impact of obesity on plasma natriuretic peptide levels.	Circulation	2004	137
17468742	Sodium	Tahiliani M	The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation.	Nature	2007	172
18356408	Sodium	Han S	Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats.	Diabetes	2008	56
18413553	Sodium	Fung TT	Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.	Archives of internal medicine	2008	191
19129748	Sodium	Komoroski B	Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects.	Clinical pharmacology and therapeutics	2009	58
19129749	Sodium	Komoroski B	Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus.	Clinical pharmacology and therapeutics	2009	69
19357717	Sodium	Bakris GL	Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications.	Kidney international	2009	52
20546255	Sodium	Gerich JE	Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.	Diabetic medicine 	2010	82
20609968	Sodium	Bailey CJ	Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial.	Lancet	2010	141
21358696	Sodium	Mather A	Glucose handling by the kidney.	Kidney international. Supplement	2011	42
21606218	Sodium	Abdul-Ghani MA	Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.	Endocrine reviews	2011	69
21672123	Sodium	Strojek K	Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial.	Diabetes, obesity & metabolism	2011	77
21705062	Sodium	Tahrani AA	Management of type 2 diabetes: new and future developments in treatment.	Lancet	2011	74
21816980	Sodium	Nauck MA	Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.	Diabetes care	2011	95
21955459	Sodium	DeFronzo RA	The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.	Diabetes, obesity & metabolism	2012	83
22238392	Sodium	Bolinder J	Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin.	The Journal of clinical endocrinology and metabolism	2012	109
22310849	Sodium	Ferrannini E	SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.	Nature reviews. Endocrinology	2012	49
22335797	Sodium	Vallon V	Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.	Annual review of physiology	2012	54
22431673	Sodium	Wilding JP	Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.	Annals of internal medicine	2012	91
23194084	Sodium	Kaku K	Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial.	Diabetes, obesity & metabolism	2013	25
23390498	Sodium	Panchapakesan U	Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?	PloS one	2013	38
23487174	Sodium	Powell DR	LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose.	The Journal of pharmacology and experimental therapeutics	2013	25
23563279	Sodium	Kurosaki E	Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data.	Pharmacology & therapeutics	2013	28
23668478	Sodium	Lambers Heerspink HJ	Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.	Diabetes, obesity & metabolism	2013	62
23735727	Sodium	DeFronzo RA	Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes.	Diabetes care	2013	34
23850055	Sodium	Cefalu WT	Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial.	Lancet	2013	142
23906445	Sodium	Bolinder J	Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.	Diabetes, obesity & metabolism	2014	58
23911013	Sodium	Wilding JP	Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.	Diabetes, obesity & metabolism	2014	47
24026259	Sodium	Vasilakou D	Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.	Annals of internal medicine	2013	98
24065789	Sodium	Abdul-Ghani MA	Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load in humans.	Diabetes	2013	27
24067431	Sodium	Kohan DE	Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.	Kidney international	2014	79
24158986	Sodium	Scialla JJ	Fibroblast growth factor-23 and cardiovascular events in CKD.	Journal of the American Society of Nephrology 	2014	76
24226519	Sodium	Rieg T	Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.	American journal of physiology. Renal physiology	2014	32
24257692	Sodium	Gilbert RE	Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?	Kidney international	2014	23
24334175	Sodium	Cherney DZ	Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.	Circulation	2014	136
24375052	Sodium	Muskiet MH	The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?	Nature reviews. Nephrology	2014	27
24378206	Sodium	Ji L	Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study.	Clinical therapeutics	2014	28
24463448	Sodium	Merovci A	Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.	The Journal of clinical investigation	2014	110
24463454	Sodium	Ferrannini E	Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.	The Journal of clinical investigation	2014	109
24529566	Sodium	Geerlings S	Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria.	Diabetes research and clinical practice	2014	22
24595630	Sodium	Perkins BA	Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial.	Diabetes care	2014	42
24602971	Sodium	Baker WL	Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis.	Journal of the American Society of Hypertension 	2014	52
24622320	Sodium	Tahrani AA	SGLT inhibitors in management of diabetes.	The lancet. Diabetes & endocrinology	2013	28
24673844	Sodium	De Nicola L	Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.	American journal of kidney diseases 	2014	24
24678906	Sodium	Kaku K	Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study.	Cardiovascular diabetology	2014	30
24732974	Sodium	DeMarco VG	The pathophysiology of hypertension in patients with obesity.	Nature reviews. Endocrinology	2014	51
24766495	Sodium	Liakos A	Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis.	Diabetes, obesity & metabolism	2014	36
24890683	Sodium	Leiter LA	Dapagliflozin added to usual care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension.	Journal of the American Geriatrics Society	2014	21
24903467	Sodium	Chin MP	Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.	American journal of nephrology	2014	26
25205142	Sodium	Leiter LA	Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study.	Diabetes care	2015	43
25271207	Sodium	Henry RR	Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.	Diabetes care	2015	36
25414155	Sodium	Lovshin JA	Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.	Diabetes care	2015	18
25468945	Sodium	Neal B	Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes.	Diabetes care	2015	46
25488697	Sodium	Scheen AJ	Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.	Drugs	2015	31
25767285	Sodium	Hall JE	Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.	Circulation research	2015	66
25894829	Sodium	Bonner C	Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.	Nature medicine	2015	58
26009231	Sodium	Gilbert RE	Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.	Lancet	2015	37
26078479	Sodium	Peters AL	Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.	Diabetes care	2015	62
26086328	Sodium	Srinivasa S	RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.	The Journal of clinical endocrinology and metabolism	2015	17
26497848	Sodium	Chan MM	Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.	European journal of heart failure	2016	10
26604280	Sodium	Mudaliar S	Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to Bedside.	Diabetes care	2015	25
26861783	Sodium	Ferrannini E	Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.	Diabetes	2016	20
26880444	Sodium	Rajasekeran H	Sodium-glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis.	Kidney international	2016	13
26895767	Sodium	Sonesson C	Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis.	Cardiovascular diabetology	2016	26
27009625	Sodium	Wu JH	Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.	The lancet. Diabetes & endocrinology	2016	45
27059700	Sodium	Zaccardi F	Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.	Diabetes, obesity & metabolism	2016	21
27088241	Sodium	Maruthur NM	Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis.	Annals of internal medicine	2016	27
27112340	Sodium	Sattar N	SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?	Diabetologia	2016	16
27208375	Sodium	Abdul-Ghani M	SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study.	Diabetes care	2016	30
27289124	Sodium	Mudaliar S	Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis.	Diabetes care	2016	43
27299675	Sodium	Wanner C	Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.	The New England journal of medicine	2016	143
27470431	Sodium	Gnudi L	Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms.	Trends in endocrinology and metabolism	2016	16
27488726	Sodium	Monami M	Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.	Acta diabetologica	2017	11
27539604	Sodium	Heerspink HJ	Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects.	Journal of the American Society of Nephrology 	2017	20
27651331	Sodium	Frías JP	Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.	The lancet. Diabetes & endocrinology	2016	13
27941935	Sodium	DeFronzo RA	Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.	Nature reviews. Nephrology	2017	8
28055075	Sodium	Qaseem A	Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.	Annals of internal medicine	2017	8
28244644	Sodium	Neal B	Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.	Diabetes, obesity & metabolism	2017	12
28522450	Sodium	Kosiborod M	Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).	Circulation	2017	27
11679420	Estradiol	Goran MI	Longitudinal study on pubertal insulin resistance.	Diabetes	2001	120
17716297	Estradiol	Vona-Davis L	Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.	Obesity reviews 	2007	70
17911176	Estradiol	Laughlin GA	Low serum testosterone and mortality in older men.	The Journal of clinical endocrinology and metabolism	2008	132
20573783	Estradiol	Krassas GE	Thyroid function and human reproductive health.	Endocrine reviews	2010	106
21195217	Estradiol	Bredella MA	Determinants of bone mineral density in obese premenopausal women.	Bone	2011	44
21741057	Estradiol	Sienkiewicz E	Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.	Metabolism	2011	41
26071095	Estradiol	Hay DL	Amylin: Pharmacology, Physiology, and Clinical Potential.	Pharmacological reviews	2015	22
26580234	Estradiol	Bilezikian JP	Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin.	The Journal of clinical endocrinology and metabolism	2016	14
11250914	Cortisone	Seckl JR	Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.	Endocrinology	2001	104
19200161	Cortisone	van Raalte DH	Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?	European journal of clinical investigation	2009	66
20413513	Cortisone	Rosenstock J	The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy.	Diabetes care	2010	62
10318828	L-Lactic acid	Jonas JC	Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes.	The Journal of biological chemistry	1999	100
20086073	L-Lactic acid	Tappy L	Metabolic effects of fructose and the worldwide increase in obesity.	Physiological reviews	2010	200
21751887	L-Lactic acid	DeYoung MB	Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes.	Diabetes technology & therapeutics	2011	42
23135760	L-Lactic acid	Dewulf EM	Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women.	Gut	2013	84
24789919	L-Lactic acid	Carrière A	Browning of white adipose cells by intermediate metabolites: an adaptive mechanism to alleviate redox pressure.	Diabetes	2014	37
24847880	L-Lactic acid	Madiraju AK	Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.	Nature	2014	164
25748677	L-Lactic acid	McCommis KS	Mitochondrial pyruvate transport: a historical perspective and future research directions.	The Biochemical journal	2015	18
26780750	L-Lactic acid	McCreight LJ	Metformin and the gastrointestinal tract.	Diabetologia	2016	28
1357346	D-Glucose	Martin BC	Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.	Lancet	1992	147
1551497	D-Glucose	Van Cauter E	Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.	Diabetes	1992	162
1671422	D-Glucose	McKeigue PM	Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.	Lancet	1991	270
1954451	D-Glucose	Hales CN	Fetal and infant growth and impaired glucose tolerance at age 64.	BMJ	1991	383
2044434	D-Glucose	DeFronzo RA	Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.	Diabetes care	1991	390
2403659	D-Glucose	Shulman GI	Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.	The New England journal of medicine	1990	200
3288530	D-Glucose	Ricordi C	Automated method for isolation of human pancreatic islets.	Diabetes	1988	215
3894418	D-Glucose	DeFronzo RA	Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.	The Journal of clinical investigation	1985	184
7587918	D-Glucose	Ohkubo Y	Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.	Diabetes research and clinical practice	1995	343
7622004	D-Glucose	-	The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.	Diabetes	1995	217
7624391	D-Glucose	Reaven GM	Pathophysiology of insulin resistance in human disease.	Physiological reviews	1995	133
7677463	D-Glucose	Pories WJ	Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.	Annals of surgery	1995	266
7738205	D-Glucose	Hotamisligil GS	Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.	The Journal of clinical investigation	1995	501
7935656	D-Glucose	Nolan JJ	Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.	The New England journal of medicine	1994	127
8040759	D-Glucose	-	Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.	The Journal of pediatrics	1994	230
8115596	D-Glucose	Haig D	Genetic conflicts in human pregnancy.	The Quarterly review of biology	1993	132
8247074	D-Glucose	Lillioja S	Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.	The New England journal of medicine	1993	212
8353913	D-Glucose	Newman AB	Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.	Circulation	1993	159
8405741	D-Glucose	Nauck MA	Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.	Diabetologia	1993	140
8423228	D-Glucose	Nauck MA	Preserved incretin activity of glucagon-like peptide 1 7-36 amide but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.	The Journal of clinical investigation	1993	216
8635647	D-Glucose	Haffner SM	Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.	Diabetes	1996	142
8857019	D-Glucose	Perseghin G	Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects.	The New England journal of medicine	1996	117
8945471	D-Glucose	Yamagata K	Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)	Nature	1996	216
9042129	D-Glucose	Anderson B	Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus.	The Journal of pediatrics	1997	111
9303923	D-Glucose	Ferrannini E	Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).	The Journal of clinical investigation	1997	122
9353126	D-Glucose	Ogg S	The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans.	Nature	1997	593
9408743	D-Glucose	Dunaif A	Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.	Endocrine reviews	1997	289
9449872	D-Glucose	Ravelli AC	Glucose tolerance in adults after prenatal exposure to famine.	Lancet	1998	221
9495343	D-Glucose	Withers DJ	Disruption of IRS-2 causes type 2 diabetes in mice.	Nature	1998	328
9509261	D-Glucose	Goodyear LJ	Exercise, glucose transport, and insulin sensitivity.	Annual review of medicine	1998	157
9619798	D-Glucose	Carr A	A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.	AIDS	1998	273
9742976	D-Glucose	-	Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.	Lancet	1998	2807
9749880	D-Glucose	Csermely P	The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review.	Pharmacology & therapeutics	1998	183
9753305	D-Glucose	Bonora E	Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.	Diabetes	1998	104
9773724	D-Glucose	Williams GC	Supporting autonomy to motivate patients with diabetes for glucose control.	Diabetes care	1998	166
9867845	D-Glucose	Postic C	Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.	The Journal of biological chemistry	1999	389
9916795	D-Glucose	Aitman TJ	Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.	Nature genetics	1999	120
9920074	D-Glucose	Banerji MA	Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.	The Journal of clinical endocrinology and metabolism	1999	105
10064092	D-Glucose	Poulsen P	Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study.	Diabetologia	1999	135
10189543	D-Glucose	-	The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.	Diabetes care	1999	189
10331418	D-Glucose	Jacob S	Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.	Diabetes	1999	109
10359389	D-Glucose	Turner RC	Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.	JAMA	1999	352
10382692	D-Glucose	Carr A	Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.	Lancet	1999	175
10413736	D-Glucose	Cline GW	Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.	The New England journal of medicine	1999	106
10413738	D-Glucose	Shepherd PR	Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.	The New England journal of medicine	1999	191
10454950	D-Glucose	DeFronzo RA	Pharmacologic therapy for type 2 diabetes mellitus.	Annals of internal medicine	1999	114
10491414	D-Glucose	Weyer C	The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.	The Journal of clinical investigation	1999	293
10571771	D-Glucose	Gilbert RE	The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?	Kidney international	1999	121
10622252	D-Glucose	Barroso I	Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.	Nature	1999	224
10645822	D-Glucose	Hanson RL	Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.	American journal of epidemiology	2000	101
10675357	D-Glucose	Cusi K	Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.	The Journal of clinical investigation	2000	169
10731493	D-Glucose	Goodpaster BH	Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus.	The American journal of clinical nutrition	2000	152
10806189	D-Glucose	Murata H	The mechanism of insulin resistance caused by HIV protease inhibitor therapy.	The Journal of biological chemistry	2000	93
10819232	D-Glucose	Ahrén B	Autonomic regulation of islet hormone secretion--implications for health and disease.	Diabetologia	2000	148
10845877	D-Glucose	Hotta K	Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.	Arteriosclerosis, thrombosis, and vascular biology	2000	454
10857936	D-Glucose	Boyko EJ	Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.	Diabetes care	2000	122
10857969	D-Glucose	Bonora E	Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.	Diabetes care	2000	367
10860187	D-Glucose	Shichiri M	Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.	Diabetes care	2000	109
10868930	D-Glucose	Soria B	Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.	Diabetes	2000	116
10882139	D-Glucose	Gampe RT Jr	Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.	Molecular cell	2000	109
10884429	D-Glucose	Bonner-Weir S	In vitro cultivation of human islets from expanded ductal tissue.	Proceedings of the National Academy of Sciences of the United States of America	2000	175
10886574	D-Glucose	Muntner P	Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.	Kidney international	2000	108
10902785	D-Glucose	Katz A	Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.	The Journal of clinical endocrinology and metabolism	2000	508
10905472	D-Glucose	Kelley DE	Fuel selection in human skeletal muscle in insulin resistance: a reexamination.	Diabetes	2000	175
10911004	D-Glucose	Shapiro AM	Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.	The New England journal of medicine	2000	757
10953027	D-Glucose	Li AC	Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.	The Journal of clinical investigation	2000	163
11067779	D-Glucose	Vionnet N	Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.	American journal of human genetics	2000	114
11151758	D-Glucose	Weyer C	Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.	Diabetologia	2000	137
11157411	D-Glucose	Geffken DF	Association between physical activity and markers of inflammation in a healthy elderly population.	American journal of epidemiology	2001	103
11246881	D-Glucose	Vilsbøll T	Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.	Diabetes	2001	145
11287357	D-Glucose	Kern PA	Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.	American journal of physiology. Endocrinology and metabolism	2001	300
11289033	D-Glucose	Ryan EA	Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.	Diabetes	2001	95
11315831	D-Glucose	Isomaa B	Cardiovascular morbidity and mortality associated with the metabolic syndrome.	Diabetes care	2001	599
11334417	D-Glucose	Hotta K	Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.	Diabetes	2001	139
11395411	D-Glucose	Willson TM	Peroxisome proliferator-activated receptor gamma and metabolic disease.	Annual review of biochemistry	2001	114
11445664	D-Glucose	Vozarova B	Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.	Obesity research	2001	88
11502801	D-Glucose	Toft-Nielsen MB	Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.	The Journal of clinical endocrinology and metabolism	2001	143
11502817	D-Glucose	Yang WS	Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.	The Journal of clinical endocrinology and metabolism	2001	130
11508264	D-Glucose	Hu FB	Diet and risk of Type II diabetes: the role of types of fat and carbohydrate.	Diabetologia	2001	105
11574423	D-Glucose	Barzilay JI	The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.	Diabetes	2001	92
11584370	D-Glucose	Paradis V	High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis.	Hepatology	2001	92
11681807	D-Glucose	Trayhurn P	Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.	The Proceedings of the Nutrition Society	2001	152
11742415	D-Glucose	Moller DE	New drug targets for type 2 diabetes and the metabolic syndrome.	Nature	2001	114
11755481	D-Glucose	Kuzuya T	Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.	Diabetes research and clinical practice	2002	102
11794168	D-Glucose	van den Berghe G	Intensive insulin therapy in critically ill patients.	The New England journal of medicine	2001	1200
11809615	D-Glucose	Hales CN	The thrifty phenotype hypothesis.	British medical bulletin	2001	401
11812755	D-Glucose	Vozarova B	High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.	Diabetes	2002	90
11826411	D-Glucose	Chitturi S	NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.	Hepatology	2002	167
11861436	D-Glucose	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2002	123
11872682	D-Glucose	Mayerson AB	The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.	Diabetes	2002	106
11889194	D-Glucose	Nauck MA	Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.	The Journal of clinical endocrinology and metabolism	2002	83
11893791	D-Glucose	Sinha R	Prevalence of impaired glucose tolerance among children and adolescents with marked obesity.	The New England journal of medicine	2002	218
11895820	D-Glucose	Whincup PH	Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children.	BMJ	2002	83
11897280	D-Glucose	Zander M	Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.	Lancet	2002	197
11914736	D-Glucose	Melloul D	Regulation of insulin gene transcription.	Diabetologia	2002	81
11916936	D-Glucose	Festa A	Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.	Diabetes	2002	194
11916953	D-Glucose	Peila R	Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.	Diabetes	2002	265
11923038	D-Glucose	Nappo F	Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.	Journal of the American College of Cardiology	2002	93
11935150	D-Glucose	Agersø H	The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men.	Diabetologia	2002	83
11978661	D-Glucose	Freeman DJ	C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.	Diabetes	2002	127
11994345	D-Glucose	Bastard JP	Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.	The Journal of clinical endocrinology and metabolism	2002	97
12011435	D-Glucose	Olbrot M	Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA.	Proceedings of the National Academy of Sciences of the United States of America	2002	93
12021247	D-Glucose	Hundal RS	Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.	The Journal of clinical investigation	2002	148
12021250	D-Glucose	Petersen KF	Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.	The Journal of clinical investigation	2002	172
12028371	D-Glucose	Boden G	Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.	European journal of clinical investigation	2002	220
12037147	D-Glucose	Diabetes Prevention Trial--Type 1 Diabetes Study Group.	Effects of insulin in relatives of patients with type 1 diabetes mellitus.	The New England journal of medicine	2002	154
12081851	D-Glucose	Willett W	Glycemic index, glycemic load, and risk of type 2 diabetes.	The American journal of clinical nutrition	2002	83
12086956	D-Glucose	Romeo G	Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes.	Diabetes	2002	89
12087016	D-Glucose	Hanley AJ	Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.	Diabetes care	2002	101
12136392	D-Glucose	Cryer PE	Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.	Diabetologia	2002	172
12145144	D-Glucose	Fernández-Real JM	Cross-talk between iron metabolism and diabetes.	Diabetes	2002	85
12196473	D-Glucose	Buchanan TA	Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.	Diabetes	2002	191
12225719	D-Glucose	Abbasi F	Relationship between obesity, insulin resistance, and coronary heart disease risk.	Journal of the American College of Cardiology	2002	88
12242452	D-Glucose	Frayn KN	Adipose tissue as a buffer for daily lipid flux.	Diabetologia	2002	103
12354786	D-Glucose	Vasseur F	Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians.	Human molecular genetics	2002	93
12360255	D-Glucose	De Meyts P	Structural biology of insulin and IGF1 receptors: implications for drug design.	Nature reviews. Drug discovery	2002	135
12372842	D-Glucose	Evans JL	Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.	Endocrine reviews	2002	325
12518001	D-Glucose	Francis GA	Nuclear receptors and the control of metabolism.	Annual review of physiology	2003	122
12540592	D-Glucose	Tschritter O	Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.	Diabetes	2003	97
12540611	D-Glucose	Kjems LL	The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.	Diabetes	2003	91
12540621	D-Glucose	Garvey WT	Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.	Diabetes	2003	100
12558712	D-Glucose	Haan MN	Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors.	Journal of the American Geriatrics Society	2003	107
12562574	D-Glucose	Ryan MC	Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.	The American journal of psychiatry	2003	110
12576937	D-Glucose	Van den Berghe G	Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.	Critical care medicine	2003	114
12611609	D-Glucose	Díez JJ	The role of the novel adipocyte-derived hormone adiponectin in human disease.	European journal of endocrinology	2003	165
12626323	D-Glucose	Jiang G	Glucagon and regulation of glucose metabolism.	American journal of physiology. Endocrinology and metabolism	2003	128
12629551	D-Glucose	Itoh Y	Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.	Nature	2003	277
12634421	D-Glucose	Farris W	Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	329
12668987	D-Glucose	Marchesini G	Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.	Hepatology	2003	457
12679416	D-Glucose	Goran MI	Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents.	The Journal of clinical endocrinology and metabolism	2003	107
12684358	D-Glucose	Esposito K	Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.	JAMA	2003	235
12750520	D-Glucose	Petersen KF	Mitochondrial dysfunction in the elderly: possible role in insulin resistance.	Science	2003	471
12766131	D-Glucose	Cryer PE	Hypoglycemia in diabetes.	Diabetes care	2003	198
12788800	D-Glucose	Fernández-Real JM	Insulin resistance and chronic cardiovascular inflammatory syndrome.	Endocrine reviews	2003	116
12788877	D-Glucose	Vilsbøll T	Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2003	95
12791994	D-Glucose	Du K	TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver.	Science	2003	250
12808457	D-Glucose	Mootha VK	PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.	Nature genetics	2003	1829
12815107	D-Glucose	Lieberman SM	Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2003	112
12854339	D-Glucose	Gary TL	Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes.	The Diabetes educator	2003	89
12869762	D-Glucose	Grimsby J	Allosteric activators of glucokinase: potential role in diabetes therapy.	Science	2003	98
12879249	D-Glucose	Rorsman P	Insulin granule dynamics in pancreatic beta cells.	Diabetologia	2003	159
12941770	D-Glucose	Butler AE	Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.	Diabetes	2003	104
12952969	D-Glucose	Rotter V	Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects.	The Journal of biological chemistry	2003	170
12959938	D-Glucose	Kelley DE	Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.	American journal of physiology. Endocrinology and metabolism	2003	76
12960095	D-Glucose	Farilla L	Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.	Endocrinology	2003	117
14623617	D-Glucose	McLaughlin T	Use of metabolic markers to identify overweight individuals who are insulin resistant.	Annals of internal medicine	2003	162
14633821	D-Glucose	Ascaso JF	Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism.	Diabetes care	2003	89
14633846	D-Glucose	Russell AP	Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle.	Diabetes	2003	108
14670831	D-Glucose	Yan SF	Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.	Circulation research	2003	82
14698276	D-Glucose	Dandona P	Inflammation: the link between insulin resistance, obesity and diabetes.	Trends in immunology	2004	349
14699128	D-Glucose	Pajvani UB	Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.	The Journal of biological chemistry	2004	234
14709204	D-Glucose	Boston RC	MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test.	Diabetes technology & therapeutics	2003	142
14715836	D-Glucose	Cruz ML	The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.	The Journal of clinical endocrinology and metabolism	2004	100
14747241	D-Glucose	McKeown NM	Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort.	Diabetes care	2004	104
14747278	D-Glucose	Holten MK	Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes.	Diabetes	2004	103
14749265	D-Glucose	Ferré P	The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.	Diabetes	2004	122
14960743	D-Glucose	Petersen KF	Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.	The New England journal of medicine	2004	490
14985484	D-Glucose	Bhargava SK	Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood.	The New England journal of medicine	2004	192
15007034	D-Glucose	Benson SC	Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.	Hypertension	2004	162
15016359	D-Glucose	Kamata K	Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.	Structure	2004	99
15043959	D-Glucose	Gale EA	European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.	Lancet	2004	76
15047607	D-Glucose	Morton NM	Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.	Diabetes	2004	87
15057233	D-Glucose	Evans RM	PPARs and the complex journey to obesity.	Nature medicine	2004	373
15059920	D-Glucose	Schwartzenberg-Bar-Yoseph F	The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.	Cancer research	2004	160
15094078	D-Glucose	Hoyer S	Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.	European journal of pharmacology	2004	75
15107844	D-Glucose	Koo SH	PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.	Nature medicine	2004	164
15111517	D-Glucose	Laaksonen DE	Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.	Diabetes care	2004	126
15118095	D-Glucose	Paterson JM	Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2004	85
15126524	D-Glucose	Ahrén B	Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2004	81
15143161	D-Glucose	Salma N	Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor.	Molecular and cellular biology	2004	73
15159263	D-Glucose	Hu G	Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.	Archives of internal medicine	2004	129
15161755	D-Glucose	Butler AE	Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes.	Diabetes	2004	73
15161770	D-Glucose	Heise T	Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.	Diabetes	2004	81
15165749	D-Glucose	Rangwala SM	Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.	Trends in pharmacological sciences	2004	77
15181024	D-Glucose	Goldstein BJ	Adiponectin: A novel adipokine linking adipocytes and vascular function.	The Journal of clinical endocrinology and metabolism	2004	107
15181049	D-Glucose	Mohanty P	Evidence for a potent antiinflammatory effect of rosiglitazone.	The Journal of clinical endocrinology and metabolism	2004	74
15197140	D-Glucose	Esposito K	Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.	Circulation	2004	75
15201411	D-Glucose	Klein S	Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.	The New England journal of medicine	2004	117
15265818	D-Glucose	Meier U	Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin.	Clinical chemistry	2004	118
15271645	D-Glucose	Holst JJ	Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.	American journal of physiology. Endocrinology and metabolism	2004	88
15272020	D-Glucose	Kamei Y	Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.	The Journal of biological chemistry	2004	146
15273546	D-Glucose	Rubino F	The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.	Annals of surgery	2004	98
15277403	D-Glucose	Tiikkainen M	Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.	Diabetes	2004	78
15292279	D-Glucose	Hull RL	Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2004	128
15308380	D-Glucose	DeFronzo RA	Pathogenesis of type 2 diabetes mellitus.	The Medical clinics of North America	2004	180
15331562	D-Glucose	Duncan BB	Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study.	Diabetes	2004	75
15364812	D-Glucose	Ghanim H	Circulating mononuclear cells in the obese are in a proinflammatory state.	Circulation	2004	117
15546003	D-Glucose	Ling C	Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins.	The Journal of clinical investigation	2004	74
15548778	D-Glucose	Hofman PL	Premature birth and later insulin resistance.	The New England journal of medicine	2004	80
15604363	D-Glucose	Fukuhara A	Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.	Science	2005	283
15616025	D-Glucose	Lyssenko V	Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.	Diabetes	2005	92
15619630	D-Glucose	Hirasawa A	Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.	Nature medicine	2005	265
15629253	D-Glucose	Kota BP	An overview on biological mechanisms of PPARs.	Pharmacological research	2005	120
15632335	D-Glucose	Dansinger ML	Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial.	JAMA	2005	226
15653324	D-Glucose	Harrington LS	Restraining PI3K: mTOR signalling goes back to the membrane.	Trends in biochemical sciences	2005	127
15655035	D-Glucose	Lihn AS	Adiponectin: action, regulation and association to insulin sensitivity.	Obesity reviews 	2005	95
15662004	D-Glucose	Lowell BB	Mitochondrial dysfunction and type 2 diabetes.	Science	2005	502
15669880	D-Glucose	Krentz AJ	Oral antidiabetic agents: current role in type 2 diabetes mellitus.	Drugs	2005	137
15705778	D-Glucose	Minn AH	Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis.	Endocrinology	2005	108
15728645	D-Glucose	Malmberg K	Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.	European heart journal	2005	121
15734833	D-Glucose	Petersen KF	Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.	Diabetes	2005	194
15750215	D-Glucose	Steen E	Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?	Journal of Alzheimer's disease 	2005	298
15766369	D-Glucose	Kiran M	The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus.	Journal of clinical periodontology	2005	66
15767618	D-Glucose	Boden G	Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes.	Annals of internal medicine	2005	74
15814847	D-Glucose	Srivastava SK	Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.	Endocrine reviews	2005	97
15837923	D-Glucose	Xu A	Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2005	74
15911795	D-Glucose	Enzinger C	Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.	Neurology	2005	80
15925013	D-Glucose	Ginsberg HN	Regulation of plasma triglycerides in insulin resistance and diabetes.	Archives of medical research	2005	88
15925327	D-Glucose	Feinstein DL	Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?	Biochemical pharmacology	2005	82
15938030	D-Glucose	Schena FP	Pathogenetic mechanisms of diabetic nephropathy.	Journal of the American Society of Nephrology 	2005	85
15946424	D-Glucose	Wickremesekera K	Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.	Obesity surgery	2005	74
15951574	D-Glucose	Crowther CA	Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.	The New England journal of medicine	2005	362
15971409	D-Glucose	Havel PJ	Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.	Nutrition reviews	2005	139
15983199	D-Glucose	Javor ED	Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.	Diabetes	2005	65
15983207	D-Glucose	Ryan EA	Five-year follow-up after clinical islet transplantation.	Diabetes	2005	359
15983313	D-Glucose	Pitteloud N	Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.	Diabetes care	2005	70
16025115	D-Glucose	Meyre D	Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes.	Nature genetics	2005	68
16026270	D-Glucose	Caldwell RB	Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.	Current drug targets	2005	65
16030142	D-Glucose	Hida K	Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity.	Proceedings of the National Academy of Sciences of the United States of America	2005	95
16030278	D-Glucose	Ingelsson E	Insulin resistance and risk of congestive heart failure.	JAMA	2005	112
16046295	D-Glucose	Di Gregorio GB	Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.	Diabetes	2005	116
16046308	D-Glucose	Kitabchi AE	Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.	Diabetes	2005	134
16046315	D-Glucose	Staels B	Therapeutic roles of peroxisome proliferator-activated receptor agonists.	Diabetes	2005	101
16054085	D-Glucose	Lin J	Metabolic control through the PGC-1 family of transcription coactivators.	Cell metabolism	2005	546
16091421	D-Glucose	Wang H	ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity.	Journal of cell science	2005	82
16096055	D-Glucose	Gunton JE	Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes.	Cell	2005	149
16123357	D-Glucose	Tremblay F	Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability.	Diabetes	2005	98
16144950	D-Glucose	Fehse F	Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2005	68
16155268	D-Glucose	Robertson MD	Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism.	The American journal of clinical nutrition	2005	76
16186392	D-Glucose	Berndt J	Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.	Diabetes	2005	93
16214598	D-Glucose	Dormandy JA	Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.	Lancet	2005	537
16219666	D-Glucose	Theodorakis MJ	Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.	American journal of physiology. Endocrinology and metabolism	2006	76
16227461	D-Glucose	Punjabi NM	Disorders of glucose metabolism in sleep apnea.	Journal of applied physiology	2005	88
16227462	D-Glucose	Spiegel K	Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes.	Journal of applied physiology	2005	277
16230722	D-Glucose	Heine RJ	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.	Annals of internal medicine	2005	145
16239637	D-Glucose	Nissen SE	Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.	JAMA	2005	71
16249538	D-Glucose	Peyrot M	Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.	Diabetes care	2005	158
16284649	D-Glucose	Morino K	Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.	The Journal of clinical investigation	2005	218
16306329	D-Glucose	Kristiansen OP	Interleukin-6 and diabetes: the good, the bad, or the indifferent?	Diabetes	2005	106
16311215	D-Glucose	Koerner A	Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come.	Best practice & research. Clinical endocrinology & metabolism	2005	79
16352795	D-Glucose	Stolzenberg-Solomon RZ	Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.	JAMA	2005	108
16352960	D-Glucose	Kanji S	Reliability of point-of-care testing for glucose measurement in critically ill adults.	Critical care medicine	2005	88
16361024	D-Glucose	Biessels GJ	Risk of dementia in diabetes mellitus: a systematic review.	The Lancet. Neurology	2006	331
16380500	D-Glucose	Lara-Castro C	Adiponectin multimeric complexes and the metabolic syndrome trait cluster.	Diabetes	2006	108
16385087	D-Glucose	Isoda K	Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.	Arteriosclerosis, thrombosis, and vascular biology	2006	88
16388523	D-Glucose	Basaria S	Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.	Cancer	2006	66
16409152	D-Glucose	Beaven SW	Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.	Annual review of medicine	2006	78
16415884	D-Glucose	Grant SF	Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.	Nature genetics	2006	563
16434464	D-Glucose	Smith MR	Insulin sensitivity during combined androgen blockade for prostate cancer.	The Journal of clinical endocrinology and metabolism	2006	99
16443778	D-Glucose	Ostenson CG	Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients.	Diabetes	2006	69
16456680	D-Glucose	Yki-Järvinen H	Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.	Diabetologia	2006	84
16463046	D-Glucose	Adiels M	Overproduction of large VLDL particles is driven by increased liver fat content in man.	Diabetologia	2006	110
16492903	D-Glucose	Nigro J	Insulin resistance and atherosclerosis.	Endocrine reviews	2006	63
16517403	D-Glucose	Drucker DJ	The biology of incretin hormones.	Cell metabolism	2006	428
16531507	D-Glucose	Yang RZ	Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.	American journal of physiology. Endocrinology and metabolism	2006	108
16534530	D-Glucose	Kim CS	Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.	International journal of obesity	2006	79
16541101	D-Glucose	Houten SM	Endocrine functions of bile acids.	The EMBO journal	2006	120
16550171	D-Glucose	Coucke PJ	Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.	Nature genetics	2006	77
16563942	D-Glucose	Petersen KF	Etiology of insulin resistance.	The American journal of medicine	2006	174
16567536	D-Glucose	Festa A	The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.	Diabetes	2006	78
16567827	D-Glucose	Stefan N	Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.	Diabetes care	2006	96
16570048	D-Glucose	Kelesidis I	Adiponectin and cancer: a systematic review.	British journal of cancer	2006	104
16600341	D-Glucose	Zittermann A	Vitamin D and disease prevention with special reference to cardiovascular disease.	Progress in biophysics and molecular biology	2006	83
16613757	D-Glucose	Bastard JP	Recent advances in the relationship between obesity, inflammation, and insulin resistance.	European cytokine network	2006	413
16618833	D-Glucose	Kim JA	Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.	Circulation	2006	288
16627931	D-Glucose	Lester-Coll N	Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.	Journal of Alzheimer's disease 	2006	109
16644654	D-Glucose	Abdul-Ghani MA	Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.	Diabetes care	2006	150
16644701	D-Glucose	Abdul-Ghani MA	Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.	Diabetes	2006	110
16644702	D-Glucose	Clerk LH	Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle.	Diabetes	2006	85
16670091	D-Glucose	Armoni M	FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity.	The Journal of biological chemistry	2006	60
16731817	D-Glucose	Cancello R	Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.	Diabetes	2006	112
16786033	D-Glucose	Martins IJ	Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.	Molecular psychiatry	2006	80
16816950	D-Glucose	Matikainen N	Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.	Diabetologia	2006	61
16855264	D-Glucose	Florez JC	TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.	The New England journal of medicine	2006	230
16860976	D-Glucose	Vuksan V	Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.	Nutrition, metabolism, and cardiovascular diseases 	2008	52
16873706	D-Glucose	Draznin B	Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin.	Diabetes	2006	75
16894525	D-Glucose	Gurney JG	Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.	Cancer	2006	64
16908160	D-Glucose	Lee FY	FXR, a multipurpose nuclear receptor.	Trends in biochemical sciences	2006	67
16912128	D-Glucose	Herman GA	Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2006	86
16918589	D-Glucose	Salpeter SR	Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.	Diabetes, obesity & metabolism	2006	61
16936218	D-Glucose	Damcott CM	Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.	Diabetes	2006	67
16970929	D-Glucose	Fülöp N	Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.	Cardiovascular research	2007	56
16979422	D-Glucose	McEwen BS	Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load.	Metabolism	2006	110
17010638	D-Glucose	Howard JK	Attenuation of leptin and insulin signaling by SOCS proteins.	Trends in endocrinology and metabolism	2006	98
17043079	D-Glucose	Fitzpatrick AL	Leukocyte telomere length and cardiovascular disease in the cardiovascular health study.	American journal of epidemiology	2007	219
17065355	D-Glucose	Van den Berghe G	Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.	Diabetes	2006	77
17065679	D-Glucose	Lee JM	Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study.	Diabetes care	2006	103
17065684	D-Glucose	Cho YM	Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.	Diabetes care	2006	85
17068132	D-Glucose	Kharitonenkov A	The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.	Endocrinology	2007	166
17088535	D-Glucose	Lee RH	Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	186
17093941	D-Glucose	Chandak GR	Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population.	Diabetologia	2007	61
17098089	D-Glucose	Drucker DJ	The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.	Lancet	2006	626
17114290	D-Glucose	Petersen KF	Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.	Proceedings of the National Academy of Sciences of the United States of America	2006	89
17123962	D-Glucose	Williamson JA	Direct detection of transient alpha-helical states in islet amyloid polypeptide.	Protein science 	2007	71
17130196	D-Glucose	Aschner P	Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.	Diabetes care	2006	161
17130197	D-Glucose	Charbonnel B	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.	Diabetes care	2006	127
17130488	D-Glucose	Wolins NE	OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.	Diabetes	2006	103
17130651	D-Glucose	Morino K	Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.	Diabetes	2006	205
17141632	D-Glucose	Zhang W	PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis.	Cell metabolism	2006	99
17145742	D-Glucose	Kahn SE	Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.	The New England journal of medicine	2006	549
17148564	D-Glucose	Sharma AM	Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.	The Journal of clinical endocrinology and metabolism	2007	107
17151862	D-Glucose	Krabbe KS	Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.	Diabetologia	2007	97
17157112	D-Glucose	Rosenstock J	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.	Clinical therapeutics	2006	92
17167471	D-Glucose	Kahn SE	Mechanisms linking obesity to insulin resistance and type 2 diabetes.	Nature	2006	828
17179929	D-Glucose	Rask-Madsen C	Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.	Nature clinical practice. Endocrinology & metabolism	2007	108
17192339	D-Glucose	Abdul-Ghani MA	Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.	Diabetes care	2007	86
17202130	D-Glucose	Popa C	The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.	Journal of lipid research	2007	95
17213325	D-Glucose	Knudsen LB	Small-molecule agonists for the glucagon-like peptide 1 receptor.	Proceedings of the National Academy of Sciences of the United States of America	2007	56
17267743	D-Glucose	Inaba M	Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.	Journal of the American Society of Nephrology 	2007	82
17277036	D-Glucose	Bosi E	Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.	Diabetes care	2007	79
17285001	D-Glucose	Delarue J	Free fatty acids and insulin resistance.	Current opinion in clinical nutrition and metabolic care	2007	87
17300595	D-Glucose	Nauck MA	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.	Diabetes, obesity & metabolism	2007	121
17327345	D-Glucose	Kilpatrick ES	Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.	Diabetes care	2007	56
17327428	D-Glucose	Mallone R	CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.	Diabetes	2007	72
17327434	D-Glucose	Thum T	Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.	Diabetes	2007	103
17344486	D-Glucose	Corcoran MP	Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise.	The American journal of clinical nutrition	2007	62
17344645	D-Glucose	Ferré P	SREBP-1c transcription factor and lipid homeostasis: clinical perspective.	Hormone research	2007	59
17374708	D-Glucose	Anderson PD	Innate immunity modulates adipokines in humans.	The Journal of clinical endocrinology and metabolism	2007	57
17374712	D-Glucose	Harman-Boehm I	Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity.	The Journal of clinical endocrinology and metabolism	2007	114
17387446	D-Glucose	Fonseca V	Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.	Diabetologia	2007	69
17389326	D-Glucose	Chen YH	High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms.	Diabetes	2007	78
17391153	D-Glucose	Oh DK	Adiponectin in health and disease.	Diabetes, obesity & metabolism	2007	56
17416796	D-Glucose	Laferrère B	Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes.	Diabetes care	2007	123
17429083	D-Glucose	Larsen CM	Interleukin-1-receptor antagonist in type 2 diabetes mellitus.	The New England journal of medicine	2007	437
17443605	D-Glucose	Horvath K	Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.	The Cochrane database of systematic reviews	2007	70
17463246	D-Glucose	Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research.	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.	Science	2007	1043
17463248	D-Glucose	Scott LJ	A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.	Science	2007	1016
17472435	D-Glucose	Parikh H	TXNIP regulates peripheral glucose metabolism in humans.	PLoS medicine	2007	130
17485570	D-Glucose	Goldstein BJ	Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.	Diabetes care	2007	109
17498508	D-Glucose	Baggio LL	Biology of incretins: GLP-1 and GIP.	Gastroenterology	2007	589
17498512	D-Glucose	Parekh S	Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.	Gastroenterology	2007	76
17525361	D-Glucose	Muniyappa R	Cardiovascular actions of insulin.	Endocrine reviews	2007	186
17533210	D-Glucose	Wilson PW	Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.	Archives of internal medicine	2007	236
17574431	D-Glucose	Das Evcimen N	The role of protein kinase C activation and the vascular complications of diabetes.	Pharmacological research	2007	86
17591623	D-Glucose	Farmer A	Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial.	BMJ	2007	95
17593236	D-Glucose	Hermansen K	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.	Diabetes, obesity & metabolism	2007	107
17615265	D-Glucose	Karnieli O	Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.	Stem cells	2007	73
17618108	D-Glucose	Galisteo M	Effects of dietary fibers on disturbances clustered in the metabolic syndrome.	The Journal of nutritional biochemistry	2008	58
17618858	D-Glucose	Klöting N	Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.	Cell metabolism	2007	92
17620449	D-Glucose	Tso AW	Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.	Diabetes care	2007	57
17640997	D-Glucose	Bozaoglu K	Chemerin is a novel adipokine associated with obesity and metabolic syndrome.	Endocrinology	2007	147
17661009	D-Glucose	Schäfer SA	Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.	Diabetologia	2007	83
17666010	D-Glucose	Tremblay F	Role of dietary proteins and amino acids in the pathogenesis of insulin resistance.	Annual review of nutrition	2007	60
17671651	D-Glucose	Lyssenko V	Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.	The Journal of clinical investigation	2007	204
17681171	D-Glucose	Gastaldelli A	Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.	Gastroenterology	2007	98
17690317	D-Glucose	Kotronen A	Fatty liver: a novel component of the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	167
17715056	D-Glucose	Parthier C	Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor.	Proceedings of the National Academy of Sciences of the United States of America	2007	85
17724330	D-Glucose	Jang HJ	Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.	Proceedings of the National Academy of Sciences of the United States of America	2007	228
17804762	D-Glucose	Pascoe L	Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.	Diabetes	2007	79
17827400	D-Glucose	Grarup N	Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.	Diabetes	2007	95
17846126	D-Glucose	Rampersaud E	Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations.	Diabetes	2007	61
17895322	D-Glucose	Goldfine AB	Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.	The Journal of clinical endocrinology and metabolism	2007	71
17924864	D-Glucose	Russell-Jones D	Insulin-associated weight gain in diabetes--causes, effects and coping strategies.	Diabetes, obesity & metabolism	2007	71
17926232	D-Glucose	Chen WW	Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus.	Experimental and clinical endocrinology & diabetes 	2008	52
17926672	D-Glucose	Dalla Man C	Meal simulation model of the glucose-insulin system.	IEEE transactions on bio-medical engineering	2007	88
17928588	D-Glucose	Holst JJ	The physiology of glucagon-like peptide 1.	Physiological reviews	2007	487
17932564	D-Glucose	Handschin C	Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk.	The Journal of clinical investigation	2007	126
17933414	D-Glucose	Nonaka K	Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes.	Diabetes research and clinical practice	2008	60
17940659	D-Glucose	Dias WB	O-GlcNAc modification in diabetes and Alzheimer's disease.	Molecular bioSystems	2007	77
17942823	D-Glucose	Andreasen CH	Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation.	Diabetes	2008	133
17957034	D-Glucose	Muniyappa R	Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.	American journal of physiology. Endocrinology and metabolism	2008	275
17959861	D-Glucose	Fleischman A	Salsalate improves glycemia and inflammatory parameters in obese young adults.	Diabetes care	2008	97
17959933	D-Glucose	Li H	Variants in the fat mass- and obesity-associated (FTO) gene are not associated with obesity in a Chinese Han population.	Diabetes	2008	74
17977954	D-Glucose	Taksali SE	High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.	Diabetes	2008	76
17977958	D-Glucose	Vaxillaire M	Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study.	Diabetes	2008	59
17981116	D-Glucose	Pospisilik JA	Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.	Cell	2007	154
17982337	D-Glucose	Lain KY	Metabolic changes in pregnancy.	Clinical obstetrics and gynecology	2007	83
17991760	D-Glucose	Youn BS	Serum vaspin concentrations in human obesity and type 2 diabetes.	Diabetes	2008	64
18039092	D-Glucose	Waki H	Endocrine functions of adipose tissue.	Annual review of pathology	2007	83
18055507	D-Glucose	Jensen RT	International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.	Pharmacological reviews	2008	103
18057090	D-Glucose	Varma V	Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance.	Diabetes	2008	64
18057091	D-Glucose	Vollmer K	Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.	Diabetes	2008	80
18080106	D-Glucose	Laakso M	Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.	Diabetologia	2008	51
18091002	D-Glucose	Auchincloss AH	Neighborhood resources for physical activity and healthy foods and their association with insulin resistance.	Epidemiology	2008	58
18158075	D-Glucose	Barnett AH	Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.	Clinical therapeutics	2007	62
18162504	D-Glucose	Muscelli E	Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.	Diabetes	2008	68
18175744	D-Glucose	Wolever TM	The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.	The American journal of clinical nutrition	2008	57
18179892	D-Glucose	Wallace C	Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.	American journal of human genetics	2008	178
18197261	D-Glucose	Chao KC	Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.	PloS one	2008	70
18212116	D-Glucose	Aguiari P	High glucose induces adipogenic differentiation of muscle-derived stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2008	67
18220619	D-Glucose	Simó R	Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.	Current diabetes reviews	2006	79
18220694	D-Glucose	Ziyadeh FN	Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.	Current diabetes reviews	2008	91
18223156	D-Glucose	Chung J	HSP72 protects against obesity-induced insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2008	122
18227495	D-Glucose	Shanik MH	Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?	Diabetes care	2008	98
18230953	D-Glucose	Aronson D	Hyperglycemia and the pathobiology of diabetic complications.	Advances in cardiology	2008	69
18239636	D-Glucose	Rodieux F	Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.	Obesity	2008	71
18250214	D-Glucose	Tasali E	Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation.	Proceedings of the American Thoracic Society	2008	78
18252893	D-Glucose	Zhang X	Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.	Diabetes	2008	175
18256393	D-Glucose	Gaede P	Effect of a multifactorial intervention on mortality in type 2 diabetes.	The New England journal of medicine	2008	548
18267070	D-Glucose	Chibalin AV	Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance.	Cell	2008	69
18287102	D-Glucose	Runge S	Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.	The Journal of biological chemistry	2008	104
18288110	D-Glucose	Kroon E	Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.	Nature biotechnology	2008	510
18297260	D-Glucose	Ellard S	Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.	Diabetologia	2008	53
18299316	D-Glucose	Hayashi T	Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans.	Diabetes	2008	53
18316358	D-Glucose	Do R	Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study.	Diabetes	2008	58
18323454	D-Glucose	Dentin R	Hepatic glucose sensing via the CREB coactivator CRTC2.	Science	2008	119
18334488	D-Glucose	Keller P	Fat-specific protein 27 regulates storage of triacylglycerol.	The Journal of biological chemistry	2008	72
18347614	D-Glucose	Lawrence MC	The roles of MAPKs in disease.	Cell research	2008	60
18355813	D-Glucose	Korenblat KM	Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.	Gastroenterology	2008	117
18374840	D-Glucose	Bretzel RG	Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.	Lancet	2008	72
18378618	D-Glucose	Schramm TK	Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.	Circulation	2008	79
18391974	D-Glucose	Gross DN	The role of FoxO in the regulation of metabolism.	Oncogene	2008	152
18393104	D-Glucose	Elliott PJ	Sirtuins: novel targets for metabolic disease.	Current opinion in investigational drugs	2008	54
18397542	D-Glucose	Trayhurn P	Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?	The British journal of nutrition	2008	87
18397984	D-Glucose	Zhang Y	Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.	The Journal of clinical endocrinology and metabolism	2008	80
18401346	D-Glucose	Guilherme A	Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.	Nature reviews. Molecular cell biology	2008	462
18402643	D-Glucose	Berthoud HR	Vagal and hormonal gut-brain communication: from satiation to satisfaction.	Neurogastroenterology and motility 	2008	66
18430778	D-Glucose	Laferrère B	Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2008	148
18442638	D-Glucose	Yin J	Efficacy of berberine in patients with type 2 diabetes mellitus.	Metabolism	2008	78
18445751	D-Glucose	Copeland RJ	Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.	American journal of physiology. Endocrinology and metabolism	2008	95
18451265	D-Glucose	Bouatia-Naji N	A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels.	Science	2008	101
18458145	D-Glucose	Fonseca VA	Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.	Diabetes care	2008	51
18460560	D-Glucose	Saudek CD	A new look at screening and diagnosing diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2008	100
18463376	D-Glucose	Rowan JA	Metformin versus insulin for the treatment of gestational diabetes.	The New England journal of medicine	2008	121
18474251	D-Glucose	Kotronen A	Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.	Gastroenterology	2008	56
18477703	D-Glucose	Sakamoto K	Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic.	American journal of physiology. Endocrinology and metabolism	2008	116
18492747	D-Glucose	Hivert MF	Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.	The Journal of clinical endocrinology and metabolism	2008	73
18502299	D-Glucose	Weng J	Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.	Lancet	2008	145
18515784	D-Glucose	Park TS	Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.	Journal of lipid research	2008	101
18544448	D-Glucose	Shaw JE	Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention.	Diabetes research and clinical practice	2008	65
18556336	D-Glucose	Vaxillaire M	The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.	Diabetes	2008	55
18563385	D-Glucose	Di Marzo V	The endocannabinoid system in obesity and type 2 diabetes.	Diabetologia	2008	57
18584872	D-Glucose	Wong TY	Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study.	Ophthalmology	2008	71
18598135	D-Glucose	Saggerson D	Malonyl-CoA, a key signaling molecule in mammalian cells.	Annual review of nutrition	2008	58
18612115	D-Glucose	Ix JH	Fetuin-A and incident diabetes mellitus in older persons.	JAMA	2008	67
18633108	D-Glucose	Wu Y	Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.	Diabetes	2008	80
18633113	D-Glucose	Stefan N	Plasma fetuin-A levels and the risk of type 2 diabetes.	Diabetes	2008	74
18650365	D-Glucose	Dasu MR	High glucose induces toll-like receptor expression in human monocytes: mechanism of activation.	Diabetes	2008	90
18651836	D-Glucose	Agius L	Glucokinase and molecular aspects of liver glycogen metabolism.	The Biochemical journal	2008	76
18654640	D-Glucose	Reed BD	Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes.	PLoS genetics	2008	78
18664780	D-Glucose	Egi M	Blood glucose concentration and outcome of critical illness: the impact of diabetes.	Critical care medicine	2008	84
18678614	D-Glucose	Orho-Melander M	Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.	Diabetes	2008	97
18680716	D-Glucose	Gälman C	The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.	Cell metabolism	2008	118
18682512	D-Glucose	Aguilar-Salinas CA	High adiponectin concentrations are associated with the metabolically healthy obese phenotype.	The Journal of clinical endocrinology and metabolism	2008	56
18689695	D-Glucose	Balkau B	Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).	Diabetes care	2008	56
18694998	D-Glucose	Cohen RM	Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.	Blood	2008	78
18700811	D-Glucose	Brunner EJ	Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.	PLoS medicine	2008	50
18715214	D-Glucose	Hirsch IB	Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.	Diabetes technology & therapeutics	2008	67
18716028	D-Glucose	Wang Q	MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.	FASEB journal 	2008	128
18726182	D-Glucose	Iynedjian PB	Molecular physiology of mammalian glucokinase.	Cellular and molecular life sciences 	2009	80
18775919	D-Glucose	Hajer GR	Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.	European heart journal	2008	242
18776125	D-Glucose	Lindenmeyer MT	Proteinuria and hyperglycemia induce endoplasmic reticulum stress.	Journal of the American Society of Nephrology 	2008	62
18776141	D-Glucose	Hivert MF	Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study.	Diabetes	2008	52
18782641	D-Glucose	Drucker DJ	Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.	Lancet	2008	212
18782754	D-Glucose	Tateishi K	Generation of insulin-secreting islet-like clusters from human skin fibroblasts.	The Journal of biological chemistry	2008	104
18786605	D-Glucose	Holst JJ	The incretin system and its role in type 2 diabetes mellitus.	Molecular and cellular endocrinology	2009	79
18796548	D-Glucose	Cacho J	Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats.	American journal of physiology. Endocrinology and metabolism	2008	85
18802479	D-Glucose	Skowera A	CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.	The Journal of clinical investigation	2008	125
18823409	D-Glucose	Mahon JL	The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.	Pediatric diabetes	2009	60
18834431	D-Glucose	Rahier J	Pancreatic beta-cell mass in European subjects with type 2 diabetes.	Diabetes, obesity & metabolism	2008	191
18852465	D-Glucose	Lewis EC	alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	54
18854421	D-Glucose	Deepa SS	APPL1: role in adiponectin signaling and beyond.	American journal of physiology. Endocrinology and metabolism	2009	65
18929315	D-Glucose	Van Cauter E	Metabolic consequences of sleep and sleep loss.	Sleep medicine	2008	99
18929493	D-Glucose	Tilg H	Insulin resistance, inflammation, and non-alcoholic fatty liver disease.	Trends in endocrinology and metabolism	2008	85
18931681	D-Glucose	Chadt A	Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity.	Nature genetics	2008	64
18984661	D-Glucose	Kanazawa I	Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2009	70
18984664	D-Glucose	Lauenborg J	Common type 2 diabetes risk gene variants associate with gestational diabetes.	The Journal of clinical endocrinology and metabolism	2009	52
18984744	D-Glucose	Martin B	Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.	Diabetes	2009	64
18984776	D-Glucose	Ferrara A	Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study.	Diabetes care	2009	46
19026743	D-Glucose	Zhao WQ	Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.	Biochimica et biophysica acta	2009	59
19028792	D-Glucose	Laczy B	Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.	American journal of physiology. Heart and circulatory physiology	2009	55
19032965	D-Glucose	Risérus U	Dietary fats and prevention of type 2 diabetes.	Progress in lipid research	2009	103
19037628	D-Glucose	Højberg PV	Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.	Diabetologia	2009	49
19056578	D-Glucose	Greenfield JR	Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.	The American journal of clinical nutrition	2009	49
19060907	D-Glucose	Prokopenko I	Variants in MTNR1B influence fasting glucose levels.	Nature genetics	2009	259
19060908	D-Glucose	Lyssenko V	Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.	Nature genetics	2009	179
19060909	D-Glucose	Bouatia-Naji N	A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.	Nature genetics	2009	179
19066313	D-Glucose	Gregor MF	Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss.	Diabetes	2009	141
19074209	D-Glucose	Azadbakht L	Red meat intake is associated with metabolic syndrome and the plasma C-reactive protein concentration in women.	The Journal of nutrition	2009	48
19074620	D-Glucose	Kim W	The role of incretins in glucose homeostasis and diabetes treatment.	Pharmacological reviews	2008	141
19074989	D-Glucose	Staiger H	Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.	Diabetes	2009	50
19083400	D-Glucose	Kajiyama S	Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.	Nutrition research	2008	68
19088155	D-Glucose	Cryer PE	Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.	The Journal of clinical endocrinology and metabolism	2009	116
19088165	D-Glucose	Pittas AG	Association between serum osteocalcin and markers of metabolic phenotype.	The Journal of clinical endocrinology and metabolism	2009	90
19136653	D-Glucose	Fiaschi-Taesch N	Survey of the human pancreatic beta-cell G1/S proteome reveals a potential therapeutic role for cdk-6 and cyclin D1 in enhancing human beta-cell replication and function in vivo.	Diabetes	2009	58
19141606	D-Glucose	Maratou E	Studies of insulin resistance in patients with clinical and subclinical hypothyroidism.	European journal of endocrinology	2009	56
19153412	D-Glucose	Vetter ML	Narrative review: effect of bariatric surgery on type 2 diabetes mellitus.	Annals of internal medicine	2009	46
19183311	D-Glucose	Katulanda P	Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka--Sri Lanka Diabetes, Cardiovascular Study (SLDCS).	Diabetic medicine 	2008	56
19189073	D-Glucose	Yan SF	Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.	Journal of molecular medicine	2009	54
19196887	D-Glucose	Bunck MC	One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.	Diabetes care	2009	105
19199892	D-Glucose	Crawford TN	Diabetic retinopathy and angiogenesis.	Current diabetes reviews	2009	73
19221011	D-Glucose	Ma J	Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects.	American journal of physiology. Gastrointestinal and liver physiology	2009	56
19228809	D-Glucose	Becker ML	Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study.	Diabetes	2009	57
19238145	D-Glucose	Lynch LA	Are natural killer cells protecting the metabolically healthy obese patient?	Obesity	2009	48
19252892	D-Glucose	Roberts R	Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans.	Diabetologia	2009	73
19255591	D-Glucose	Zhang D	Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells.	Cell research	2009	145
19259271	D-Glucose	Klöting N	MicroRNA expression in human omental and subcutaneous adipose tissue.	PloS one	2009	77
19265200	D-Glucose	Lin HM	Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function.	The Journal of biological chemistry	2009	49
19272022	D-Glucose	Ooms LM	The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.	The Biochemical journal	2009	72
19272486	D-Glucose	Buchwald H	Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.	The American journal of medicine	2009	369
19283361	D-Glucose	Barrett EJ	The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action.	Diabetologia	2009	82
19286634	D-Glucose	Orimo M	Protective role of SIRT1 in diabetic vascular dysfunction.	Arteriosclerosis, thrombosis, and vascular biology	2009	52
19289857	D-Glucose	Zinman B	Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).	Diabetes care	2009	188
19295913	D-Glucose	Guo T	Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.	PloS one	2009	76
19317822	D-Glucose	Marre M	Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).	Diabetic medicine 	2009	183
19332493	D-Glucose	Brøns C	Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men.	The Journal of physiology	2009	52
19337387	D-Glucose	Goldfine AB	Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.	Clinical and translational science	2008	88
19342601	D-Glucose	Barcelos LS	Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling.	Circulation research	2009	68
19346330	D-Glucose	Chiang JY	Bile acids: regulation of synthesis.	Journal of lipid research	2009	245
19358976	D-Glucose	Profenno LA	Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.	Biological psychiatry	2010	123
19363506	D-Glucose	Cummings DE	Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery.	International journal of obesity	2009	52
19365392	D-Glucose	Ahrén B	Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.	Nature reviews. Drug discovery	2009	115
19372197	D-Glucose	Thaler JP	Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery.	Endocrinology	2009	93
19373249	D-Glucose	Matschinsky FM	Assessing the potential of glucokinase activators in diabetes therapy.	Nature reviews. Drug discovery	2009	95
19376193	D-Glucose	Confavreux CB	A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms.	Molecular and cellular endocrinology	2009	51
19381165	D-Glucose	Becker ML	Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus.	The pharmacogenomics journal	2009	49
19399017	D-Glucose	Fève B	The role of interleukins in insulin resistance and type 2 diabetes mellitus.	Nature reviews. Endocrinology	2009	48
19401422	D-Glucose	Capel F	Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization.	Diabetes	2009	45
19407273	D-Glucose	Fernandez-Egea E	Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.	The British journal of psychiatry 	2009	56
19433249	D-Glucose	Nadal A	The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes.	Molecular and cellular endocrinology	2009	53
19442898	D-Glucose	Jansen J	Zinc and diabetes--clinical links and molecular mechanisms.	The Journal of nutritional biochemistry	2009	47
19444259	D-Glucose	Lovshin JA	Incretin-based therapies for type 2 diabetes mellitus.	Nature reviews. Endocrinology	2009	153
19450229	D-Glucose	Pound LD	Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion.	The Biochemical journal	2009	56
19478200	D-Glucose	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	47
19487637	D-Glucose	Chavez AO	Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.	Diabetes care	2009	71
19487712	D-Glucose	Sowers JR	Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.	Annals of internal medicine	2009	65
19490822	D-Glucose	Gross DN	The role of FOXO in the regulation of metabolism.	Current diabetes reports	2009	57
19515410	D-Glucose	Tabák AG	Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.	Lancet	2009	165
19515413	D-Glucose	Buse JB	Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).	Lancet	2009	310
19515415	D-Glucose	Henry RR	Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.	Lancet	2009	49
19542260	D-Glucose	Stamatakis KA	Effects of sleep fragmentation on glucose metabolism in normal subjects.	Chest	2010	133
19549731	D-Glucose	Tuch BE	Safety and viability of microencapsulated human islets transplanted into diabetic humans.	Diabetes care	2009	55
19567526	D-Glucose	Nedeltcheva AV	Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance.	The Journal of clinical endocrinology and metabolism	2009	86
19581401	D-Glucose	Kato M	MicroRNAs and their role in progressive kidney diseases.	Clinical journal of the American Society of Nephrology 	2009	67
19581419	D-Glucose	Molina AJ	Mitochondrial networking protects beta-cells from nutrient-induced apoptosis.	Diabetes	2009	84
19584347	D-Glucose	Li S	Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis.	JAMA	2009	228
19602480	D-Glucose	Prokunina-Olsson L	Tissue-specific alternative splicing of TCF7L2.	Human molecular genetics	2009	45
19620249	D-Glucose	Vigneri P	Diabetes and cancer.	Endocrine-related cancer	2009	199
19623253	D-Glucose	Muzumdar RH	Humanin: a novel central regulator of peripheral insulin action.	PloS one	2009	51
19629071	D-Glucose	Shackelford DB	The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.	Nature reviews. Cancer	2009	446
19638921	D-Glucose	Peterli R	Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.	Annals of surgery	2009	95
19647786	D-Glucose	Butkinaree C	O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.	Biochimica et biophysica acta	2010	114
19651814	D-Glucose	Kantartzis K	Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.	Diabetes	2009	72
19654916	D-Glucose	Turyk M	Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers.	Environmental health perspectives	2009	49
19670459	D-Glucose	Gastaldelli A	Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.	Hepatology	2009	49
19706465	D-Glucose	Lemaire K	Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	91
19715772	D-Glucose	Poitout V	Glucolipotoxicity of the pancreatic beta cell.	Biochimica et biophysica acta	2010	75
19720798	D-Glucose	Sell H	Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.	Diabetes	2009	59
19723556	D-Glucose	Galic S	Adipose tissue as an endocrine organ.	Molecular and cellular endocrinology	2010	309
19759171	D-Glucose	Catalano PM	Perinatal risk factors for childhood obesity and metabolic dysregulation.	The American journal of clinical nutrition	2009	105
19789205	D-Glucose	Kalyani RR	The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women.	The Journal of clinical endocrinology and metabolism	2009	55
19790256	D-Glucose	Osbak KK	Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.	Human mutation	2009	82
19797280	D-Glucose	Landon MB	A multicenter, randomized trial of treatment for mild gestational diabetes.	The New England journal of medicine	2009	247
19800084	D-Glucose	Zhang H	Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.	Metabolism	2010	56
19800254	D-Glucose	Lynn FC	Meta-regulation: microRNA regulation of glucose and lipid metabolism.	Trends in endocrinology and metabolism	2009	59
19808920	D-Glucose	Carson AP	Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults.	Diabetes care	2010	55
19819943	D-Glucose	Böni-Schnetzler M	Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I.	Endocrinology	2009	59
19833888	D-Glucose	Simonis-Bik AM	Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function.	Diabetes	2010	45
19858063	D-Glucose	Rodbard HW	Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.	Endocrine practice 	2009	204
19862325	D-Glucose	Hu C	PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population.	PloS one	2009	60
19864158	D-Glucose	Pinney SE	Epigenetic mechanisms in the development of type 2 diabetes.	Trends in endocrinology and metabolism	2010	44
19877133	D-Glucose	Hwang YC	The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects.	Diabetes/metabolism research and reviews	2009	47
19883376	D-Glucose	Wang F	Brd2 disruption in mice causes severe obesity without Type 2 diabetes.	The Biochemical journal	2009	46
19896496	D-Glucose	Castañeda TR	Ghrelin in the regulation of body weight and metabolism.	Frontiers in neuroendocrinology	2010	78
19897009	D-Glucose	Saji M	The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.	Molecular and cellular endocrinology	2010	47
19906796	D-Glucose	Higgins LS	Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation.	The American journal of clinical nutrition	2010	45
19906806	D-Glucose	Ziemke F	Adiponectin in insulin resistance: lessons from translational research.	The American journal of clinical nutrition	2010	87
19931306	D-Glucose	Reynolds GP	Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.	Pharmacology & therapeutics	2010	66
19934006	D-Glucose	Oudit GY	Human recombinant ACE2 reduces the progression of diabetic nephropathy.	Diabetes	2010	71
19958890	D-Glucose	Botros N	Obstructive sleep apnea as a risk factor for type 2 diabetes.	The American journal of medicine	2009	68
19965390	D-Glucose	Rosengren AH	Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes.	Science	2010	68
19966268	D-Glucose	Nelson SM	Maternal metabolism and obesity: modifiable determinants of pregnancy outcome.	Human reproduction update	2010	67
20005308	D-Glucose	Dominy JE Jr	Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5.	Biochimica et biophysica acta	2010	53
20007948	D-Glucose	Holzinger U	Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial.	Diabetes care	2010	52
20022465	D-Glucose	Das UN	Obesity: genes, brain, gut, and environment.	Nutrition	2010	49
20029383	D-Glucose	Kashyap SR	Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.	International journal of obesity	2010	63
20056746	D-Glucose	Krupa A	Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.	Journal of the American Society of Nephrology 	2010	108
20061378	D-Glucose	Pacholec M	SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.	The Journal of biological chemistry	2010	286
20065965	D-Glucose	Manolopoulos KN	Gluteofemoral body fat as a determinant of metabolic health.	International journal of obesity	2010	123
20067961	D-Glucose	Deopurkar R	Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3.	Diabetes care	2010	55
20067962	D-Glucose	Dasu MR	Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.	Diabetes care	2010	116
20075143	D-Glucose	Read PA	DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease.	Circulation. Cardiovascular imaging	2010	46
20081858	D-Glucose	Dupuis J	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Nature genetics	2010	750
20086228	D-Glucose	Roggli E	Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.	Diabetes	2010	83
20092409	D-Glucose	Jain SK	Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?	Antioxidants & redox signaling	2010	56
20092585	D-Glucose	Vilsbøll T	Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2010	70
20097779	D-Glucose	Bertoni AG	Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).	Diabetes care	2010	51
20126310	D-Glucose	Ortega FJ	MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation.	PloS one	2010	82
20129687	D-Glucose	Pan HY	Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes.	Diabetes research and clinical practice	2010	43
20151996	D-Glucose	Elhayany A	A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study.	Diabetes, obesity & metabolism	2010	43
20159883	D-Glucose	Moran LJ	Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.	Human reproduction update	2010	100
20165834	D-Glucose	Kanazawa I	Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.	Osteoporosis international 	2011	44
20179247	D-Glucose	Frisard MI	Toll-like receptor 4 modulates skeletal muscle substrate metabolism.	American journal of physiology. Endocrinology and metabolism	2010	45
20185635	D-Glucose	Ortiz-Muñoz G	Suppressors of cytokine signaling abrogate diabetic nephropathy.	Journal of the American Society of Nephrology 	2010	40
20185812	D-Glucose	Yang X	Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.	Diabetes	2010	43
20215450	D-Glucose	Kayaniyil S	Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes.	Diabetes care	2010	67
20215461	D-Glucose	Buse JB	DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.	Diabetes care	2010	56
20226138	D-Glucose	Clar C	Self-monitoring of blood glucose in type 2 diabetes: systematic review.	Health technology assessment	2010	53
20228402	D-Glucose	NAVIGATOR Study Group.	Effect of nateglinide on the incidence of diabetes and cardiovascular events.	The New England journal of medicine	2010	83
20308787	D-Glucose	Li Y	GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	65
20336705	D-Glucose	Speliotes EK	Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.	Hepatology	2010	86
20353613	D-Glucose	Gallagher IJ	Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.	Genome medicine	2010	61
20357360	D-Glucose	Wentworth JM	Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity.	Diabetes	2010	123
20357361	D-Glucose	Velthuis JH	Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.	Diabetes	2010	58
20357365	D-Glucose	Sarruf DA	Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.	Diabetes	2010	68
20368410	D-Glucose	Isbell JM	The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery.	Diabetes care	2010	61
20370677	D-Glucose	Bugianesi E	Insulin resistance in nonalcoholic fatty liver disease.	Current pharmaceutical design	2010	55
20371664	D-Glucose	Donga E	A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects.	The Journal of clinical endocrinology and metabolism	2010	79
20372150	D-Glucose	Freathy RM	Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight.	Nature genetics	2010	75
20375212	D-Glucose	Sell H	Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.	The Journal of clinical endocrinology and metabolism	2010	51
20376506	D-Glucose	Nicolucci A	Epidemiological aspects of neoplasms in diabetes.	Acta diabetologica	2010	48
20385436	D-Glucose	Bellomo G	Association of uric acid with change in kidney function in healthy normotensive individuals.	American journal of kidney diseases 	2010	45
20392876	D-Glucose	Pearen MA	Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.	Molecular endocrinology	2010	90
20417856	D-Glucose	Pratley RE	Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial.	Lancet	2010	127
20418489	D-Glucose	Qi L	Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes.	Human molecular genetics	2010	95
20424233	D-Glucose	German JP	Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.	Diabetes	2010	46
20444434	D-Glucose	Frisardi V	Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.	Ageing research reviews	2010	46
20445742	D-Glucose	Abdul-Ghani MA	Pathogenesis of insulin resistance in skeletal muscle.	Journal of biomedicine & biotechnology	2010	97
20480025	D-Glucose	Hanhineva K	Impact of dietary polyphenols on carbohydrate metabolism.	International journal of molecular sciences	2010	83
20497976	D-Glucose	Widyantoro B	Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.	Circulation	2010	85
20501948	D-Glucose	Maier B	The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.	The Journal of clinical investigation	2010	60
20508640	D-Glucose	Chao EC	SGLT2 inhibition--a novel strategy for diabetes treatment.	Nature reviews. Drug discovery	2010	80
20511061	D-Glucose	Takiishi T	Vitamin D and diabetes.	Endocrinology and metabolism clinics of North America	2010	49
20516647	D-Glucose	So A	Uric acid transport and disease.	The Journal of clinical investigation	2010	88
20526369	D-Glucose	Gall WE	alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.	PloS one	2010	137
20530747	D-Glucose	Sun L	A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese.	Diabetes care	2010	61
20556549	D-Glucose	Cusi K	The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes.	Current diabetes reports	2010	79
20562852	D-Glucose	Marcheva B	Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes.	Nature	2010	345
20580422	D-Glucose	Bergenstal RM	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.	Lancet	2010	131
20581420	D-Glucose	HEALTHY Study Group.	A school-based intervention for diabetes risk reduction.	The New England journal of medicine	2010	96
20584998	D-Glucose	Tong J	Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans.	Diabetes	2010	82
20587723	D-Glucose	Gogitidze Joy N	Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals.	Diabetes care	2010	44
20588114	D-Glucose	Dinarello CA	Role of IL-1beta in type 2 diabetes.	Current opinion in endocrinology, diabetes, and obesity	2010	83
20609969	D-Glucose	Diamant M	Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.	Lancet	2010	90
20609972	D-Glucose	Samuel VT	Lipid-induced insulin resistance: unravelling the mechanism.	Lancet	2010	263
20623580	D-Glucose	Li T	Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.	Hepatology	2010	59
20628408	D-Glucose	Velho S	Metabolically healthy obesity: different prevalences using different criteria.	European journal of clinical nutrition	2010	49
20638012	D-Glucose	Ingerski LM	Blood glucose monitoring and glycemic control in adolescence: contribution of diabetes-specific responsibility and family conflict.	The Journal of adolescent health 	2010	42
20646185	D-Glucose	Aversa A	Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.	The journal of sexual medicine	2010	45
20651284	D-Glucose	Zampetaki A	Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes.	Circulation research	2010	289
20660625	D-Glucose	Bindom SM	Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.	Diabetes	2010	43
20664016	D-Glucose	Brown TT	Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.	Diabetes care	2010	63
20668154	D-Glucose	D'Adamo E	Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.	Diabetes care	2010	52
20693352	D-Glucose	Nettleton JA	Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies.	Diabetes care	2010	51
20694148	D-Glucose	Zabaneh D	A genome-wide association study of the metabolic syndrome in Indian Asian men.	PloS one	2010	44
20724651	D-Glucose	Bouchard L	Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy.	Diabetes care	2010	52
20739649	D-Glucose	Matsuzaki T	Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.	Neurology	2010	89
20798346	D-Glucose	Unger RH	Paracrinology of islets and the paracrinopathy of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2010	71
20816089	D-Glucose	Kim HS	Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.	Cell metabolism	2010	128
20817486	D-Glucose	Ernst MC	Chemerin: at the crossroads of inflammation and obesity.	Trends in endocrinology and metabolism	2010	60
20829514	D-Glucose	Lima FO	The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion.	Stroke	2010	48
20835230	D-Glucose	Masters SL	Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.	Nature immunology	2010	307
20837822	D-Glucose	Baker LD	Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.	Archives of neurology	2011	138
20842602	D-Glucose	Yessoufou A	Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.	Swiss medical weekly	2010	40
20843952	D-Glucose	Liu J	Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study.	The Journal of clinical endocrinology and metabolism	2010	87
20857148	D-Glucose	Kong L	Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.	Acta diabetologica	2011	102
20871975	D-Glucose	Nauck MA	Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?	Diabetologia	2011	84
20876708	D-Glucose	Musso G	Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?	Diabetes care	2010	119
20881129	D-Glucose	Lane RF	Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex.	The Journal of neuroscience 	2010	54
20923485	D-Glucose	Durán A	Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups.	Journal of diabetes	2010	42
20929995	D-Glucose	Best JH	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database.	Diabetes care	2011	57
20932932	D-Glucose	Fenton TR	Functions and regulation of the 70kDa ribosomal S6 kinases.	The international journal of biochemistry & cell biology	2011	86
20937689	D-Glucose	Calori G	Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study.	Diabetes care	2011	65
20943795	D-Glucose	Mozaffarian D	Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.	The American journal of clinical nutrition	2010	48
20947447	D-Glucose	Gill RS	Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review.	Surgery for obesity and related diseases 	2010	40
20975552	D-Glucose	Egi M	The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes.	Critical care medicine	2011	37
20978091	D-Glucose	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	56
21029304	D-Glucose	Ferré P	Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.	Diabetes, obesity & metabolism	2010	94
21088486	D-Glucose	Cufí S	Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.	Cell cycle	2010	75
21104225	D-Glucose	Yang BT	Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets.	Diabetologia	2011	50
21114598	D-Glucose	Deacon CF	Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review.	Diabetes, obesity & metabolism	2011	81
21114605	D-Glucose	Taskinen MR	Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.	Diabetes, obesity & metabolism	2011	65
21115952	D-Glucose	Schrijvers EM	Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study.	Neurology	2010	72
21128002	D-Glucose	Nguyen NT	Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006.	Obesity surgery	2011	59
21138825	D-Glucose	Buse JB	Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.	Annals of internal medicine	2011	97
21188353	D-Glucose	Ramos E	Replication of genome-wide association studies (GWAS) loci for fasting plasma glucose in African-Americans.	Diabetologia	2011	37
21194578	D-Glucose	Nauck MA	Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications.	The American journal of medicine	2011	67
21205122	D-Glucose	Del Prato S	Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.	Diabetes, obesity & metabolism	2011	71
21205128	D-Glucose	Garber A	Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2011	42
21208359	D-Glucose	Madsbad S	An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.	Diabetes, obesity & metabolism	2011	42
21226820	D-Glucose	Tremblay AJ	Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2011	41
21233852	D-Glucose	Donath MY	Type 2 diabetes as an inflammatory disease.	Nature reviews. Immunology	2011	545
21241070	D-Glucose	Graham GG	Clinical pharmacokinetics of metformin.	Clinical pharmacokinetics	2011	127
21241768	D-Glucose	Fröjdö S	Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1.	Molecular and cellular endocrinology	2011	38
21261639	D-Glucose	Szkudelski T	Anti-diabetic effects of resveratrol.	Annals of the New York Academy of Sciences	2011	38
21266331	D-Glucose	Elbein SC	Global gene expression profiles of subcutaneous adipose and muscle from glucose-tolerant, insulin-sensitive, and insulin-resistant individuals matched for BMI.	Diabetes	2011	38
21270174	D-Glucose	Birkeland KI	Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.	Diabetes care	2011	43
21270197	D-Glucose	Pussinen PJ	Endotoxemia is associated with an increased risk of incident diabetes.	Diabetes care	2011	61
21270272	D-Glucose	Tan Y	Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo.	Diabetes	2011	90
21288502	D-Glucose	Catalano PM	Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic?	American journal of obstetrics and gynecology	2011	73
21307137	D-Glucose	Blevins T	DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2011	75
21321189	D-Glucose	Li Y	Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver.	FASEB journal 	2011	83
21325336	D-Glucose	Liu C	PGC-1 coactivators in the control of energy metabolism.	Acta biochimica et biophysica Sinica	2011	50
21340625	D-Glucose	Shimoda M	The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.	Diabetologia	2011	37
21349201	D-Glucose	Su G	Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.	Cardiovascular diabetology	2011	48
21358855	D-Glucose	Schmid SM	Disturbed glucoregulatory response to food intake after moderate sleep restriction.	Sleep	2011	43
21362136	D-Glucose	Wang A	Hyaluronan matrices in pathobiological processes.	The FEBS journal	2011	51
21367930	D-Glucose	Steil GM	The effect of insulin feedback on closed loop glucose control.	The Journal of clinical endocrinology and metabolism	2011	49
21375707	D-Glucose	Nedergaard J	Three years with adult human brown adipose tissue.	Annals of the New York Academy of Sciences	2010	51
21377179	D-Glucose	Jorge ML	The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus.	Metabolism	2011	47
21386085	D-Glucose	Kraja AT	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Diabetes	2011	83
21391816	D-Glucose	Hart GW	Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.	Annual review of biochemistry	2011	314
21393865	D-Glucose	Jin W	Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance.	The Journal of clinical investigation	2011	39
21403394	D-Glucose	Rhee EP	Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.	The Journal of clinical investigation	2011	134
21410628	D-Glucose	Gomis R	Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study.	Diabetes, obesity & metabolism	2011	38
21430088	D-Glucose	Nauck MA	Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans.	Diabetes	2011	55
21435176	D-Glucose	Bosco D	Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis.	Journal of cellular and molecular medicine	2011	45
21481590	D-Glucose	Gurzov EN	Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction.	Trends in cell biology	2011	50
21489811	D-Glucose	Marino JS	Central insulin and leptin-mediated autonomic control of glucose homeostasis.	Trends in endocrinology and metabolism	2011	40
21495788	D-Glucose	Musso G	A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (SGLT) inhibitors: systematic review and meta-analysis of randomized trials.	Annals of medicine	2012	45
21518883	D-Glucose	Kimura I	Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41).	Proceedings of the National Academy of Sciences of the United States of America	2011	101
21523780	D-Glucose	Dinarello CA	A clinical perspective of IL-1β as the gatekeeper of inflammation.	European journal of immunology	2011	164
21527729	D-Glucose	Morton GJ	Leptin and the central nervous system control of glucose metabolism.	Physiological reviews	2011	81
21531886	D-Glucose	Bakris GL	Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.	Mayo Clinic proceedings	2011	35
21593290	D-Glucose	Katula JA	One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project.	Diabetes care	2011	64
21598254	D-Glucose	Liu Y	Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.	The Journal of pathology	2011	91
21599535	D-Glucose	Leavens KF	Insulin signaling to hepatic lipid metabolism in health and disease.	Critical reviews in biochemistry and molecular biology	2011	41
21614570	D-Glucose	Camastra S	Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.	Diabetologia	2011	41
21617108	D-Glucose	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Diabetes care	2011	73
21617152	D-Glucose	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2011	58
21633176	D-Glucose	Gautron L	Sixteen years and counting: an update on leptin in energy balance.	The Journal of clinical investigation	2011	117
21638209	D-Glucose	Samarakoon R	TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.	Cell and tissue research	2012	39
21646372	D-Glucose	Grossmann M	Low testosterone in men with type 2 diabetes: significance and treatment.	The Journal of clinical endocrinology and metabolism	2011	39
21647189	D-Glucose	Barrera JG	GLP-1 and energy balance: an integrated model of short-term and long-term control.	Nature reviews. Endocrinology	2011	58
21647700	D-Glucose	Below JE	Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals.	Diabetologia	2011	51
21693741	D-Glucose	de Boer IH	Temporal trends in the prevalence of diabetic kidney disease in the United States.	JAMA	2011	180
21697254	D-Glucose	DeFronzo RA	Preservation of β-cell function: the key to diabetes prevention.	The Journal of clinical endocrinology and metabolism	2011	55
21723505	D-Glucose	Yadav H	Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.	Cell metabolism	2011	117
21730284	D-Glucose	Giannini C	The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds.	Diabetes care	2011	48
21778224	D-Glucose	Srikanthan P	Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey.	The Journal of clinical endocrinology and metabolism	2011	111
21778425	D-Glucose	Zhou S	Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction.	Circulation research	2011	49
21781152	D-Glucose	Owens DR	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study.	Diabetic medicine 	2011	55
21805476	D-Glucose	Borena W	Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.	International journal of cancer	2012	41
21809358	D-Glucose	Cardinale V	Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets.	Hepatology	2011	75
21812507	D-Glucose	Baetta R	Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences.	Drugs	2011	42
21813778	D-Glucose	Westwell-Roper C	IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.	Journal of immunology	2011	42
21816244	D-Glucose	Kousteni S	FoxO1, the transcriptional chief of staff of energy metabolism.	Bone	2012	43
21824266	D-Glucose	D'Alessio D	The role of dysregulated glucagon secretion in type 2 diabetes.	Diabetes, obesity & metabolism	2011	55
21829658	D-Glucose	Karolina DS	MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.	PloS one	2011	88
21841312	D-Glucose	Wei FY	Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice.	The Journal of clinical investigation	2011	66
21841783	D-Glucose	Ohtsubo K	Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.	Nature medicine	2011	39
21855697	D-Glucose	Reaven GM	Insulin resistance: the link between obesity and cardiovascular disease.	The Medical clinics of North America	2011	93
21860458	D-Glucose	Xiang Y	Using personal glucose meters and functional DNA sensors to quantify a variety of analytical targets.	Nature chemistry	2011	56
21861177	D-Glucose	Wannamethee SG	Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study.	Diabetologia	2012	34
21864752	D-Glucose	Dimitriadis G	Insulin effects in muscle and adipose tissue.	Diabetes research and clinical practice	2011	41
21865645	D-Glucose	Ravassard P	A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion.	The Journal of clinical investigation	2011	90
21868679	D-Glucose	Little JP	Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes.	Journal of applied physiology	2011	87
21868791	D-Glucose	Salehi M	Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans.	Diabetes	2011	76
21873549	D-Glucose	Strawbridge RJ	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Diabetes	2011	102
21890681	D-Glucose	Pirola L	Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.	Genome research	2011	43
21909109	D-Glucose	Kim YJ	Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.	Nature genetics	2011	83
21911743	D-Glucose	Eller K	Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy.	Diabetes	2011	58
21917523	D-Glucose	Diano S	Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism.	Trends in molecular medicine	2012	46
21933988	D-Glucose	Kowluru RA	Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.	Diabetes	2011	43
21950636	D-Glucose	Donnelly D	The structure and function of the glucagon-like peptide-1 receptor and its ligands.	British journal of pharmacology	2012	37
21962509	D-Glucose	Zhu H	The Lin28/let-7 axis regulates glucose metabolism.	Cell	2011	235
21969371	D-Glucose	Wang Z	Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo.	The Journal of biological chemistry	2011	43
21975753	D-Glucose	Shyangdan DS	Glucagon-like peptide analogues for type 2 diabetes mellitus.	The Cochrane database of systematic reviews	2011	38
21976745	D-Glucose	Klonoff DC	Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline.	The Journal of clinical endocrinology and metabolism	2011	41
21978918	D-Glucose	Qin Z	The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature.	Atherosclerosis	2012	62
21984584	D-Glucose	Christensen M	Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.	Diabetes	2011	40
21985634	D-Glucose	Grempler R	Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.	Diabetes, obesity & metabolism	2012	60
21986512	D-Glucose	Newbern D	Placental hormones and the control of maternal metabolism and fetal growth.	Current opinion in endocrinology, diabetes, and obesity	2011	57
21994424	D-Glucose	Meininger GE	Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes.	Diabetes care	2011	40
22008454	D-Glucose	Ryan AS	Exercise with calorie restriction improves insulin sensitivity and glycogen synthase activity in obese postmenopausal women with impaired glucose tolerance.	American journal of physiology. Endocrinology and metabolism	2012	32
22011407	D-Glucose	Gunderson EP	Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort.	Diabetes care	2012	31
22021391	D-Glucose	Bailey-Downs LC	Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2012	54
22021706	D-Glucose	Lin M	Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.	Journal of the American Society of Nephrology 	2012	69
22035595	D-Glucose	Mirza S	Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study.	Cytokine	2012	38
22038520	D-Glucose	Rees MG	Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.	Diabetologia	2012	31
22134839	D-Glucose	Beysen C	Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.	Diabetologia	2012	32
22158537	D-Glucose	Cho YS	Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians.	Nature genetics	2011	202
22162232	D-Glucose	Li D	Diabetes and pancreatic cancer.	Molecular carcinogenesis	2012	55
22166985	D-Glucose	Cryer PE	Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.	Endocrinology	2012	42
22167125	D-Glucose	Dai C	Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets.	Diabetologia	2012	57
22167127	D-Glucose	Cooper AR	Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes.	Diabetologia	2012	42
22169009	D-Glucose	Sanchez-Niño MD	Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.	American journal of physiology. Renal physiology	2012	38
22191795	D-Glucose	de la Monte SM	Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.	Drugs	2012	43
22215383	D-Glucose	Monami M	DPP-4 inhibitors and lipids: systematic review and meta-analysis.	Advances in therapy	2012	39
22226086	D-Glucose	Devineni D	Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin.	Diabetes, obesity & metabolism	2012	48
22233865	D-Glucose	Zhao Y	Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.	BMC medicine	2012	38
22240132	D-Glucose	Matsubara J	A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.	Journal of the American College of Cardiology	2012	68
22240811	D-Glucose	Kono T	PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.	Molecular endocrinology	2012	35
22245737	D-Glucose	Bulek AM	Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.	Nature immunology	2012	54
22258980	D-Glucose	Langendam M	Continuous glucose monitoring systems for type 1 diabetes mellitus.	The Cochrane database of systematic reviews	2012	44
22268455	D-Glucose	Gillen JB	Acute high-intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycaemia in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2012	37
22302938	D-Glucose	Krishnan J	Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system.	Genes & development	2012	64
22313123	D-Glucose	Peyrot M	Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.	Diabetic medicine 	2012	90
22315324	D-Glucose	Santulli G	Age-related impairment in insulin release: the essential role of β(2)-adrenergic receptor.	Diabetes	2012	35
22315431	D-Glucose	Wei W	Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ.	Proceedings of the National Academy of Sciences of the United States of America	2012	88
22322078	D-Glucose	Grundy SM	Pre-diabetes, metabolic syndrome, and cardiovascular risk.	Journal of the American College of Cardiology	2012	101
22323472	D-Glucose	Ussher JR	Cardiovascular biology of the incretin system.	Endocrine reviews	2012	109
22330739	D-Glucose	Tiano JP	Importance of oestrogen receptors to preserve functional β-cell mass in diabetes.	Nature reviews. Endocrinology	2012	41
22340904	D-Glucose	Elliott B	The central role of myostatin in skeletal muscle and whole body homeostasis.	Acta physiologica	2012	30
22340932	D-Glucose	Desai NR	Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.	The American journal of medicine	2012	36
22344039	D-Glucose	Fraser A	Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children.	Circulation	2012	59
22355097	D-Glucose	Dowling RJ	Metformin in cancer: translational challenges.	Journal of molecular endocrinology	2012	77
22355316	D-Glucose	Liang Y	Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.	PloS one	2012	47
22374408	D-Glucose	Burant CF	TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.	Lancet	2012	59
22374636	D-Glucose	Dunstan DW	Breaking up prolonged sitting reduces postprandial glucose and insulin responses.	Diabetes care	2012	191
22396530	D-Glucose	Ji Y	Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity.	The Journal of biological chemistry	2012	60
22399527	D-Glucose	Kristiansson K	Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits.	Circulation. Cardiovascular genetics	2012	65
22413962	D-Glucose	Henry RR	Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.	International journal of clinical practice	2012	51
22414897	D-Glucose	Calkin AC	Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.	Nature reviews. Molecular cell biology	2012	149
22421977	D-Glucose	Srikanthan P	Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III.	PloS one	2010	80
22427379	D-Glucose	Greco S	MicroRNA dysregulation in diabetic ischemic heart failure patients.	Diabetes	2012	58
22432104	D-Glucose	Fonseca VA	Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono).	Diabetes care	2012	53
22457523	D-Glucose	Bose SK	Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance.	Journal of virology	2012	31
22466288	D-Glucose	Herman MA	A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.	Nature	2012	138
22471248	D-Glucose	Deacon CF	Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.	Diabetes, obesity & metabolism	2012	34
22476949	D-Glucose	Zhou B	Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity.	Diabetologia	2012	42
22479202	D-Glucose	Dastani Z	Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.	PLoS genetics	2012	149
22482906	D-Glucose	Bogan JS	Regulation of glucose transporter translocation in health and diabetes.	Annual review of biochemistry	2012	56
22486204	D-Glucose	George PS	Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis.	Diabetic medicine 	2012	64
22486948	D-Glucose	Harris SS	A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans.	Diabetes, obesity & metabolism	2012	33
22496159	D-Glucose	Cheng S	Metabolite profiling identifies pathways associated with metabolic risk in humans.	Circulation	2012	116
22496545	D-Glucose	Buxton OM	Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption.	Science translational medicine	2012	154
22499789	D-Glucose	Kodama K	Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2012	45
22500228	D-Glucose	Duarte AI	Insulin in central nervous system: more than just a peripheral hormone.	Journal of aging research	2012	50
22513163	D-Glucose	Cariou B	Thiazolidinediones and PPARγ agonists: time for a reassessment.	Trends in endocrinology and metabolism	2012	79
22519295	D-Glucose	Salcedo I	Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders.	British journal of pharmacology	2012	39
22521071	D-Glucose	Heller S	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.	Lancet	2012	76
22521072	D-Glucose	Garber AJ	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.	Lancet	2012	74
22537941	D-Glucose	Roggli E	Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice.	Diabetes	2012	45
22547887	D-Glucose	Weinstock TG	A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea.	Sleep	2012	41
22550135	D-Glucose	Porez G	Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.	Journal of lipid research	2012	47
22564709	D-Glucose	Seino Y	Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia).	Diabetes, obesity & metabolism	2012	69
22564993	D-Glucose	Bonanni B	Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.	Journal of clinical oncology 	2012	66
22570331	D-Glucose	Yang BT	Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes.	Molecular endocrinology	2012	55
22572877	D-Glucose	Cani PD	Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.	Gut microbes	2012	81
22581228	D-Glucose	Manning AK	A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.	Nature genetics	2012	232
22594461	D-Glucose	Heise T	Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.	Diabetes, obesity & metabolism	2012	88
22608780	D-Glucose	Aroda VR	Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review.	Clinical therapeutics	2012	48
22614056	D-Glucose	Enhörning S	Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.	International journal of obesity	2013	26
22617471	D-Glucose	Leto D	Regulation of glucose transport by insulin: traffic control of GLUT4.	Nature reviews. Molecular cell biology	2012	134
22659620	D-Glucose	Cho YM	Targeting the glucagon receptor family for diabetes and obesity therapy.	Pharmacology & therapeutics	2012	31
22672914	D-Glucose	Feng RN	BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in northern Chinese adults.	Journal of epidemiology	2012	32
22683134	D-Glucose	Perreault L	Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.	Lancet	2012	81
22688551	D-Glucose	Rizzo MR	Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition.	Diabetes care	2012	55
22703861	D-Glucose	Patil HR	Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus.	The American journal of cardiology	2012	40
22719752	D-Glucose	Hsieh MC	The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.	Experimental diabetes research	2012	42
22723582	D-Glucose	Barton FB	Improvement in outcomes of clinical islet transplantation: 1999-2010.	Diabetes care	2012	145
22738663	D-Glucose	Yan S	The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey.	Obesity reviews 	2012	47
22740171	D-Glucose	Rezania A	Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice.	Diabetes	2012	112
22745245	D-Glucose	Makdissi A	Sitagliptin exerts an antinflammatory action.	The Journal of clinical endocrinology and metabolism	2012	45
22751341	D-Glucose	Buchanan TA	Gestational diabetes mellitus: risks and management during and after pregnancy.	Nature reviews. Endocrinology	2012	35
22773666	D-Glucose	Cunha DA	Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis.	Diabetes	2012	36
22773704	D-Glucose	Ruggenenti P	Glomerular hyperfiltration and renal disease progression in type 2 diabetes.	Diabetes care	2012	34
22776039	D-Glucose	Meloni AR	GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence.	Diabetes, obesity & metabolism	2013	28
22777524	D-Glucose	Yeh HC	Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.	Annals of internal medicine	2012	54
22796579	D-Glucose	Sparks JD	Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia.	Arteriosclerosis, thrombosis, and vascular biology	2012	31
22815298	D-Glucose	Weinzimer SA	Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.	Diabetes care	2012	31
22820012	D-Glucose	Banks WA	Insulin in the brain: there and back again.	Pharmacology & therapeutics	2012	71
22827862	D-Glucose	Lucassen EA	Interacting epidemics? Sleep curtailment, insulin resistance, and obesity.	Annals of the New York Academy of Sciences	2012	39
22844441	D-Glucose	Reynolds AC	Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men.	PloS one	2012	42
22858285	D-Glucose	Mehta NN	Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.	Atherosclerosis	2012	32
22876189	D-Glucose	Voight BF	The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits.	PLoS genetics	2012	208
22883232	D-Glucose	Ruan HB	O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability.	Cell metabolism	2012	55
22895668	D-Glucose	Abel ED	Insulin resistance: metabolic mechanisms and consequences in the heart.	Arteriosclerosis, thrombosis, and vascular biology	2012	39
22945360	D-Glucose	Meier JJ	GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.	Nature reviews. Endocrinology	2012	122
22960655	D-Glucose	Aggarwal G	Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.	Gastroenterology	2012	31
22961080	D-Glucose	Li H	A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans.	Diabetes	2013	49
22965295	D-Glucose	Marchetti P	A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.	Diabetologia	2012	39
22970944	D-Glucose	Pal A	PTEN mutations as a cause of constitutive insulin sensitivity and obesity.	The New England journal of medicine	2012	48
22974438	D-Glucose	Rorsman P	Regulation of insulin secretion in human pancreatic islets.	Annual review of physiology	2013	89
22996660	D-Glucose	Gabrielsen JS	Adipocyte iron regulates adiponectin and insulin sensitivity.	The Journal of clinical investigation	2012	50
22997257	D-Glucose	Yuen DA	eNOS deficiency predisposes podocytes to injury in diabetes.	Journal of the American Society of Nephrology 	2012	39
23032062	D-Glucose	Karolina DS	Circulating miRNA profiles in patients with metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2012	64
23043166	D-Glucose	Zinman B	Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).	Diabetes care	2012	69
23048186	D-Glucose	Kievit P	Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques.	Diabetes	2013	36
23061800	D-Glucose	Passtoors WM	Gene expression analysis of mTOR pathway: association with human longevity.	Aging cell	2013	38
23062489	D-Glucose	Satoh-Asahara N	A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.	Metabolism	2013	29
23063129	D-Glucose	Teperino R	Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat.	Cell	2012	65
23069842	D-Glucose	Willette AA	Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults.	Diabetes care	2013	42
23070488	D-Glucose	Broussard JL	Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study.	Annals of internal medicine	2012	74
23083681	D-Glucose	Zhong J	An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease.	Atherosclerosis	2013	45
23099275	D-Glucose	Kwon KC	Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.	Advanced drug delivery reviews	2013	37
23129601	D-Glucose	Ridker PM	Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.	Circulation	2012	89
23134073	D-Glucose	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	47
23144172	D-Glucose	Mocharla P	AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.	Blood	2013	37
23159449	D-Glucose	Zechner JF	Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans.	Gastroenterology	2013	29
23180627	D-Glucose	Williamson G	Possible effects of dietary polyphenols on sugar absorption and digestion.	Molecular nutrition & food research	2013	31
23183535	D-Glucose	Thatava T	Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.	Molecular therapy 	2013	29
23187122	D-Glucose	Bradley D	Gastric bypass and banding equally improve insulin sensitivity and β cell function.	The Journal of clinical investigation	2012	55
23193181	D-Glucose	Poulsen MM	High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.	Diabetes	2013	92
23207292	D-Glucose	Djiogue S	Insulin resistance and cancer: the role of insulin and IGFs.	Endocrine-related cancer	2013	42
23223406	D-Glucose	Pisprasert V	Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans.	Diabetes care	2013	33
23250986	D-Glucose	Spinetti G	Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway.	Circulation research	2013	25
23251491	D-Glucose	Ribel-Madsen R	Genome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes.	PloS one	2012	46
23263489	D-Glucose	Huyghe JR	Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion.	Nature genetics	2013	109
23265947	D-Glucose	Vogt MC	CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age.	Trends in endocrinology and metabolism	2013	39
23267855	D-Glucose	Stocker SL	The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.	Clinical pharmacology and therapeutics	2013	28
23269411	D-Glucose	Ye J	Inflammation during obesity is not all bad: evidence from animal and human studies.	American journal of physiology. Endocrinology and metabolism	2013	32
23277185	D-Glucose	Pillon NJ	Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications.	American journal of physiology. Endocrinology and metabolism	2013	44
23296071	D-Glucose	Scheen AJ	Cardiovascular effects of gliptins.	Nature reviews. Cardiology	2013	28
23305646	D-Glucose	Habegger KM	Fibroblast growth factor 21 mediates specific glucagon actions.	Diabetes	2013	31
23315061	D-Glucose	Stepto NK	Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.	Human reproduction	2013	67
23325474	D-Glucose	Fernández-Hernando C	MicroRNAs in metabolic disease.	Arteriosclerosis, thrombosis, and vascular biology	2013	57
23337872	D-Glucose	Abedini A	Mechanisms of islet amyloidosis toxicity in type 2 diabetes.	FEBS letters	2013	32
23337953	D-Glucose	Stefan N	The role of hepatokines in metabolism.	Nature reviews. Endocrinology	2013	42
23342163	D-Glucose	Mortuza R	High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway.	PloS one	2013	40
23344728	D-Glucose	Kim YG	Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis.	Diabetologia	2013	71
23359039	D-Glucose	Haidar A	Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.	CMAJ 	2013	38
23368510	D-Glucose	Kapitza C	Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin.	Diabetes, obesity & metabolism	2013	36
23369227	D-Glucose	Choi YK	Serum irisin levels in new-onset type 2 diabetes.	Diabetes research and clinical practice	2013	63
23370525	D-Glucose	Goldfine AB	A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance.	Diabetologia	2013	34
23372846	D-Glucose	van de Bunt M	The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.	PloS one	2013	40
23375680	D-Glucose	Barbieri M	Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.	Atherosclerosis	2013	29
23377698	D-Glucose	Calanna S	Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.	Diabetologia	2013	37
23386232	D-Glucose	Matsubara J	Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.	Circulation journal 	2013	34
23388637	D-Glucose	Qian SW	BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2013	59
23393185	D-Glucose	Mathieu C	Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.	The Journal of clinical endocrinology and metabolism	2013	41
23398530	D-Glucose	Ferrannini E	A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2013	32
23400783	D-Glucose	Brännmark C	Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes.	The Journal of biological chemistry	2013	33
23431266	D-Glucose	Girousse A	Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass.	PLoS biology	2013	41
23433305	D-Glucose	Wang B	Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.	Diabetes, obesity & metabolism	2013	31
23434589	D-Glucose	Bramswig NC	Epigenomic plasticity enables human pancreatic α to β cell reprogramming.	The Journal of clinical investigation	2013	110
23436032	D-Glucose	Xu YJ	Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.	Heart failure reviews	2014	20
23439261	D-Glucose	Safar Zadeh E	The liver diseases of lipodystrophy: the long-term effect of leptin treatment.	Journal of hepatology	2013	26
23449634	D-Glucose	Rosenstock J	Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial.	Diabetes & vascular disease research	2013	30
23464594	D-Glucose	Yale JF	Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.	Diabetes, obesity & metabolism	2013	94
23466711	D-Glucose	Duggan C	Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.	Clinical gastroenterology and hepatology 	2013	39
23475416	D-Glucose	Moon HS	Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.	Endocrine reviews	2013	25
23478327	D-Glucose	Sadry SA	Emerging combinatorial hormone therapies for the treatment of obesity and T2DM.	Nature reviews. Endocrinology	2013	28
23482247	D-Glucose	Basaranoglu M	Fructose as a key player in the development of fatty liver disease.	World journal of gastroenterology	2013	47
23493574	D-Glucose	Chen YH	miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.	Diabetes	2013	35
23498294	D-Glucose	Katula JA	The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial.	American journal of preventive medicine	2013	29
23514733	D-Glucose	Sloan-Lancaster J	Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes.	Diabetes care	2013	33
23516412	D-Glucose	de Bock M	Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial.	PloS one	2013	25
23528347	D-Glucose	Sah RP	New insights into pancreatic cancer-induced paraneoplastic diabetes.	Nature reviews. Gastroenterology & hepatology	2013	45
23539729	D-Glucose	Yoneda S	Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes.	The Journal of clinical endocrinology and metabolism	2013	28
23557933	D-Glucose	Tomé-Carneiro J	One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.	Pharmacological research	2013	43
23561637	D-Glucose	Breslavsky A	Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients.	Clinical nutrition	2013	28
23564915	D-Glucose	Riddle MC	Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1).	Diabetes care	2013	57
23564919	D-Glucose	Schernthaner G	Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial.	Diabetes care	2013	97
23568441	D-Glucose	Berryman DE	The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.	Nature reviews. Endocrinology	2013	34
23582329	D-Glucose	Lee YS	The fractalkine/CX3CR1 system regulates β cell function and insulin secretion.	Cell	2013	31
23584084	D-Glucose	Klop B	Dyslipidemia in obesity: mechanisms and potential targets.	Nutrients	2013	93
23594109	D-Glucose	Monami M	Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2013	31
23619195	D-Glucose	Liu JJ	Lower circulating irisin is associated with type 2 diabetes mellitus.	Journal of diabetes and its complications	2013	65
23628617	D-Glucose	Riddle MC	Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L).	Diabetes care	2013	61
23633524	D-Glucose	Pepino MY	Sucralose affects glycemic and hormonal responses to an oral glucose load.	Diabetes care	2013	27
23638642	D-Glucose	Gu Z	Injectable nano-network for glucose-mediated insulin delivery.	ACS nano	2013	33
23645884	D-Glucose	Nauck MA	A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risks.	Diabetes care	2013	51
23645885	D-Glucose	Butler PC	A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?	Diabetes care	2013	62
23649520	D-Glucose	Jørgensen NB	Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.	Diabetes	2013	52
23684623	D-Glucose	Campbell JE	Pharmacology, physiology, and mechanisms of incretin hormone action.	Cell metabolism	2013	152
23698396	D-Glucose	Rosenstock J	Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X).	Diabetes care	2013	43
23715753	D-Glucose	Gough SC	Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial.	Diabetes care	2013	31
23733199	D-Glucose	Lazo M	NH2-terminal pro-brain natriuretic peptide and risk of diabetes.	Diabetes	2013	27
23764390	D-Glucose	Croze ML	Potential role and therapeutic interests of myo-inositol in metabolic diseases.	Biochimie	2013	36
23778747	D-Glucose	Ho M	Impact of dietary and exercise interventions on weight change and metabolic outcomes in obese children and adolescents: a systematic review and meta-analysis of randomized trials.	JAMA pediatrics	2013	38
23781214	D-Glucose	Kwon H	Adipokines mediate inflammation and insulin resistance.	Frontiers in endocrinology	2013	73
23791483	D-Glucose	Prentki M	Metabolic signaling in fuel-induced insulin secretion.	Cell metabolism	2013	96
23792151	D-Glucose	Hijmans BS	Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences.	Biochimie	2014	32
23817699	D-Glucose	Goldfine AB	Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial.	Annals of internal medicine	2013	54
23818527	D-Glucose	Drucker DJ	Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls.	Diabetes	2013	62
23823329	D-Glucose	Bouchonville M	Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial.	International journal of obesity	2014	30
23826303	D-Glucose	Wang X	Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes.	PloS one	2013	27
23849632	D-Glucose	Johnsson KM	Urinary tract infections in patients with diabetes treated with dapagliflozin.	Journal of diabetes and its complications	2013	31
23850509	D-Glucose	Chen Z	Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.	Progress in neurobiology	2013	66
23852538	D-Glucose	Yao Y	A role for the endothelium in vascular calcification.	Circulation research	2013	44
23881200	D-Glucose	Barlow AD	Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.	Diabetes	2013	38
23884882	D-Glucose	Fiori JL	Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.	Diabetes	2013	31
23884885	D-Glucose	Menni C	Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.	Diabetes	2013	58
23884887	D-Glucose	Haeusler RA	Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids.	Diabetes	2013	52
23886976	D-Glucose	Geurts L	Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.	Beneficial microbes	2014	46
23887638	D-Glucose	Chow WS	Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.	Arteriosclerosis, thrombosis, and vascular biology	2013	32
23891854	D-Glucose	Anguizola J	Review: Glycation of human serum albumin.	Clinica chimica acta; international journal of clinical chemistry	2013	31
23895803	D-Glucose	Neal B	Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial.	American heart journal	2013	72
23897112	D-Glucose	Thambisetty M	Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.	JAMA neurology	2013	39
23897760	D-Glucose	Rezania A	Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo.	Stem cells	2013	48
23900589	D-Glucose	Lipska KJ	HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study.	Diabetes care	2013	33
23906374	D-Glucose	Rosenstock J	Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia.	Diabetes, obesity & metabolism	2013	33
23906415	D-Glucose	Kovacs CS	Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial.	Diabetes, obesity & metabolism	2014	57
23963895	D-Glucose	Häring HU	Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.	Diabetes care	2013	59
23992419	D-Glucose	Ma J	Protein O-GlcNAcylation in diabetes and diabetic complications.	Expert review of proteomics	2013	36
24011069	D-Glucose	Gaich G	The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.	Cell metabolism	2013	115
24014835	D-Glucose	Jansen F	Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles.	Circulation	2013	77
24018562	D-Glucose	Hodson DJ	Lipotoxicity disrupts incretin-regulated human β cell connectivity.	The Journal of clinical investigation	2013	53
24026211	D-Glucose	Lavalle-González FJ	Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial.	Diabetologia	2013	89
24026560	D-Glucose	Groop PH	Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction.	Diabetes care	2013	51
24029069	D-Glucose	Babu PV	Recent advances in understanding the anti-diabetic actions of dietary flavonoids.	The Journal of nutritional biochemistry	2013	45
24030890	D-Glucose	Fink LN	Pro-inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans.	Obesity	2014	30
24037093	D-Glucose	Taniguchi CM	Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.	Nature medicine	2013	33
24041680	D-Glucose	Stahn A	Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias.	Diabetes care	2014	23
24057293	D-Glucose	Nannipieri M	Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.	The Journal of clinical endocrinology and metabolism	2013	31
24062249	D-Glucose	Heppner KM	Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors.	Diabetes	2014	21
24062327	D-Glucose	Yki-Järvinen H	Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a ≥52-week randomized, double-blind study.	Diabetes care	2013	35
24073995	D-Glucose	Stenlöf K	Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study.	Current medical research and opinion	2014	30
24077098	D-Glucose	Erickson JR	Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.	Nature	2013	117
24089513	D-Glucose	Shah M	Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass.	Diabetes	2014	28
24113348	D-Glucose	Liu J	Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.	Cellular signalling	2014	23
24118688	D-Glucose	Wilding JP	Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial.	International journal of clinical practice	2013	65
24127133	D-Glucose	Winer DA	B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.	Cellular and molecular life sciences 	2014	22
24140094	D-Glucose	Lee YS	Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.	Metabolism	2014	29
24144654	D-Glucose	Jabbour SA	Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.	Diabetes care	2014	48
24153444	D-Glucose	Kerti L	Higher glucose levels associated with lower memory and reduced hippocampal microstructure.	Neurology	2013	33
24170695	D-Glucose	Hidalgo B	Epigenome-wide association study of fasting measures of glucose, insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network study.	Diabetes	2014	49
24174327	D-Glucose	Finan B	Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.	Science translational medicine	2013	27
24189526	D-Glucose	Anisimov VN	Metformin: do we finally have an anti-aging drug?	Cell cycle	2013	26
24204837	D-Glucose	Alvarez ML	Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy.	PloS one	2013	25
24209692	D-Glucose	Pearce LR	KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation.	Cell	2013	36
24215793	D-Glucose	Mezza T	Insulin resistance alters islet morphology in nondiabetic humans.	Diabetes	2014	31
24222351	D-Glucose	Westwell-Roper CY	Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.	Diabetes	2014	28
24223694	D-Glucose	Barutta F	Urinary exosomal microRNAs in incipient diabetic nephropathy.	PloS one	2013	49
24224750	D-Glucose	van Bon AC	Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home under free-living conditions for 48 hours.	Diabetes technology & therapeutics	2014	23
24227685	D-Glucose	Shang L	β-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome.	Diabetes	2014	31
24230488	D-Glucose	Kellow NJ	Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials.	The British journal of nutrition	2014	26
24233056	D-Glucose	Marselli L	Are we overestimating the loss of beta cells in type 2 diabetes?	Diabetologia	2014	23
24238363	D-Glucose	Oh KJ	CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis.	BMB reports	2013	32
24241533	D-Glucose	Bojsen-Møller KN	Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.	Diabetes	2014	31
24245943	D-Glucose	Cho YM	Glucagon-like peptide-1: glucose homeostasis and beyond.	Annual review of physiology	2014	21
24252877	D-Glucose	Lee J	Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells.	eLife	2013	41
24284436	D-Glucose	Ley SH	Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women.	The American journal of clinical nutrition	2014	25
24296717	D-Glucose	Dimas AS	Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.	Diabetes	2014	80
24315990	D-Glucose	Salehi M	Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.	Gastroenterology	2014	30
24320621	D-Glucose	Monami M	Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2014	28
24323910	D-Glucose	Turner N	Fatty acid metabolism, energy expenditure and insulin resistance in muscle.	The Journal of endocrinology	2014	27
24325907	D-Glucose	Remely M	Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.	Gene	2014	29
24335483	D-Glucose	Palmer CS	Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection.	AIDS	2014	24
24347174	D-Glucose	Jayashree B	Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes.	Molecular and cellular biochemistry	2014	31
24353182	D-Glucose	Cassuto J	Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients.	Diabetes	2014	23
24355926	D-Glucose	Gebremariam T	CotH3 mediates fungal invasion of host cells during mucormycosis.	The Journal of clinical investigation	2014	25
24356592	D-Glucose	Nathan DM	The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.	Diabetes care	2014	80
24356594	D-Glucose	de Boer IH	Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.	Diabetes care	2014	26
24358186	D-Glucose	Mai M	Serum levels of acylcarnitines are altered in prediabetic conditions.	PloS one	2013	26
24370923	D-Glucose	Daniele G	The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.	Acta diabetologica	2014	26
24373234	D-Glucose	Nadkarni P	Regulation of glucose homeostasis by GLP-1.	Progress in molecular biology and translational science	2014	23
24384568	D-Glucose	Boucher J	Insulin receptor signaling in normal and insulin-resistant states.	Cold Spring Harbor perspectives in biology	2014	78
24411018	D-Glucose	Morris JK	Impaired glycemia increases disease progression in mild cognitive impairment.	Neurobiology of aging	2014	23
24417942	D-Glucose	Yamauchi T	Adiponectin receptors: a review of their structure, function and how they work.	Best practice & research. Clinical endocrinology & metabolism	2014	32
24423324	D-Glucose	Colao A	Pasireotide versus octreotide in acromegaly: a head-to-head superiority study.	The Journal of clinical endocrinology and metabolism	2014	30
24423344	D-Glucose	O'Reilly MW	Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.	The Journal of clinical endocrinology and metabolism	2014	25
24429158	D-Glucose	Aurora RN	Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association.	The Lancet. Respiratory medicine	2013	35
24456991	D-Glucose	Dutta D	Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: an open label randomized prospective study from Eastern India.	Diabetes research and clinical practice	2014	22
24462370	D-Glucose	Holmes MV	Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.	American journal of human genetics	2014	42
24467746	D-Glucose	Pyke C	GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.	Endocrinology	2014	68
24475922	D-Glucose	Cherney DZ	The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.	Cardiovascular diabetology	2014	58
24478399	D-Glucose	Ortega FJ	Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.	Diabetes care	2014	52
24497850	D-Glucose	Service SK	Re-sequencing expands our understanding of the phenotypic impact of variants at GWAS loci.	PLoS genetics	2014	23
24520123	D-Glucose	Dalmas E	T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.	Diabetes	2014	32
24558077	D-Glucose	Bakris GL	Microalbuminuria as a risk predictor in diabetes: the continuing saga.	Diabetes care	2014	22
24561261	D-Glucose	Brissova M	Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes β cell regeneration.	Cell metabolism	2014	32
24563869	D-Glucose	Golbidi S	Exercise induced adipokine changes and the metabolic syndrome.	Journal of diabetes research	2014	25
24568896	D-Glucose	Bhindi B	Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.	European urology	2015	20
24570140	D-Glucose	Mortuza R	miR-195 regulates SIRT1-mediated changes in diabetic retinopathy.	Diabetologia	2014	27
24577463	D-Glucose	Ng TP	Long-term metformin usage and cognitive function among older adults with diabetes.	Journal of Alzheimer's disease 	2014	22
24613355	D-Glucose	Chen YJ	De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts.	Cell reports	2014	33
24622415	D-Glucose	Hartemann A	Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.	The lancet. Diabetes & endocrinology	2013	55
24622668	D-Glucose	Yang W	Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial.	The lancet. Diabetes & endocrinology	2014	24
24622715	D-Glucose	Preiss D	Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.	The lancet. Diabetes & endocrinology	2014	22
24626293	D-Glucose	Mo R	Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.	Chemical Society reviews	2014	27
24628249	D-Glucose	Reutrakul S	Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes.	Annals of the New York Academy of Sciences	2014	39
24631482	D-Glucose	Oliva RV	Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors.	Journal of the American Society of Hypertension 	2014	38
24650952	D-Glucose	Rosenstock J	Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S).	Journal of diabetes and its complications	2014	31
24651807	D-Glucose	Cobelli C	The oral minimal model method.	Diabetes	2014	28
24662521	D-Glucose	Karnevi E	Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion.	Immunology and cell biology	2014	24
24668104	D-Glucose	Emerging Risk Factors Collaboration.	Glycated hemoglobin measurement and prediction of cardiovascular disease.	JAMA	2014	35
24670948	D-Glucose	Shao M	Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling.	Nature communications	2014	24
24676639	D-Glucose	Fiorina P	Role of podocyte B7-1 in diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	31
24695890	D-Glucose	Liu K	Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.	The American journal of clinical nutrition	2014	22
24699409	D-Glucose	Prokopenko I	A central role for GRB10 in regulation of islet function in man.	PLoS genetics	2014	28
24703046	D-Glucose	Selvin E	Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.	The lancet. Diabetes & endocrinology	2014	38
24708805	D-Glucose	Sajja RK	Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line.	Fluids and barriers of the CNS	2014	20
24709991	D-Glucose	Yan B	Association of serum irisin with metabolic syndrome in obese Chinese adults.	PloS one	2014	25
24722249	D-Glucose	Li N	Pleiotropic effects of lipid genes on plasma glucose, HbA1c, and HOMA-IR levels.	Diabetes	2014	21
24722494	D-Glucose	Häring HU	Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.	Diabetes care	2014	47
24725149	D-Glucose	Peyser T	The artificial pancreas: current status and future prospects in the management of diabetes.	Annals of the New York Academy of Sciences	2014	31
24731669	D-Glucose	Yki-Järvinen H	Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.	The lancet. Diabetes & endocrinology	2014	83
24731672	D-Glucose	Diamant M	Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial.	The lancet. Diabetes & endocrinology	2014	25
24732719	D-Glucose	Carson V	Patterns of sedentary time and cardiometabolic risk among Canadian adults.	Preventive medicine	2014	33
24750644	D-Glucose	Wu S	Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants.	Cardiovascular therapeutics	2014	29
24757202	D-Glucose	Chow E	Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.	Diabetes	2014	50
24760977	D-Glucose	Goldstone AP	Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food.	The American journal of clinical nutrition	2014	23
24781596	D-Glucose	Paneni F	Insulin resistance, diabetes, and cardiovascular risk.	Current atherosclerosis reports	2014	23
24812432	D-Glucose	Fulcher GR	Comparison of insulin degludec/insulin aspart and biphasic insulin aspart 30 in uncontrolled, insulin-treated type 2 diabetes: a phase 3a, randomized, treat-to-target trial.	Diabetes care	2014	21
24812434	D-Glucose	Hirakawa Y	Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.	Diabetes care	2014	26
24813368	D-Glucose	Gallego-Escuredo JM	Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.	International journal of obesity	2015	18
24821328	D-Glucose	Kuipers F	Beyond intestinal soap--bile acids in metabolic control.	Nature reviews. Endocrinology	2014	55
24846769	D-Glucose	Ghosh S	Elevated muscle TLR4 expression and metabolic endotoxemia in human aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2015	25
24848981	D-Glucose	Albert JS	Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes.	The New England journal of medicine	2014	30
24855202	D-Glucose	Ussher JR	Cardiovascular actions of incretin-based therapies.	Circulation research	2014	44
24898300	D-Glucose	Rosenstock J	Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro.	Diabetes care	2014	35
24898304	D-Glucose	Ahrén B	HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin.	Diabetes care	2014	46
24899464	D-Glucose	Halperin F	Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.	JAMA surgery	2014	40
24911120	D-Glucose	Shalev A	Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell.	Molecular endocrinology	2014	21
24925721	D-Glucose	Yoo TH	Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.	Journal of the American Society of Nephrology 	2015	25
24927146	D-Glucose	Liu Y	The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus.	International journal of molecular sciences	2014	23
24929430	D-Glucose	Rosenstock J	Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes.	Diabetes care	2014	50
24930970	D-Glucose	Macintyre AN	The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.	Cell metabolism	2014	137
24931034	D-Glucose	Kleinridders A	Insulin action in brain regulates systemic metabolism and brain function.	Diabetes	2014	52
24943000	D-Glucose	Zinman B	Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™).	Cardiovascular diabetology	2014	23
24943065	D-Glucose	Thabit H	Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study.	The lancet. Diabetes & endocrinology	2014	37
24948511	D-Glucose	Ridderstråle M	Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial.	The lancet. Diabetes & endocrinology	2014	53
24954193	D-Glucose	Lee P	Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans.	Diabetes	2014	60
24963110	D-Glucose	Leelarathna L	Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.	Diabetes care	2014	35
24965700	D-Glucose	Yale JF	Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.	Diabetes, obesity & metabolism	2014	29
24981880	D-Glucose	Yang Z	Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes.	Acta diabetologica	2014	24
24993615	D-Glucose	Barnosky AR	Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings.	Translational research 	2014	23
24997608	D-Glucose	Oh DY	A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.	Nature medicine	2014	32
25011946	D-Glucose	Diamant M	Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.	Diabetes care	2014	24
25028522	D-Glucose	Heni M	Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men.	Diabetes	2014	26
25036706	D-Glucose	Shigihara N	Human IAPP-induced pancreatic β cell toxicity and its regulation by autophagy.	The Journal of clinical investigation	2014	30
25043022	D-Glucose	Moltke I	A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes.	Nature	2014	59
25043058	D-Glucose	Suh JM	Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer.	Nature	2014	32
25043059	D-Glucose	Srivastava A	High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875.	Nature	2014	41
25056438	D-Glucose	Chondronikola M	Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans.	Diabetes	2014	114
25062042	D-Glucose	Arnold N	Regulation of cardiac expression of the diabetic marker microRNA miR-29.	PloS one	2014	21
25073467	D-Glucose	Li T	Bile acid signaling in metabolic disease and drug therapy.	Pharmacological reviews	2014	72
25074318	D-Glucose	Nakamura K	DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study.	Cardiovascular diabetology	2014	27
25083916	D-Glucose	Wang L	Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review.	Biochemical pharmacology	2014	51
25086906	D-Glucose	Yan J	Obesity- and aging-induced excess of central transforming growth factor-β potentiates diabetic development via an RNA stress response.	Nature medicine	2014	29
25102180	D-Glucose	Ng MC	Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes.	PLoS genetics	2014	46
25104103	D-Glucose	Wilding JP	The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.	Metabolism	2014	23
25114296	D-Glucose	Buse JB	Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).	Diabetes care	2014	43
25179915	D-Glucose	Haahr H	A review of the pharmacological properties of insulin degludec and their clinical relevance.	Clinical pharmacokinetics	2014	23
25182023	D-Glucose	Ballak DB	IL-37 protects against obesity-induced inflammation and insulin resistance.	Nature communications	2014	27
25185947	D-Glucose	Cypess AM	Brown fat in humans: consensus points and experimental guidelines.	Cell metabolism	2014	38
25190523	D-Glucose	Gough SC	Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes.	The lancet. Diabetes & endocrinology	2014	45
25201977	D-Glucose	Fadista J	Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2014	74
25204974	D-Glucose	Carlsson PO	Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells.	Diabetes	2015	22
25204977	D-Glucose	Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.	Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.	Diabetes	2015	33
25211370	D-Glucose	Rezania A	Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.	Nature biotechnology	2014	165
25212743	D-Glucose	Zhang R	A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy.	Cardiovascular diabetology	2014	22
25220191	D-Glucose	Eng C	Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis.	Lancet	2014	44
25239226	D-Glucose	Liu X	IL-1β induces IL-6 production in retinal Müller cells predominantly through the activation of p38 MAPK/NF-κB signaling pathway.	Experimental cell research	2015	17
25242225	D-Glucose	Soccio RE	Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes.	Cell metabolism	2014	52
25246775	D-Glucose	Nauck MA	Update on developments with SGLT2 inhibitors in the management of type 2 diabetes.	Drug design, development and therapy	2014	40
25249673	D-Glucose	Avogaro A	The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications.	Diabetes care	2014	25
25262344	D-Glucose	Swerdlow DI	HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.	Lancet	2015	82
25262977	D-Glucose	Hodgson K	Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.	Immunology	2015	27
25281430	D-Glucose	Murahovschi V	WISP1 is a novel adipokine linked to inflammation in obesity.	Diabetes	2015	16
25287289	D-Glucose	Frier BM	Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.	Nature reviews. Endocrinology	2014	35
25287317	D-Glucose	Crujeiras AB	Irisin: 'fat' or artefact.	Clinical endocrinology	2015	16
25303484	D-Glucose	Chen X	Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance.	The Journal of clinical endocrinology and metabolism	2015	29
25303528	D-Glucose	Yore MM	Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.	Cell	2014	77
25303535	D-Glucose	Pagliuca FW	Generation of functional human pancreatic β cells in vitro.	Cell	2014	241
25307742	D-Glucose	Haeusler RA	Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.	Nature communications	2014	32
25324472	D-Glucose	Olivieri F	Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells.	Aging	2014	22
25325735	D-Glucose	Balestrieri ML	Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment.	Diabetes	2015	22
25329075	D-Glucose	Rangasamy S	Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.	PloS one	2014	24
25336746	D-Glucose	Diabetes Prevention Program Research Group.	HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial.	Diabetes care	2015	19
25341005	D-Glucose	Vallon V	The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.	Annual review of medicine	2015	25
25342129	D-Glucose	Kapogiannis D	Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.	FASEB journal 	2015	49
25352637	D-Glucose	Fuster JJ	Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion.	Diabetes	2015	24
25362253	D-Glucose	Hasnain SZ	Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.	Nature medicine	2014	31
25377875	D-Glucose	Lin Y	In vivo pancreatic β-cell-specific expression of antiaging gene Klotho: a novel approach for preserving β-cells in type 2 diabetes.	Diabetes	2015	19
25387570	D-Glucose	Menegazzo L	NETosis is induced by high glucose and associated with type 2 diabetes.	Acta diabetologica	2015	17
25392482	D-Glucose	van Praag H	Exercise, energy intake, glucose homeostasis, and the brain.	The Journal of neuroscience 	2014	25
25399420	D-Glucose	Gao Y	The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells.	Nucleic acids research	2014	42
25408296	D-Glucose	Sebastiani G	MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion.	Acta diabetologica	2015	19
25421524	D-Glucose	Thorens B	GLUT2, glucose sensing and glucose homeostasis.	Diabetologia	2015	42
25437406	D-Glucose	Rawlings AM	Diabetes in midlife and cognitive change over 20 years: a cohort study.	Annals of internal medicine	2014	47
25445538	D-Glucose	Szkudelski T	Resveratrol and diabetes: from animal to human studies.	Biochimica et biophysica acta	2015	24
25450819	D-Glucose	Janani C	PPAR gamma gene--a review.	Diabetes & metabolic syndrome	2015	45
25456737	D-Glucose	Foretz M	Metformin: from mechanisms of action to therapies.	Cell metabolism	2014	110
25457209	D-Glucose	Zhou Y	Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.	Journal of hepatology	2015	16
25476696	D-Glucose	Everard A	Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status.	Nature communications	2014	42
25480564	D-Glucose	Reinert-Hartwall L	Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humans.	Journal of immunology	2015	16
25485909	D-Glucose	Finan B	A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.	Nature medicine	2015	30
25495720	D-Glucose	Bode B	Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes.	Diabetes, obesity & metabolism	2015	28
25497096	D-Glucose	Piccand J	Rfx6 maintains the functional identity of adult pancreatic β cells.	Cell reports	2014	25
25497344	D-Glucose	Blüher M	From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.	Metabolism	2015	46
25499872	D-Glucose	Holmen H	A Mobile Health Intervention for Self-Management and Lifestyle Change for Persons With Type 2 Diabetes, Part 2: One-Year Results From the Norwegian Randomized Controlled Trial RENEWING HEALTH.	JMIR mHealth and uHealth	2014	28
25524916	D-Glucose	Palmer ND	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Diabetes	2015	18
25528528	D-Glucose	Savarese G	Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis.	International journal of cardiology	2015	19
25576058	D-Glucose	Cifarelli V	Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.	Diabetes	2015	21
25584736	D-Glucose	Li T	Bile acids as metabolic regulators.	Current opinion in gastroenterology	2015	27
25587098	D-Glucose	Yan B	lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA.	Circulation research	2015	65
25589482	D-Glucose	Inzucchi SE	SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.	Diabetes & vascular disease research	2015	58
25592197	D-Glucose	Matthaei S	Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial.	Diabetes care	2015	19
25596529	D-Glucose	Keembiyehetty C	Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis.	The Journal of biological chemistry	2015	20
25614665	D-Glucose	Drucker DJ	Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting Lecture.	Diabetes	2015	16
25625282	D-Glucose	Mahajan A	Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.	PLoS genetics	2015	33
25631608	D-Glucose	Wessel J	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Nature communications	2015	44
25637831	D-Glucose	Satin LS	Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.	Molecular aspects of medicine	2015	19
25668019	D-Glucose	Valdearcos M	Hypothalamic inflammation in the control of metabolic function.	Annual review of physiology	2015	25
25677912	D-Glucose	Færch K	GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study.	Diabetes	2015	20
25688231	D-Glucose	Ma X	Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy.	Frontiers in endocrinology	2015	17
25697093	D-Glucose	Rutter GA	Pancreatic β-cell identity, glucose sensing and the control of insulin secretion.	The Biochemical journal	2015	40
25702040	D-Glucose	Broussard JL	Sleep restriction increases free fatty acids in healthy men.	Diabetologia	2015	18
25703085	D-Glucose	Francque S	PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis.	Journal of hepatology	2015	24
25705637	D-Glucose	Ali AH	Recent advances in the development of farnesoid X receptor agonists.	Annals of translational medicine	2015	30
25713189	D-Glucose	Nolan CJ	Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.	Diabetes	2015	20
25726255	D-Glucose	Higuchi C	Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.	Metabolism	2015	26
25733469	D-Glucose	van Bussel BC	A healthy diet is associated with less endothelial dysfunction and less low-grade inflammation over a 7-year period in adults at risk of cardiovascular disease.	The Journal of nutrition	2015	16
25754552	D-Glucose	Cederberg H	Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.	Diabetologia	2015	40
25755205	D-Glucose	Navarro G	The role of androgens in metabolism, obesity, and diabetes in males and females.	Obesity	2015	18
25787249	D-Glucose	Puthanveetil P	Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells.	Journal of cellular and molecular medicine	2015	32
25800063	D-Glucose	Allard C	Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns.	Epigenetics	2015	17
25833778	D-Glucose	Li D	Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients.	The Journal of nutrition	2015	16
25834231	D-Glucose	Sandoval DA	Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.	Physiological reviews	2015	34
25846340	D-Glucose	Heise T	Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.	Diabetes, obesity & metabolism	2015	19
25885947	D-Glucose	Portillo-Sanchez P	High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.	The Journal of clinical endocrinology and metabolism	2015	27
25908766	D-Glucose	Akinkuolie AO	Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.	Arteriosclerosis, thrombosis, and vascular biology	2015	16
25908839	D-Glucose	Russ HA	Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro.	The EMBO journal	2015	61
25943590	D-Glucose	Huckvale K	Smartphone apps for calculating insulin dose: a systematic assessment.	BMC medicine	2015	19
25944304	D-Glucose	Yabe D	β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians.	Current diabetes reports	2015	26
25948681	D-Glucose	Fall T	Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes.	Diabetes	2015	19
25961460	D-Glucose	Fu X	MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.	The Journal of clinical investigation	2015	24
25998289	D-Glucose	Miller KM	Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.	Diabetes care	2015	114
26013143	D-Glucose	Latreille M	miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development.	Journal of molecular medicine	2015	21
26050668	D-Glucose	Stanford KI	Exercise Effects on White Adipose Tissue: Beiging and Metabolic Adaptations.	Diabetes	2015	35
26063450	D-Glucose	Ferrannini E	Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.	European heart journal	2015	26
26067718	D-Glucose	Pivonello R	The Treatment of Cushing's Disease.	Endocrine reviews	2015	24
26076035	D-Glucose	van der Meulen T	Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion.	Nature medicine	2015	29
26077345	D-Glucose	Abu-Farha M	Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.	Scientific reports	2015	22
26079503	D-Glucose	Østergaard SD	Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.	PLoS medicine	2015	27
26081915	D-Glucose	Penney NC	The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review.	International journal of obesity	2015	19
26086329	D-Glucose	Taylor SI	SGLT2 Inhibitors May Predispose to Ketoacidosis.	The Journal of clinical endocrinology and metabolism	2015	51
26089386	D-Glucose	Giorgino F	Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2).	Diabetes care	2015	18
26100900	D-Glucose	Yu J	Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.	Proceedings of the National Academy of Sciences of the United States of America	2015	33
26109024	D-Glucose	NCD Risk Factor Collaboration (NCD-RisC).	Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants.	The lancet. Diabetes & endocrinology	2015	18
26112890	D-Glucose	Fadini GP	Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database.	European heart journal	2015	21
26153338	D-Glucose	Clements MA	Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.	Pediatric diabetes	2016	15
26160912	D-Glucose	Mohlke KL	Recent advances in understanding the genetic architecture of type 2 diabetes.	Human molecular genetics	2015	30
26167912	D-Glucose	Balk EM	Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.	Annals of internal medicine	2015	36
26171719	D-Glucose	Hryhorczuk C	Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids.	Neuropsychopharmacology 	2016	21
26180105	D-Glucose	Ferrannini G	Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition.	Diabetes care	2015	24
26197299	D-Glucose	Flynn CR	Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.	Nature communications	2015	19
26207054	D-Glucose	Hirsch IB	Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!	Diabetes care	2015	16
26223240	D-Glucose	Hernandez TL	Women With Gestational Diabetes Mellitus Randomized to a Higher-Complex Carbohydrate/Low-Fat Diet Manifest Lower Adipose Tissue Insulin Resistance, Inflammation, Glucose, and Free Fatty Acids: A Pilot Study.	Diabetes care	2016	12
26241401	D-Glucose	Mishra M	Epigenetic Modification of Mitochondrial DNA in the Development of Diabetic Retinopathy.	Investigative ophthalmology & visual science	2015	19
26248647	D-Glucose	Pajvani UB	The new biology of diabetes.	Diabetologia	2015	17
26304037	D-Glucose	Agulnick AD	Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo.	Stem cells translational medicine	2015	24
26305874	D-Glucose	Rosenthal N	Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus.	Annals of the New York Academy of Sciences	2015	24
26344355	D-Glucose	Meek CL	The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.	Peptides	2016	14
26355033	D-Glucose	Boden G	Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men.	Science translational medicine	2015	15
26369473	D-Glucose	Mingrone G	Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.	Lancet	2015	62
26386349	D-Glucose	Munasinghe PE	Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway.	International journal of cardiology	2016	12
26387865	D-Glucose	Altman BJ	MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.	Cell metabolism	2015	34
26394161	D-Glucose	Armstrong MJ	Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.	Journal of hepatology	2016	18
26422395	D-Glucose	Cao Y	SIRT1 and insulin resistance.	Journal of diabetes and its complications	2016	10
26424786	D-Glucose	Wang XX	G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes.	Journal of the American Society of Nephrology 	2016	11
26432775	D-Glucose	Kropff J	2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.	The lancet. Diabetes & endocrinology	2015	38
26433941	D-Glucose	Florath I	Type 2 diabetes and leucocyte DNA methylation: an epigenome-wide association study in over 1,500 older adults.	Diabetologia	2016	20
26445512	D-Glucose	Kajimura S	Brown and Beige Fat: Physiological Roles beyond Heat Generation.	Cell metabolism	2015	88
26461112	D-Glucose	Chastin SF	Combined Effects of Time Spent in Physical Activity, Sedentary Behaviors and Sleep on Obesity and Cardio-Metabolic Health Markers: A Novel Compositional Data Analysis Approach.	PloS one	2015	42
26489970	D-Glucose	Nauck M	Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.	Diabetes, obesity & metabolism	2016	23
26502220	D-Glucose	Sussman JB	Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus.	JAMA internal medicine	2015	19
26511102	D-Glucose	Madsbad S	Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists.	Diabetes, obesity & metabolism	2016	16
26513002	D-Glucose	Martino J	Maternal Body Weight and Gestational Diabetes Differentially Influence Placental and Pregnancy Outcomes.	The Journal of clinical endocrinology and metabolism	2016	13
26542580	D-Glucose	Perelis M	Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion.	Science	2015	49
26556368	D-Glucose	Yki-Järvinen H	Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.	Nutrients	2015	16
26574954	D-Glucose	Jukarainen S	Obesity Is Associated With Low NAD(+)/SIRT Pathway Expression in Adipose Tissue of BMI-Discordant Monozygotic Twins.	The Journal of clinical endocrinology and metabolism	2016	12
26577417	D-Glucose	Buse JB	Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5.	Diabetes care	2016	12
26577716	D-Glucose	Ohn JH	10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study.	The lancet. Diabetes & endocrinology	2016	23
26598716	D-Glucose	Ranger TA	Is there an association between tendinopathy and diabetes mellitus? A systematic review with meta-analysis.	British journal of sports medicine	2016	12
26621825	D-Glucose	Zaccardi F	Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.	Postgraduate medical journal	2016	16
26624892	D-Glucose	van de Bunt M	Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors.	PLoS genetics	2015	31
26628415	D-Glucose	Henson J	Breaking Up Prolonged Sitting With Standing or Walking Attenuates the Postprandial Metabolic Response in Postmenopausal Women: A Randomized Acute Study.	Diabetes care	2016	21
26628416	D-Glucose	Cai J	Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion.	Diabetes care	2016	11
26628419	D-Glucose	Mita T	Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).	Diabetes care	2016	21
26643952	D-Glucose	Soriano-Tárraga C	Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia.	Human molecular genetics	2016	17
26683796	D-Glucose	Mishra AK	Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota.	Metabolism	2016	15
26693205	D-Glucose	Verdile G	Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease.	Mediators of inflammation	2015	24
26712688	D-Glucose	Iyengar NM	Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer.	Clinical cancer research 	2016	27
26718499	D-Glucose	Hanssen MJ	Short-term Cold Acclimation Recruits Brown Adipose Tissue in Obese Humans.	Diabetes	2016	20
26718502	D-Glucose	Long M	An Essential Role of NRF2 in Diabetic Wound Healing.	Diabetes	2016	14
26733412	D-Glucose	Aguirre GA	Insulin-like growth factor-1 deficiency and metabolic syndrome.	Journal of translational medicine	2016	23
26740634	D-Glucose	Tauschmann M	Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.	Diabetes care	2016	18
26743209	D-Glucose	An H	Current understanding of metformin effect on the control of hyperglycemia in diabetes.	The Journal of endocrinology	2016	14
26784127	D-Glucose	Rodbard D	Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.	Diabetes technology & therapeutics	2016	27
26814590	D-Glucose	Krashes MJ	Melanocortin-4 receptor-regulated energy homeostasis.	Nature neuroscience	2016	26
26822324	D-Glucose	Mita T	Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.	Diabetes care	2016	24
26837280	D-Glucose	Bai X	MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy.	Scientific reports	2016	13
26848630	D-Glucose	Bailey TS	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.	Endocrine practice 	2016	15
26850709	D-Glucose	Russell SJ	Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.	The lancet. Diabetes & endocrinology	2016	16
26897744	D-Glucose	Pop-Busui R	Inflammation as a Therapeutic Target for Diabetic Neuropathies.	Current diabetes reports	2016	13
26907513	D-Glucose	Choudhary P	Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management.	Diabetes technology & therapeutics	2016	19
26912151	D-Glucose	Kim SH	Brown Fat and Browning for the Treatment of Obesity and Related Metabolic Disorders.	Diabetes & metabolism journal	2016	20
26934259	D-Glucose	Lingvay I	Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.	JAMA	2016	24
26942205	D-Glucose	Jia Y	miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy.	Journal of diabetes research	2016	15
26942597	D-Glucose	Ariemma F	Low-Dose Bisphenol-A Impairs Adipogenesis and Generates Dysfunctional 3T3-L1 Adipocytes.	PloS one	2016	13
26947067	D-Glucose	Kung CP	The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.	Cell reports	2016	18
26950362	D-Glucose	Helman A	p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.	Nature medicine	2016	30
26959184	D-Glucose	Talukdar S	A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.	Cell metabolism	2016	25
26977395	D-Glucose	Ackermann AM	Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes.	Molecular metabolism	2016	21
26988411	D-Glucose	Zaykov AN	Pursuit of a perfect insulin.	Nature reviews. Drug discovery	2016	13
26993047	D-Glucose	Wang ZV	Adiponectin, the past two decades.	Journal of molecular cell biology	2016	18
27002059	D-Glucose	Steven S	Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders.	Diabetes care	2016	12
27027351	D-Glucose	D'Esposito V	Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5.	Oncotarget	2016	12
27034277	D-Glucose	Riehle C	Insulin Signaling and Heart Failure.	Circulation research	2016	19
27040154	D-Glucose	de Courten B	Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial.	Obesity	2016	12
27061677	D-Glucose	NCD Risk Factor Collaboration (NCD-RisC).	Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.	Lancet	2016	186
27063289	D-Glucose	Saxena P	A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells.	Nature communications	2016	10
27064285	D-Glucose	Dai C	Stress-impaired transcription factor expression and insulin secretion in transplanted human islets.	The Journal of clinical investigation	2016	10
27073002	D-Glucose	Rayanagoudar G	Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women.	Diabetologia	2016	12
27099265	D-Glucose	Willeit P	Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?	European heart journal	2016	11
27111510	D-Glucose	Jazayeri A	Extra-helical binding site of a glucagon receptor antagonist.	Nature	2016	25
27144581	D-Glucose	Bonnefont-Rousselot D	Resveratrol and Cardiovascular Diseases.	Nutrients	2016	18
27159554	D-Glucose	Wong TY	Diabetic retinopathy.	Nature reviews. Disease primers	2016	21
27162351	D-Glucose	Chen Z	Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.	Proceedings of the National Academy of Sciences of the United States of America	2016	14
27165273	D-Glucose	Cardinali DP	Inflammaging, Metabolic Syndrome and Melatonin: A Call for Treatment Studies.	Neuroendocrinology	2017	7
27186364	D-Glucose	Seino Y	Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives.	Journal of diabetes investigation	2016	20
27188262	D-Glucose	Gómez-Ambrosi J	FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.	Clinical nutrition	2017	6
27196572	D-Glucose	Duparc T	Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.	Gut	2017	14
27207552	D-Glucose	Xue M	Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation.	Diabetes	2016	19
27214060	D-Glucose	Fonseca VA	CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.	Endocrine practice 	2016	18
27256476	D-Glucose	Kusminski CM	Targeting adipose tissue in the treatment of obesity-associated diabetes.	Nature reviews. Drug discovery	2016	29
27273792	D-Glucose	McCoy RG	Intensive Treatment and Severe Hypoglycemia Among Adults With Type 2 Diabetes.	JAMA internal medicine	2016	18
27286737	D-Glucose	Hsiao TJ	A common rs7903146 variant of the transcription factor 7-like 2 gene is associated with type 2 diabetes mellitus and fasting glucose in a Taiwanese population.	Diabetes & metabolism	2017	8
27322064	D-Glucose	Volkov P	A Genome-Wide mQTL Analysis in Human Adipose Tissue Identifies Genetic Variants Associated with DNA Methylation, Gene Expression and Metabolic Traits.	PloS one	2016	11
27330126	D-Glucose	Maahs DM	Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.	Diabetes care	2016	19
27345422	D-Glucose	Drucker DJ	The Cardiovascular Biology of Glucagon-like Peptide-1.	Cell metabolism	2016	25
27347932	D-Glucose	Laganà AS	Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.	International journal of molecular sciences	2016	12
27364997	D-Glucose	Thabit H	Coming of age: the artificial pancreas for type 1 diabetes.	Diabetologia	2016	26
27376324	D-Glucose	Yoon MS	The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism.	Nutrients	2016	16
27398620	D-Glucose	Bader E	Identification of proliferative and mature β-cells in the islets of Langerhans.	Nature	2016	41
27399229	D-Glucose	Dorrell C	Human islets contain four distinct subtypes of β cells.	Nature communications	2016	39
27409811	D-Glucose	Pedersen HK	Human gut microbes impact host serum metabolome and insulin sensitivity.	Nature	2016	63
27434443	D-Glucose	Palmer SC	Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.	JAMA	2016	34
27473078	D-Glucose	Polak K	New markers of insulin resistance in polycystic ovary syndrome.	Journal of endocrinological investigation	2017	6
27500523	D-Glucose	Zhou K	Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.	Nature genetics	2016	13
27514514	D-Glucose	Avogaro A	Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice.	Cardiovascular diabetology	2016	11
27532830	D-Glucose	Stewart ZA	Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.	The New England journal of medicine	2016	10
27532915	D-Glucose	Afkarian M	Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.	JAMA	2016	19
27544896	D-Glucose	Kishi S	Association of Insulin Resistance and Glycemic Metabolic Abnormalities With LV Structure and Function in Middle Age: The CARDIA Study.	JACC. Cardiovascular imaging	2017	9
27616452	D-Glucose	Villarroya F	Brown adipose tissue as a secretory organ.	Nature reviews. Endocrinology	2017	21
27623982	D-Glucose	Liu F	Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials.	European journal of clinical nutrition	2017	9
27636730	D-Glucose	Gross B	PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.	Nature reviews. Endocrinology	2017	26
27709762	D-Glucose	Heise T	Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial.	Diabetes, obesity & metabolism	2017	5
27739515	D-Glucose	Sylow L	Exercise-stimulated glucose uptake - regulation and implications for glycaemic control.	Nature reviews. Endocrinology	2017	10
27745828	D-Glucose	Rehman MB	Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials.	Diabetes & metabolism	2017	5
27761984	D-Glucose	Wu T	Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes.	Diabetes, obesity & metabolism	2017	5
27761989	D-Glucose	Pingitore A	The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro.	Diabetes, obesity & metabolism	2017	6
27796346	D-Glucose	Li X	lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy.	Scientific reports	2016	11
27797909	D-Glucose	Kjøbsted R	Enhanced Muscle Insulin Sensitivity After Contraction/Exercise Is Mediated by AMPK.	Diabetes	2017	7
27814523	D-Glucose	Li P	Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.	Cell	2016	16
27860160	D-Glucose	Mokhlesi B	Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes.	Diabetes, obesity & metabolism	2017	8
27864352	D-Glucose	Lawlor N	Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.	Genome research	2017	12
27878566	D-Glucose	Heise T	Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.	Clinical pharmacokinetics	2017	6
27901631	D-Glucose	O'Reilly MW	11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.	The Journal of clinical endocrinology and metabolism	2017	10
27908689	D-Glucose	Schmidt AF	PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.	The lancet. Diabetes & endocrinology	2017	23
27928162	D-Glucose	Hashimoto N	Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.	Journal of human genetics	2017	6
27935822	D-Glucose	Luo L	Adipose tissue in control of metabolism.	The Journal of endocrinology	2016	16
27941246	D-Glucose	Ediger BN	LIM domain-binding 1 maintains the terminally differentiated state of pancreatic β cells.	The Journal of clinical investigation	2017	8
27942709	D-Glucose	Berkowitz SA	Addressing Unmet Basic Resource Needs as Part of Chronic Cardiometabolic Disease Management.	JAMA internal medicine	2017	8
27959767	D-Glucose	Ference BA	Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.	The New England journal of medicine	2016	41
27964927	D-Glucose	Li X	Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy.	Experimental cell research	2017	5
27978584	D-Glucose	Colle R	PPAR-γ Agonists for the Treatment of Major Depression: A Review.	Pharmacopsychiatry	2017	5
27981757	D-Glucose	Htike ZZ	Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis.	Diabetes, obesity & metabolism	2017	6
27982707	D-Glucose	Kovatchev B	Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.	Diabetes technology & therapeutics	2017	10
28007348	D-Glucose	El-Khatib FH	Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.	Lancet	2017	10
28039838	D-Glucose	Gómez-Sámano MÁ	Fibroblast growth factor 21 and its novel association with oxidative stress.	Redox biology	2017	7
28041957	D-Glucose	Akerman I	Human Pancreatic β Cell lncRNAs Control Cell-Specific Regulatory Networks.	Cell metabolism	2017	11
28052845	D-Glucose	Barry E	Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions.	BMJ	2017	14
28052999	D-Glucose	Templeman NM	A causal role for hyperinsulinemia in obesity.	The Journal of endocrinology	2017	10
28053201	D-Glucose	Noakes TD	Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review.	British journal of sports medicine	2017	5
28065883	D-Glucose	Rawal S	Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy.	Cardiovascular research	2017	7
28093853	D-Glucose	Goldenberg R	Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy.	Diabetes, obesity & metabolism	2017	5
28095040	D-Glucose	Garber AJ	CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.	Endocrine practice 	2017	42
28097367	D-Glucose	Pillinger T	Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis.	JAMA psychiatry	2017	13
28118453	D-Glucose	Beck RW	Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.	JAMA	2017	35
28118454	D-Glucose	Lind M	Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.	JAMA	2017	21
28120497	D-Glucose	Neal B	Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.	Diabetes, obesity & metabolism	2017	12
28126459	D-Glucose	Riddell MC	Exercise management in type 1 diabetes: a consensus statement.	The lancet. Diabetes & endocrinology	2017	13
28134564	D-Glucose	Garg SK	Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.	Diabetes technology & therapeutics	2017	21
28208791	D-Glucose	Menezes R	Impact of Flavonols on Cardiometabolic Biomarkers:  A Meta-Analysis of Randomized Controlled Human  Trials to Explore the Role of Inter-Individual  Variability.	Nutrients	2017	7
28211512	D-Glucose	Perakakis N	Physiology and role of irisin in glucose homeostasis.	Nature reviews. Endocrinology	2017	10
28215845	D-Glucose	Chakravarthy H	Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx.	Cell metabolism	2017	5
28231835	D-Glucose	Dei Cas A	Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes.	Cardiovascular diabetology	2017	6
28237263	D-Glucose	le Roux CW	3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.	Lancet	2017	12
28314735	D-Glucose	Adams LA	Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.	Gut	2017	12
28346411	D-Glucose	Lynes MD	The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue.	Nature medicine	2017	14
28356319	D-Glucose	Russell-Jones D	Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1).	Diabetes care	2017	9
28398233	D-Glucose	Colldén G	Therapeutic Potential of Targeting the Ghrelin Pathway.	International journal of molecular sciences	2017	5
28514451	D-Glucose	Zhang H	Structure of the full-length glucagon class B G-protein-coupled receptor.	Nature	2017	8
28559417	D-Glucose	Kleinberger G	The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.	The EMBO journal	2017	6
28846098	D-Glucose	Emmerson PJ	The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.	Nature medicine	2017	12
11434828	Aspirin	Albert MA	Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.	JAMA	2001	189
14704745	Aspirin	Shoelson SE	Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance.	International journal of obesity and related metabolic disorders 	2003	88
14988310	Aspirin	Pickup JC	Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.	Diabetes care	2004	224
15069117	Aspirin	Ma J	A prospective study of plasma C-peptide and colorectal cancer risk in men.	Journal of the National Cancer Institute	2004	79
15677512	Aspirin	Schulze MB	Adiponectin and future coronary heart disease events among men with type 2 diabetes.	Diabetes	2005	69
16612330	Aspirin	Parving HH	Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.	Kidney international	2006	71
17546309	Aspirin	Mendis S	The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.	Bulletin of the World Health Organization	2007	85
17709633	Aspirin	Pou KM	Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study.	Circulation	2007	205
18832751	Aspirin	Shaw JA	Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.	Circulation research	2008	68
23283721	Aspirin	Willeit P	Circulating microRNAs as novel biomarkers for platelet activation.	Circulation research	2013	57
23792451	Aspirin	Ogino S	Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.	Oncogene	2014	43
24302675	Aspirin	Adappa ND	The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery.	International forum of allergy & rhinology	2014	36
24335073	Aspirin	Lutty GA	Effects of diabetes on the eye.	Investigative ophthalmology & visual science	2013	36
25776112	Aspirin	Solomon DH	Disease activity in rheumatoid arthritis and the risk of cardiovascular events.	Arthritis & rheumatology	2015	26
11017071	L-Cysteine	Horikawa Y	Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.	Nature genetics	2000	224
11574398	L-Cysteine	Savage DB	Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.	Diabetes	2001	106
12504108	L-Cysteine	Patel L	Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.	Biochemical and biophysical research communications	2003	151
12904165	L-Cysteine	Brigstock DR	The CCN family: a new stimulus package.	The Journal of endocrinology	2003	151
22305519	L-Cysteine	Fisher-Wellman KH	Linking mitochondrial bioenergetics to insulin resistance via redox biology.	Trends in endocrinology and metabolism	2012	77
24637463	L-Cysteine	Kratz F	A clinical update of using albumin as a drug vehicle - a commentary.	Journal of controlled release 	2014	23
24681256	L-Cysteine	Levonen AL	Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics.	Free radical biology & medicine	2014	49
25205735	L-Cysteine	Kao L	Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.	Journal of the American Society of Nephrology 	2015	25
15315818	24,25-Dihydroxyvitamin D	Uitterlinden AG	Genetics and biology of vitamin D receptor polymorphisms.	Gene	2004	229
15564440	24,25-Dihydroxyvitamin D	Cantorna MT	Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.	Experimental biology and medicine	2004	115
15971062	24,25-Dihydroxyvitamin D	Mathieu C	Vitamin D and diabetes.	Diabetologia	2005	90
16316359	24,25-Dihydroxyvitamin D	Agarwal R	Antiproteinuric effect of oral paricalcitol in chronic kidney disease.	Kidney international	2005	91
16697362	24,25-Dihydroxyvitamin D	Speeckaert M	Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.	Clinica chimica acta; international journal of clinical chemistry	2006	106
17112620	24,25-Dihydroxyvitamin D	Giulietti A	Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory.	Diabetes research and clinical practice	2007	62
18003755	24,25-Dihydroxyvitamin D	Hyppönen E	25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort.	Diabetes	2008	93
18594491	24,25-Dihydroxyvitamin D	Adorini L	Control of autoimmune diseases by the vitamin D endocrine system.	Nature clinical practice. Rheumatology	2008	81
21325459	24,25-Dihydroxyvitamin D	Yiu YF	Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2011	35
21947295	24,25-Dihydroxyvitamin D	Chen S	Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.	Circulation	2011	63
22596255	24,25-Dihydroxyvitamin D	Rosen CJ	The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.	Endocrine reviews	2012	115
22648296	24,25-Dihydroxyvitamin D	Bosworth CR	The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.	Kidney international	2012	35
23359064	24,25-Dihydroxyvitamin D	Yang CY	The implication of vitamin D and autoimmunity: a comprehensive review.	Clinical reviews in allergy & immunology	2013	31
24108316	24,25-Dihydroxyvitamin D	Ceglia L	A randomized study on the effect of vitamin D₃ supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women.	The Journal of clinical endocrinology and metabolism	2013	36
24703048	24,25-Dihydroxyvitamin D	Afzal S	Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study.	The lancet. Diabetes & endocrinology	2014	28
24915259	24,25-Dihydroxyvitamin D	Knip M	Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.	JAMA	2014	27
24974252	24,25-Dihydroxyvitamin D	Vimaleswaran KS	Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study.	The lancet. Diabetes & endocrinology	2014	48
25259922	24,25-Dihydroxyvitamin D	Sherman MH	Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.	Cell	2014	124
25813139	24,25-Dihydroxyvitamin D	Prasad P	Interplay of vitamin D and metabolic syndrome: A review.	Diabetes & metabolic syndrome	2016	16
26322175	24,25-Dihydroxyvitamin D	Husain K	Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.	World journal of biological chemistry	2015	22
10675071	Alpha-Tocopherol	-	Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.	Lancet	2000	337
18032779	Alpha-Tocopherol	Milman U	Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.	Arteriosclerosis, thrombosis, and vascular biology	2008	78
22326434	Alpha-Tocopherol	Cusi K	Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.	Gastroenterology	2012	130
23363012	Alpha-Tocopherol	Masuoka HC	Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.	Annals of the New York Academy of Sciences	2013	50
27052013	Alpha-Tocopherol	Hannah WN Jr	Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.	Digestive diseases and sciences	2016	10
27646933	Alpha-Tocopherol	Rotman Y	Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.	Gut	2017	20
25282103	Sulfate	Wood AR	Defining the role of common variation in the genomic and biological architecture of adult human height.	Nature genetics	2014	348
16041161	Uric acid	Yoo TW	Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.	Circulation journal 	2005	67
19503597	Uric acid	Kolz M	Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.	PLoS genetics	2009	180
19565556	Uric acid	Kim SY	Hyperuricemia and risk of stroke: a systematic review and meta-analysis.	Arthritis and rheumatism	2009	78
20332356	Uric acid	Ficociello LH	High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.	Diabetes care	2010	48
20538833	Uric acid	Goicoechea M	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.	Clinical journal of the American Society of Nephrology 	2010	136
21632472	Uric acid	Miao Y	Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.	Hypertension	2011	36
22028277	Uric acid	Zoppini G	Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.	Diabetes care	2012	37
22629362	Uric acid	Moreno-Navarrete JM	Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.	PloS one	2012	35
23062212	Uric acid	Gurka MJ	A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences.	Cardiovascular diabetology	2012	35
23423253	Uric acid	Rule AD	Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.	Kidney international	2013	40
23437258	Uric acid	Lv Q	High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies.	PloS one	2013	31
23798679	Uric acid	McGettrick AF	How metabolism generates signals during innate immunity and inflammation.	The Journal of biological chemistry	2013	47
23939543	Uric acid	Krolewski AS	Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.	Diabetes care	2014	50
15554887	Cortisol	Seckl JR	Prenatal glucocorticoids and long-term programming.	European journal of endocrinology	2004	113
15840727	Cortisol	Steptoe A	Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes.	Proceedings of the National Academy of Sciences of the United States of America	2005	115
16781084	Cortisol	Black PH	The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.	Medical hypotheses	2006	62
17536998	Cortisol	Jansson T	Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.	Clinical science	2007	93
21257974	Cortisol	Stetler C	Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.	Psychosomatic medicine	2011	131
22146091	Cortisol	Pervanidou P	Metabolic consequences of stress during childhood and adolescence.	Metabolism	2012	49
23735216	Cortisol	Lee MJ	Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.	Biochimica et biophysica acta	2014	44
24606092	Cortisol	Bartz S	Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality.	The Journal of clinical endocrinology and metabolism	2014	22
26443692	Cortisol	Fontana L	Effects of 2-year calorie restriction on circulating levels of IGF-1, IGF-binding proteins and cortisol in nonobese men and women: a randomized clinical trial.	Aging cell	2016	15
26930227	Cortisol	Tachikawa R	Changes in Energy Metabolism after Continuous Positive Airway Pressure for Obstructive Sleep Apnea.	American journal of respiratory and critical care medicine	2016	10
27468060	Cortisol	Kühnen P	Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist.	The New England journal of medicine	2016	18
18268214	Retinal	Zeng HY	Microglial activation in human diabetic retinopathy.	Archives of ophthalmology	2008	63
25935789	Retinal	Das A	Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.	Ophthalmology	2015	28
8436255	Ethanol	Barker DJ	Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.	Diabetologia	1993	340
8596596	Ethanol	Després JP	Hyperinsulinemia as an independent risk factor for ischemic heart disease.	The New England journal of medicine	1996	147
10484602	Ethanol	Ntambi JM	Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.	Journal of lipid research	1999	101
11466099	Ethanol	Pradhan AD	C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.	JAMA	2001	749
11864854	Ethanol	Liu S	Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.	The American journal of clinical nutrition	2002	96
12395331	Ethanol	Hassan MM	Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.	Hepatology	2002	143
12547549	Ethanol	Spranger J	Adiponectin and protection against type 2 diabetes mellitus.	Lancet	2003	167
12606524	Ethanol	Spranger J	Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.	Diabetes	2003	266
15082700	Ethanol	Pischon T	Plasma adiponectin levels and risk of myocardial infarction in men.	JAMA	2004	314
15113816	Ethanol	Meigs JB	Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.	JAMA	2004	142
15364185	Ethanol	Yusuf S	Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.	Lancet	2004	1464
15447916	Ethanol	Lopez-Garcia E	Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2004	151
15505132	Ethanol	Kim HJ	Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.	Archives of internal medicine	2004	85
15699277	Ethanol	Oei HH	Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.	Circulation	2005	84
15735094	Ethanol	Lopez-Garcia E	Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.	The Journal of nutrition	2005	70
15767524	Ethanol	Margolis KL	Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.	Archives of internal medicine	2005	69
15827312	Ethanol	Shlipak MG	Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.	JAMA	2005	162
16002815	Ethanol	Fung TT	Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2005	135
16527702	Ethanol	El-Serag HB	The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.	Clinical gastroenterology and hepatology 	2006	154
17021763	Ethanol	Sommer DM	Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.	Archives of dermatological research	2006	92
17227980	Ethanol	Joshi P	Risk factors for early myocardial infarction in South Asians compared with individuals in other countries.	JAMA	2007	162
17466744	Ethanol	Witt H	Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy.	Gastroenterology	2007	95
17728149	Ethanol	Adams LA	Nonalcoholic fatty liver disease.	Annals of epidemiology	2007	70
18414631	Ethanol	Auchincloss AH	Associations between recent exposure to ambient fine particulate matter and blood pressure in the Multi-ethnic Study of Atherosclerosis (MESA).	Environmental health perspectives	2008	90
18510434	Ethanol	Swarbrick MM	Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans.	Metabolic syndrome and related disorders	2008	67
18599522	Ethanol	Tan JT	FTO variants are associated with obesity in the Chinese and Malay populations in Singapore.	Diabetes	2008	55
19029462	Ethanol	Weikert C	Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.	Circulation	2008	62
19082520	Ethanol	Monami M	Sulphonylureas and cancer: a case-control study.	Acta diabetologica	2009	46
19802349	Ethanol	Finkelstein J	Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.	International journal of chronic obstructive pulmonary disease	2009	48
20022654	Ethanol	Dragani TA	Risk of HCC: genetic heterogeneity and complex genetics.	Journal of hepatology	2010	40
20339361	Ethanol	Preis SR	Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.	Obesity	2010	85
20561675	Ethanol	O'Donnell MJ	Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.	Lancet	2010	439
20569726	Ethanol	Soliman EZ	Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).	American heart journal	2010	51
20576628	Ethanol	Wijndaele K	Television viewing time independently predicts all-cause and cardiovascular mortality: the EPIC Norfolk study.	International journal of epidemiology	2011	78
20684021	Ethanol	Rotman Y	The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.	Hepatology	2010	96
21091952	Ethanol	Kalaria RN	Vascular basis for brain degeneration: faltering controls and risk factors for dementia.	Nutrition reviews	2010	60
21128245	Ethanol	Ertle J	Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.	International journal of cancer	2011	78
21397320	Ethanol	Braganza JM	Chronic pancreatitis.	Lancet	2011	93
21488075	Ethanol	Trépo E	Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.	Hepatology	2011	55
21544812	Ethanol	Wang C	Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies.	International journal of cancer	2012	75
21570529	Ethanol	Taylor EN	Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease.	American heart journal	2011	37
22162228	Ethanol	Klein AP	Genetic susceptibility to pancreatic cancer.	Molecular carcinogenesis	2012	46
22446023	Ethanol	Chen Y	Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies.	European journal of cancer	2012	32
22670023	Ethanol	Lal C	Neurocognitive impairment in obstructive sleep apnea.	Chest	2012	53
23142622	Ethanol	Aravinthan A	Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.	Journal of hepatology	2013	31
23143785	Ethanol	Gupta SC	Therapeutic roles of curcumin: lessons learned from clinical trials.	The AAPS journal	2013	154
23364087	Ethanol	Gómez-Olivé FX	Self-reported health and health care use in an ageing population in the Agincourt sub-district of rural South Africa.	Global health action	2013	27
23440284	Ethanol	Singh S	Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.	JAMA internal medicine	2013	66
23665288	Ethanol	Pais R	A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.	Journal of hepatology	2013	67
23670794	Ethanol	Martínez-Lapiscina EH	Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial.	Journal of neurology, neurosurgery, and psychiatry	2013	48
23703888	Ethanol	Lazo M	Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.	American journal of epidemiology	2013	136
23919770	Ethanol	Jiang T	Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors.	Current Alzheimer research	2013	27
24382882	Ethanol	Chen CH	Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.	Physiological reviews	2014	62
24402003	Ethanol	Takayanagi Y	Accuracy of reports of lifetime mental and physical disorders: results from the Baltimore Epidemiological Catchment Area study.	JAMA psychiatry	2014	27
24442222	Ethanol	Silverberg MJ	Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care.	Journal of acquired immune deficiency syndromes	2014	32
25390655	Ethanol	Willeit P	Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis.	PloS one	2014	29
25672924	Ethanol	Wang R	Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline.	Neurology	2015	20
25880521	Ethanol	Alexander BT	Fetal programming and cardiovascular pathology.	Comprehensive Physiology	2015	17
25886472	Ethanol	Stanifer JW	The epidemiology of chronic kidney disease in Northern Tanzania: a population-based survey.	PloS one	2015	19
25886648	Ethanol	Dare S	Relationship between smoking and obesity: a cross-sectional study of 499,504 middle-aged adults in the UK general population.	PloS one	2015	17
26025389	Ethanol	Saleheen D	Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.	The lancet. Diabetes & endocrinology	2015	65
26850495	Ethanol	Mancina RM	The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.	Gastroenterology	2016	26
27431356	Ethanol	O'Donnell MJ	Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.	Lancet	2016	48
27843151	Ethanol	Liu C	A DNA methylation biomarker of alcohol consumption.	Molecular psychiatry	2018	14
28467924	Ethanol	Søberg S	FGF21 Is a Sugar-Induced Hormone Associated with Sweet Intake and Preference in Humans.	Cell metabolism	2017	9
15533996	Sirolimus	Manning BD	Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis.	The Journal of cell biology	2004	174
15707400	Sirolimus	Pearl JP	Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.	American journal of transplantation 	2005	114
15718470	Sirolimus	Sarbassov DD	Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.	Science	2005	2058
15996257	Sirolimus	Froud T	Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.	American journal of transplantation 	2005	86
16354680	Sirolimus	Tzatsos A	Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.	Molecular and cellular biology	2006	125
16446424	Sirolimus	Furuya F	Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.	Proceedings of the National Academy of Sciences of the United States of America	2006	65
17273556	Sirolimus	Le Bacquer O	Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.	The Journal of clinical investigation	2007	97
17275731	Sirolimus	Tsang CK	Targeting mammalian target of rapamycin (mTOR) for health and diseases.	Drug discovery today	2007	109
17419990	Sirolimus	Bhaskar PT	The two TORCs and Akt.	Developmental cell	2007	302
17452018	Sirolimus	Dann SG	mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer.	Trends in molecular medicine	2007	170
18367868	Sirolimus	Mammucari C	Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle.	Autophagy	2008	76
18431516	Sirolimus	Monti P	Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells.	The Journal of clinical investigation	2008	52
18460336	Sirolimus	Gulati P	Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34.	Cell metabolism	2008	131
19074986	Sirolimus	Putnam AL	Expansion of human regulatory T-cells from patients with type 1 diabetes.	Diabetes	2009	112
19771169	Sirolimus	Balgi AD	Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.	PloS one	2009	113
19864431	Sirolimus	Foster KG	Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.	The Journal of biological chemistry	2010	58
19875810	Sirolimus	Lieberthal W	The role of the mammalian target of rapamycin (mTOR) in renal disease.	Journal of the American Society of Nephrology 	2009	81
19948145	Sirolimus	Laplante M	An emerging role of mTOR in lipid biosynthesis.	Current biology 	2009	156
20007560	Sirolimus	Hsieh MM	Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.	The New England journal of medicine	2009	86
20117946	Sirolimus	Krycer JR	The Akt-SREBP nexus: cell signaling meets lipid metabolism.	Trends in endocrinology and metabolism	2010	58
20491627	Sirolimus	Zhou H	The complexes of mammalian target of rapamycin.	Current protein & peptide science	2010	42
20498714	Sirolimus	Squarize CH	Accelerated wound healing by mTOR activation in genetically defined mouse models.	PloS one	2010	40
20938440	Sirolimus	Famulla S	Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells.	International journal of obesity	2011	37
21099108	Sirolimus	Badell IR	LFA-1-specific therapy prolongs allograft survival in rhesus macaques.	The Journal of clinical investigation	2010	53
21157483	Sirolimus	Zoncu R	mTOR: from growth signal integration to cancer, diabetes and ageing.	Nature reviews. Molecular cell biology	2011	1286
21269838	Sirolimus	Howell JJ	mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.	Trends in endocrinology and metabolism	2011	113
21284988	Sirolimus	Kim S	Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase.	Cell metabolism	2011	47
21325617	Sirolimus	Guevara-Aguirre J	Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans.	Science translational medicine	2011	183
21376236	Sirolimus	Zinzalla V	Activation of mTORC2 by association with the ribosome.	Cell	2011	210
21470407	Sirolimus	Dowling RJ	Understanding the benefit of metformin use in cancer treatment.	BMC medicine	2011	100
21521467	Sirolimus	Thompson P	CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.	American journal of transplantation 	2011	45
21576258	Sirolimus	Dai N	mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry.	Genes & development	2011	41
21576368	Sirolimus	Ekim B	mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression.	Molecular and cellular biology	2011	37
22065737	Sirolimus	Shin S	Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation.	Proceedings of the National Academy of Sciences of the United States of America	2011	40
22354785	Sirolimus	Wiza C	Role of PRAS40 in Akt and mTOR signaling in health and disease.	American journal of physiology. Endocrinology and metabolism	2012	39
22500797	Sirolimus	Laplante M	mTOR signaling in growth control and disease.	Cell	2012	2019
22545721	Sirolimus	Chong ZZ	Mammalian target of rapamycin signaling in diabetic cardiovascular disease.	Cardiovascular diabetology	2012	39
22711699	Sirolimus	Winbanks CE	Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin.	The Journal of cell biology	2012	32
22749019	Sirolimus	Efeyan A	Amino acids and mTORC1: from lysosomes to disease.	Trends in molecular medicine	2012	126
22773877	Sirolimus	Yuan M	Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.	The Journal of biological chemistry	2012	49
23124837	Sirolimus	Hung CM	mTOR-dependent cell survival mechanisms.	Cold Spring Harbor perspectives in biology	2012	34
23150676	Sirolimus	Jansson N	Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies.	The Journal of clinical endocrinology and metabolism	2013	50
23203037	Sirolimus	Maiese K	Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade.	International journal of molecular sciences	2012	32
23223022	Sirolimus	Wang Y	MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells.	Diabetes	2013	38
23238567	Sirolimus	Ben-Sahra I	Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death.	Cell death and differentiation	2013	38
23317514	Sirolimus	Cornu M	mTOR in aging, metabolism, and cancer.	Current opinion in genetics & development	2013	151
23460185	Sirolimus	Alayev A	mTOR signaling for biological control and cancer.	Journal of cellular physiology	2013	36
23641065	Sirolimus	Laplante M	Regulation of mTORC1 and its impact on gene expression at a glance.	Journal of cell science	2013	147
23694989	Sirolimus	Kim SG	Nutrient regulation of the mTOR complex 1 signaling pathway.	Molecules and cells	2013	58
23708729	Sirolimus	Ryter SW	Autophagy: a critical regulator of cellular metabolism and homeostasis.	Molecules and cells	2013	53
24336084	Sirolimus	Blagosklonny MV	TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.	Cell death & disease	2013	35
24685370	Sirolimus	Kaplan B	Strategies for the management of adverse events associated with mTOR inhibitors.	Transplantation reviews	2014	28
24698685	Sirolimus	Bar-Peled L	Regulation of mTORC1 by amino acids.	Trends in cell biology	2014	170
24899720	Sirolimus	Caccamo A	Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.	The Journal of neuroscience 	2014	34
25224527	Sirolimus	Kumari D	Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.	Human mutation	2014	21
25242279	Sirolimus	Huang K	Growing knowledge of the mTOR signaling network.	Seminars in cell & developmental biology	2014	66
25247581	Sirolimus	Jenwitheesuk A	Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways.	International journal of molecular sciences	2014	20
25253086	Sirolimus	Jia G	Overnutrition, mTOR signaling, and cardiovascular diseases.	American journal of physiology. Regulatory, integrative and comparative physiology	2014	31
25468195	Sirolimus	Charbonnier LM	Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA.	The Journal of allergy and clinical immunology	2015	28
25688110	Sirolimus	Cargnello M	The expanding role of mTOR in cancer cell growth and proliferation.	Mutagenesis	2015	23
26678875	Sirolimus	Aylett CH	Architecture of human mTOR complex 1.	Science	2016	54
26740601	Sirolimus	Stamateris RE	Glucose Induces Mouse β-Cell Proliferation via IRS2, MTOR, and Cyclin D2 but Not the Insulin Receptor.	Diabetes	2016	12
27748764	Sirolimus	Kim LC	mTORC1 and mTORC2 in cancer and the tumor microenvironment.	Oncogene	2017	23
28283069	Sirolimus	Saxton RA	mTOR Signaling in Growth, Metabolism, and Disease.	Cell	2017	128
17341558	Vitamin A	Balagopal P	Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation.	The Journal of clinical endocrinology and metabolism	2007	63
18987272	Vitamin A	Rasouli N	Adipocytokines and the metabolic complications of obesity.	The Journal of clinical endocrinology and metabolism	2008	132
21835764	Vitamin A	Kotnik P	RBP4: a controversial adipokine.	European journal of endocrinology	2011	46
22200617	Vitamin A	Harwood HJ Jr	The adipocyte as an endocrine organ in the regulation of metabolic homeostasis.	Neuropharmacology	2012	51
22567167	Vitamin A	Pasco MY	High sugar-induced insulin resistance in Drosophila relies on the lipocalin Neural Lazarillo.	PloS one	2012	53
23105095	Vitamin A	Alapatt P	Liver retinol transporter and receptor for serum retinol-binding protein (RBP4).	The Journal of biological chemistry	2013	30
26022934	Vitamin A	Fasshauer M	Adipokines in health and disease.	Trends in pharmacological sciences	2015	47
18560516	Tacrolimus	Huurman VA	Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.	PloS one	2008	51
22814600	Tacrolimus	Goodyer WR	Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT.	Developmental cell	2012	30
18291668	Sterol	Raghow R	SREBPs: the crossroads of physiological and pathological lipid homeostasis.	Trends in endocrinology and metabolism	2008	91
23000402	Sterol	Shao W	Expanding roles for SREBP in metabolism.	Cell metabolism	2012	85
23708292	Sterol	Li Q	Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly.	Nature medicine	2013	57
24657242	Sterol	Sirtori CR	The pharmacology of statins.	Pharmacological research	2014	25
11861525	1,1-Dimethylbiguanide	Combs TP	Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization.	Endocrinology	2002	96
16443869	1,1-Dimethylbiguanide	Bowker SL	Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.	Diabetes care	2006	244
16932311	1,1-Dimethylbiguanide	Roden M	Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.	Nature clinical practice. Endocrinology & metabolism	2006	76
17101640	1,1-Dimethylbiguanide	Mazzone T	Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.	JAMA	2006	113
17519421	1,1-Dimethylbiguanide	Pearson ER	Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.	Diabetes	2007	68
17638715	1,1-Dimethylbiguanide	Bolen S	Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.	Annals of internal medicine	2007	116
18469241	1,1-Dimethylbiguanide	Bray GA	Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program.	The American journal of clinical nutrition	2008	55
19367387	1,1-Dimethylbiguanide	Masini M	Autophagy in human type 2 diabetes pancreatic beta cells.	Diabetologia	2009	70
19930006	1,1-Dimethylbiguanide	Jendle J	Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.	Diabetes, obesity & metabolism	2009	48
20222801	1,1-Dimethylbiguanide	Luo Z	AMPK as a metabolic tumor suppressor: control of metabolism and cell growth.	Future oncology	2010	106
20357375	1,1-Dimethylbiguanide	Fadini GP	The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.	Diabetes care	2010	70
21129444	1,1-Dimethylbiguanide	Bao B	The complexities of obesity and diabetes with the development and progression of pancreatic cancer.	Biochimica et biophysica acta	2011	36
21355967	1,1-Dimethylbiguanide	Pratley R	One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.	International journal of clinical practice	2011	51
21403054	1,1-Dimethylbiguanide	Bennett WL	Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.	Annals of internal medicine	2011	96
21471135	1,1-Dimethylbiguanide	Schramm TK	Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.	European heart journal	2011	66
21989078	1,1-Dimethylbiguanide	Christensen MM	The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c.	Pharmacogenetics and genomics	2011	44
22046219	1,1-Dimethylbiguanide	McIntosh B	Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis.	Open medicine 	2011	40
22129971	1,1-Dimethylbiguanide	Lai SW	Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan.	Clinical lung cancer	2012	40
22194737	1,1-Dimethylbiguanide	Mazza A	The role of metformin in the management of NAFLD.	Experimental diabetes research	2012	37
22326465	1,1-Dimethylbiguanide	Baffy G	Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.	Journal of hepatology	2012	152
22356132	1,1-Dimethylbiguanide	Haak T	Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled study.	Diabetes, obesity & metabolism	2012	33
22411919	1,1-Dimethylbiguanide	Karagiannis T	Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.	BMJ	2012	79
22446170	1,1-Dimethylbiguanide	Rosenstock J	Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy.	Diabetes care	2012	64
22593429	1,1-Dimethylbiguanide	Cohen DH	Obesity, type 2 diabetes, and cancer: the insulin and IGF connection.	Endocrine-related cancer	2012	55
22683137	1,1-Dimethylbiguanide	Gallwitz B	Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.	Lancet	2012	37
22748821	1,1-Dimethylbiguanide	Gallwitz B	2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.	Lancet	2012	78
22926251	1,1-Dimethylbiguanide	Pollak MN	Investigating metformin for cancer prevention and treatment: the end of the beginning.	Cancer discovery	2012	131
22985213	1,1-Dimethylbiguanide	Nauck M	Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study.	Diabetes, obesity & metabolism	2013	26
23292119	1,1-Dimethylbiguanide	Hou G	Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.	Breast cancer research and treatment	2013	26
23381014	1,1-Dimethylbiguanide	Singh S	Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.	The American journal of gastroenterology	2013	51
23806570	1,1-Dimethylbiguanide	Johnsson KM	Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin.	Journal of diabetes and its complications	2013	31
24186878	1,1-Dimethylbiguanide	Ferrannini E	Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.	Diabetes care	2013	34
24742660	1,1-Dimethylbiguanide	Nauck M	Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5).	Diabetes care	2014	41
24842985	1,1-Dimethylbiguanide	Umpierrez G	Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3).	Diabetes care	2014	39
24879836	1,1-Dimethylbiguanide	Wysham C	Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1).	Diabetes care	2014	49
24998080	1,1-Dimethylbiguanide	Weir DL	Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study.	JACC. Heart failure	2014	28
25018121	1,1-Dimethylbiguanide	Dungan KM	Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial.	Lancet	2014	55
25051360	1,1-Dimethylbiguanide	Davis NM	Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.	Oncotarget	2014	61
25735400	1,1-Dimethylbiguanide	Del Prato S	Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.	Diabetes, obesity & metabolism	2015	23
25792818	1,1-Dimethylbiguanide	Li X	Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.	Clinical interventions in aging	2015	17
26065921	1,1-Dimethylbiguanide	Takahashi RU	Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1.	Nature communications	2015	19
26377054	1,1-Dimethylbiguanide	Diabetes Prevention Program Research Group.	Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.	The lancet. Diabetes & endocrinology	2015	47
26597596	1,1-Dimethylbiguanide	Deacon CF	Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.	Diabetes, obesity & metabolism	2016	13
26769791	1,1-Dimethylbiguanide	Sharma M	Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study.	BMJ open	2016	22
26831302	1,1-Dimethylbiguanide	Farr OM	GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial.	Diabetologia	2016	11
26932742	1,1-Dimethylbiguanide	Ou HT	Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.	Cardiovascular diabetology	2016	14
27399082	1,1-Dimethylbiguanide	Ko SH	Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study.	Medicine	2016	11
27549367	1,1-Dimethylbiguanide	Feng Y	Metformin - a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis.	The journal of maternal-fetal & neonatal medicine 	2017	5
27589252	1,1-Dimethylbiguanide	Rodbard HW	Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial.	Diabetic medicine 	2017	11
27902459	1,1-Dimethylbiguanide	Yu X	Anti-tumor activity of metformin: from metabolic and epigenetic perspectives.	Oncotarget	2017	9
27935183	1,1-Dimethylbiguanide	Petrie JR	Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial.	Diabetes, obesity & metabolism	2017	5
15516696	Enalapril	Barnett AH	Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.	The New England journal of medicine	2004	112
25125488	Enalapril	Garg R	Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.	Diabetes	2015	20
26754626	Enalapril	Kristensen SL	Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.	Circulation. Heart failure	2016	16
15302780	Losartan	de Zeeuw D	Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.	Circulation	2004	108
18525041	Losartan	Parving HH	Aliskiren combined with losartan in type 2 diabetes and nephropathy.	The New England journal of medicine	2008	183
23487168	Losartan	Michel MC	A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists.	Pharmacological reviews	2013	33
24206457	Losartan	Fried LF	Combined angiotensin inhibition for the treatment of diabetic nephropathy.	The New England journal of medicine	2013	121
18378520	Ramipril	ONTARGET Investigators.	Telmisartan, ramipril, or both in patients at high risk for vascular events.	The New England journal of medicine	2008	443
18707986	Ramipril	Mann JF	Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.	Lancet	2008	252
22135311	Ramipril	Vegter S	Sodium intake, ACE inhibition, and progression to ESRD.	Journal of the American Society of Nephrology 	2012	43
17707755	Simvastatin	Messerli FH	Essential hypertension.	Lancet	2007	81
18650507	Simvastatin	SEARCH Collaborative Group.	SLCO1B1 variants and statin-induced myopathy--a genomewide study.	The New England journal of medicine	2008	370
18663180	Simvastatin	Cramer C	Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study.	Neurology	2008	59
21178985	Simvastatin	Donnelly LA	Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.	Clinical pharmacology and therapeutics	2011	44
23034020	Simvastatin	Emerging Risk Factors Collaboration.	C-reactive protein, fibrinogen, and cardiovascular disease prediction.	The New England journal of medicine	2012	197
23973688	Simvastatin	Albers JJ	Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).	Journal of the American College of Cardiology	2013	35
24743428	Simvastatin	Byrne CD	Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.	Arteriosclerosis, thrombosis, and vascular biology	2014	28
25066560	Simvastatin	Blazing MA	Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.	American heart journal	2014	22
25082583	Simvastatin	Boekholdt SM	Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.	Journal of the American College of Cardiology	2014	42
9598824	Nitric oxide	Traub O	Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force.	Arteriosclerosis, thrombosis, and vascular biology	1998	172
11773611	Nitric oxide	Roman RJ	P-450 metabolites of arachidonic acid in the control of cardiovascular function.	Physiological reviews	2002	329
11940543	Nitric oxide	Guzik TJ	Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.	Circulation	2002	204
15284284	Nitric oxide	Endemann DH	Endothelial dysfunction.	Journal of the American Society of Nephrology 	2004	161
15677503	Nitric oxide	Cardozo AK	Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells.	Diabetes	2005	163
15723618	Nitric oxide	Pacher P	Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.	Current medicinal chemistry	2005	73
15728243	Nitric oxide	Barshes NR	Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.	Journal of leukocyte biology	2005	91
16380482	Nitric oxide	Segal MS	Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes.	Diabetes	2006	69
16971655	Nitric oxide	Zhao HJ	Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.	Journal of the American Society of Nephrology 	2006	111
17229978	Nitric oxide	Guzik TJ	Adipocytokines - novel link between inflammation and vascular function?	Journal of physiology and pharmacology 	2006	87
17592079	Nitric oxide	Sorrentino SA	Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.	Circulation	2007	88
17654441	Nitric oxide	Hartge MM	The endothelium and vascular inflammation in diabetes.	Diabetes & vascular disease research	2007	56
18801863	Nitric oxide	Cade WT	Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.	Physical therapy	2008	80
20678595	Nitric oxide	Sitia S	From endothelial dysfunction to atherosclerosis.	Autoimmunity reviews	2010	52
21300066	Nitric oxide	Grover M	Cellular changes in diabetic and idiopathic gastroparesis.	Gastroenterology	2011	78
21471513	Nitric oxide	Godfrey KM	Epigenetic gene promoter methylation at birth is associated with child's later adiposity.	Diabetes	2011	162
22167522	Nitric oxide	Kietadisorn R	Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.	American journal of physiology. Endocrinology and metabolism	2012	55
22653084	Nitric oxide	Yi W	C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart.	Circulation	2012	32
23204109	Nitric oxide	Tabit CE	Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus.	Circulation	2013	43
23306778	Nitric oxide	Muniyappa R	Role of insulin resistance in endothelial dysfunction.	Reviews in endocrine & metabolic disorders	2013	44
23349535	Nitric oxide	Bender SB	Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?	Diabetes	2013	44
23684677	Nitric oxide	Paulus WJ	A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.	Journal of the American College of Cardiology	2013	257
24373826	Nitric oxide	Mancuso C	Ferulic acid: pharmacological and toxicological aspects.	Food and chemical toxicology 	2014	23
25391251	Nitric oxide	Lee RJ	Bitter and sweet taste receptors in the respiratory epithelium in health and disease.	Journal of molecular medicine	2014	22
25444755	Nitric oxide	Das A	PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer.	Pharmacology & therapeutics	2015	34
26800561	Nitric oxide	Bretón-Romero R	Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling.	Arteriosclerosis, thrombosis, and vascular biology	2016	13
28360087	Nitric oxide	Denimal D	Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P Enrichment.	Arteriosclerosis, thrombosis, and vascular biology	2017	6
15531498	Testosterone	Dhindsa S	Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2004	78
16537739	Testosterone	Ding EL	Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.	JAMA	2006	255
21896895	Testosterone	Dandona P	Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity.	The Journal of clinical endocrinology and metabolism	2011	36
23118429	Testosterone	Groth KA	Clinical review: Klinefelter syndrome--a clinical update.	The Journal of clinical endocrinology and metabolism	2013	39
23425925	Testosterone	Camacho EM	Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.	European journal of endocrinology	2013	42
25457200	Testosterone	Baxter M	Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes.	Journal of hepatology	2015	44
26055108	Testosterone	Zoch ML	New insights into the biology of osteocalcin.	Bone	2016	14
26865584	Testosterone	Turcu AF	Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency.	European journal of endocrinology	2016	13
27459230	Testosterone	Rosenfield RL	The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.	Endocrine reviews	2016	16
15213209	L-Arginine	Esposito K	Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.	JAMA	2004	76
23485969	L-Arginine	Chandra V	Multidomain integration in the structure of the HNF-4α nuclear receptor complex.	Nature	2013	43
26740598	L-Arginine	Fadini GP	NETosis Delays Diabetic Wound Healing in Mice and Humans.	Diabetes	2016	18
27406712	L-Arginine	Rabbani N	Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.	Glycoconjugate journal	2016	17
11686294	L-Threonine	Lawlor MA	PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?	Journal of cell science	2001	231
11955436	L-Threonine	Liu C	Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.	Cell	2002	554
15671481	L-Threonine	Zick Y	Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance.	Science's STKE 	2005	83
18606491	L-Threonine	Luo J	Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.	Cancer letters	2009	118
20166984	L-Threonine	Falasca M	PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs.	Current pharmaceutical design	2010	40
20549472	L-Threonine	Vasudevan KM	AKT signaling in physiology and disease.	Current topics in microbiology and immunology	2010	40
21924349	L-Threonine	Contreras-Vallejos E	Going out of the brain: non-nervous system physiological and pathological functions of Cdk5.	Cellular signalling	2012	37
22371497	L-Threonine	Fong JJ	β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3.	The Journal of biological chemistry	2012	40
22684109	L-Threonine	Zhao X	Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1.	The Journal of clinical investigation	2012	55
23642195	L-Threonine	Bond MR	O-GlcNAc cycling: a link between metabolism and chronic disease.	Annual review of nutrition	2013	73
24333164	L-Threonine	Hwang J	STRIPAK complexes: structure, biological function, and involvement in human diseases.	The international journal of biochemistry & cell biology	2014	38
24931005	L-Threonine	McCubrey JA	GSK-3 as potential target for therapeutic intervention in cancer.	Oncotarget	2014	83
25576057	L-Threonine	Yu A	Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes.	Diabetes	2015	27
25831499	L-Threonine	Cook PR	Phosphorylation of ORF1p is required for L1 retrotransposition.	Proceedings of the National Academy of Sciences of the United States of America	2015	18
26687681	L-Threonine	Liu CC	Cul3-KLHL20 Ubiquitin Ligase Governs the Turnover of ULK1 and VPS34 Complexes to Control Autophagy Termination.	Molecular cell	2016	26
27535340	L-Threonine	Martin K	PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.	Nature communications	2016	14
2195544	L-Serine	Westermark P	Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.	Proceedings of the National Academy of Sciences of the United States of America	1990	160
11606564	L-Serine	Aguirre V	Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action.	The Journal of biological chemistry	2002	218
12169433	L-Serine	White MF	IRS proteins and the common path to diabetes.	American journal of physiology. Endocrinology and metabolism	2002	216
12351658	L-Serine	Gao Z	Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.	The Journal of biological chemistry	2002	167
12615961	L-Serine	Doble BW	GSK-3: tricks of the trade for a multi-tasking kinase.	Journal of cell science	2003	603
17100578	L-Serine	Kockeritz L	Glycogen synthase kinase-3--an overview of an over-achieving protein kinase.	Current drug targets	2006	82
19188682	L-Serine	Qatanani M	Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.	The Journal of clinical investigation	2009	51
19837468	L-Serine	Yazbeck R	Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?	Trends in pharmacological sciences	2009	53
19958841	L-Serine	Muoio DM	Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?	Biochimica et biophysica acta	2010	49
20651683	L-Serine	Choi JH	Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.	Nature	2010	247
21593200	L-Serine	Zhao Y	Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation.	Diabetes	2011	44
22476196	L-Serine	Bomfim TR	An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.	The Journal of clinical investigation	2012	123
22476197	L-Serine	Talbot K	Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.	The Journal of clinical investigation	2012	269
22634722	L-Serine	Lewis EC	Expanding the clinical indications for α(1)-antitrypsin therapy.	Molecular medicine	2012	33
23065822	L-Serine	Diamanti-Kandarakis E	Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.	Endocrine reviews	2012	128
23982206	L-Serine	Ramakrishnan P	Activation of the transcriptional function of the NF-κB protein c-Rel by O-GlcNAc glycosylation.	Science signaling	2013	30
24939063	L-Serine	Gomes AC	Gut microbiota, probiotics and diabetes.	Nutrition journal	2014	23
25092677	L-Serine	Wang Y	Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.	Diabetes	2014	22
25658204	L-Serine	Serasinghe MN	Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors.	Molecular cell	2015	53
26578202	L-Serine	Lipinski MJ	The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis.	European heart journal	2016	33
26855967	L-Serine	In J	Enterohemorrhagic Escherichia coli reduce mucus and intermicrovillar bridges in human stem cell-derived colonoids.	Cellular and molecular gastroenterology and hepatology	2016	27
28069642	L-Serine	Wang J	α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.	Diabetes	2017	6
11110769	Angiotensin II	Frustaci A	Myocardial cell death in human diabetes.	Circulation research	2000	180
12119995	Angiotensin II	Hausman DB	The biology of white adipocyte proliferation.	Obesity reviews 	2001	125
12663475	Angiotensin II	Doublier S	Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.	Diabetes	2003	81
17324119	Angiotensin II	Savoia C	Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.	Clinical science	2007	77
17409317	Angiotensin II	Eijkelkamp WB	Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.	Journal of the American Society of Nephrology 	2007	60
23478743	Angiotensin II	Gheorghiade M	Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.	JAMA	2013	38
24776703	Angiotensin II	Jiang F	Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.	Nature reviews. Cardiology	2014	29
11237216	All-trans-retinoic acid	Kliewer SA	Peroxisome proliferator-activated receptors: from genes to physiology.	Recent progress in hormone research	2001	89
17906642	All-trans-retinoic acid	Altucci L	RAR and RXR modulation in cancer and metabolic disease.	Nature reviews. Drug discovery	2007	148
19324880	All-trans-retinoic acid	Shigemoto T	Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes.	The Journal of biological chemistry	2009	51
20592279	All-trans-retinoic acid	Honkanen J	IL-17 immunity in human type 1 diabetes.	Journal of immunology	2010	69
21488901	All-trans-retinoic acid	Weiner HL	Oral tolerance.	Immunological reviews	2011	164
23396134	All-trans-retinoic acid	Verhoeven VJ	Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia.	Nature genetics	2013	93
23630073	All-trans-retinoic acid	Mottis A	Emerging roles of the corepressors NCoR1 and SMRT in homeostasis.	Genes & development	2013	44
24577401	All-trans-retinoic acid	Kojetin DJ	REV-ERB and ROR nuclear receptors as drug targets.	Nature reviews. Drug discovery	2014	58
25231870	All-trans-retinoic acid	Perry JR	Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.	Nature	2014	93
25037695	Ezetimibe	Roth EM	Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial.	International journal of cardiology	2014	44
25282519	Ezetimibe	Raal FJ	PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.	Lancet	2015	78
26030325	Ezetimibe	Bays H	Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial.	The Journal of clinical endocrinology and metabolism	2015	31
26227186	Ezetimibe	Tsujita K	Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.	Journal of the American College of Cardiology	2015	22
26718096	Ezetimibe	Banach M	Lipids, blood pressure and kidney update 2015.	Lipids in health and disease	2015	17
26868195	Ezetimibe	Sattar N	Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data.	The lancet. Diabetes & endocrinology	2016	17
27701660	Ezetimibe	Lotta LA	Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.	JAMA	2016	31
18425967	Vildagliptin	Richter B	Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.	The Cochrane database of systematic reviews	2008	55
22106978	Vildagliptin	Monami M	Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials.	Current medical research and opinion	2011	42
23837679	Vildagliptin	Monami M	Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2014	22
24793580	Vildagliptin	Monami M	Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials.	Nutrition, metabolism, and cardiovascular diseases 	2014	31
21334333	Sitagliptin	Elashoff M	Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.	Gastroenterology	2011	136
22862847	Sitagliptin	Niswender K	Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme.	Diabetes, obesity & metabolism	2013	31
24623020	Sitagliptin	Hampp C	Use of antidiabetic drugs in the U.S., 2003-2012.	Diabetes care	2014	39
24736555	Sitagliptin	Li L	Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies.	BMJ	2014	41
26052984	Sitagliptin	Green JB	Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.	The New England journal of medicine	2015	242
26888822	Sitagliptin	Li L	Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.	BMJ	2016	22
27351380	Sitagliptin	Oyama J	The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.	PLoS medicine	2016	14
27437883	Sitagliptin	McGuire DK	Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.	JAMA cardiology	2016	14
12807871	Rosiglitazone	Tiraby C	Acquirement of brown fat cell features by human white adipocytes.	The Journal of biological chemistry	2003	108
16737350	Rosiglitazone	Yang RZ	Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications.	PLoS medicine	2006	72
17040956	Rosiglitazone	Wang Y	Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.	Clinical chemistry	2007	103
17090751	Rosiglitazone	Creely SJ	Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.	American journal of physiology. Endocrinology and metabolism	2007	175
18276926	Rosiglitazone	Duan SZ	Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.	Circulation research	2008	73
19115254	Rosiglitazone	Shockley KR	PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells.	Journal of cellular biochemistry	2009	54
22616948	Rosiglitazone	Kung J	Thiazolidinedione safety.	Expert opinion on drug safety	2012	44
23166672	Rosiglitazone	Sharp LZ	Human BAT possesses molecular signatures that resemble beige/brite cells.	PloS one	2012	158
25481707	Rosiglitazone	Levin D	Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis.	Diabetologia	2015	30
28098353	Rosiglitazone	Derosa G	The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice.	Journal of cellular physiology	2018	10
15071125	Atorvastatin	Brousseau ME	Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.	The New England journal of medicine	2004	85
16801565	Atorvastatin	Knopp RH	Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).	Diabetes care	2006	73
20957344	Atorvastatin	Ali TK	Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury.	Diabetologia	2011	46
26906014	Atorvastatin	Billings FT 4th	High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.	JAMA	2016	28
10550418	Creatinine	Meyer TW	Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria.	Diabetologia	1999	111
10692273	Creatinine	Yeun JY	C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.	American journal of kidney diseases 	2000	95
10807470	Creatinine	Gottdiener JS	Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.	Journal of the American College of Cardiology	2000	205
11453706	Creatinine	Jafar TH	Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.	Annals of internal medicine	2001	106
11916939	Creatinine	Stehouwer CD	Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.	Diabetes	2002	103
12788992	Creatinine	Perkins BA	Regression of microalbuminuria in type 1 diabetes.	The New England journal of medicine	2003	158
13679476	Creatinine	Hoek FJ	A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.	Nephrology, dialysis, transplantation 	2003	76
14685005	Creatinine	Bolton WK	Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.	American journal of nephrology	2004	72
14715185	Creatinine	Forman DE	Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.	Journal of the American College of Cardiology	2004	115
15149345	Creatinine	de Zeeuw D	Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.	Kidney international	2004	147
15615823	Creatinine	Poggio ED	Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease.	Journal of the American Society of Nephrology 	2005	99
15625072	Creatinine	Muntner P	Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.	Journal of the American Society of Nephrology 	2005	93
15716560	Creatinine	Kragelund C	N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.	The New England journal of medicine	2005	81
15788478	Creatinine	Perkins BA	Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.	Journal of the American Society of Nephrology 	2005	91
15811980	Creatinine	Kistorp C	N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.	JAMA	2005	110
16338452	Creatinine	Casas JP	Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.	Lancet	2005	82
17485598	Creatinine	Roman MJ	Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study.	Hypertension	2007	148
18076931	Creatinine	Thompson RH	Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.	The Journal of urology	2008	96
18295053	Creatinine	Zhang L	Prevalence and factors associated with CKD: a population study from Beijing.	American journal of kidney diseases 	2008	59
19119287	Creatinine	Stevens LA	Factors other than glomerular filtration rate affect serum cystatin C levels.	Kidney international	2009	120
19145003	Creatinine	Parving HH	Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.	Nephrology, dialysis, transplantation 	2009	51
20138414	Creatinine	White SL	Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.	American journal of kidney diseases 	2010	59
20172445	Creatinine	Stevens LA	Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).	American journal of kidney diseases 	2010	58
20441712	Creatinine	Black C	Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.	Health technology assessment	2010	47
20522536	Creatinine	Adler SG	Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.	Clinical journal of the American Society of Nephrology 	2010	48
20557989	Creatinine	Stevens LA	Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.	American journal of kidney diseases 	2010	112
21098347	Creatinine	Roussel R	Metformin use and mortality among patients with diabetes and atherothrombosis.	Archives of internal medicine	2010	54
21242477	Creatinine	James MT	Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography.	Circulation	2011	49
21338849	Creatinine	Stevens LA	Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).	American journal of kidney diseases 	2011	40
21355061	Creatinine	Böger CA	CUBN is a gene locus for albuminuria.	Journal of the American Society of Nephrology 	2011	71
21372210	Creatinine	Kohan DE	Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.	Journal of the American Society of Nephrology 	2011	46
21385509	Creatinine	Brasnyó P	Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.	The British journal of nutrition	2011	111
21508635	Creatinine	Pergola PE	Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD.	American journal of nephrology	2011	64
21672124	Creatinine	Graefe-Mody U	Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*).	Diabetes, obesity & metabolism	2011	44
21779943	Creatinine	Fu WJ	Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.	Endocrine	2012	30
22658574	Creatinine	Anderson AH	Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2012	68
22762315	Creatinine	Inker LA	Estimating glomerular filtration rate from serum creatinine and cystatin C.	The New England journal of medicine	2012	532
22770927	Creatinine	Roshanravan B	A prospective study of frailty in nephrology-referred patients with CKD.	American journal of kidney diseases 	2012	54
23111824	Creatinine	Hallan SI	Age and association of kidney measures with mortality and end-stage renal disease.	JAMA	2012	103
23413806	Creatinine	Jones AG	The clinical utility of C-peptide measurement in the care of patients with diabetes.	Diabetic medicine 	2013	52
23619125	Creatinine	Grams ME	Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.	American journal of kidney diseases 	2013	29
23886566	Creatinine	Sharma SG	The modern spectrum of renal biopsy findings in patients with diabetes.	Clinical journal of the American Society of Nephrology 	2013	31
24206458	Creatinine	Parsa A	APOL1 risk variants, race, and progression of chronic kidney disease.	The New England journal of medicine	2013	175
24206459	Creatinine	de Zeeuw D	Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.	The New England journal of medicine	2013	134
24211404	Creatinine	Zubiri I	Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.	Journal of proteomics	2014	32
24322626	Creatinine	Tseng CL	Assessing potential glycemic overtreatment in persons at hypoglycemic risk.	JAMA internal medicine	2014	29
24722445	Creatinine	de Zeeuw D	The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	42
25029429	Creatinine	Langefeld CD	Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.	Kidney international	2015	33
25054777	Creatinine	Freedman BI	APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.	Kidney international	2015	30
25063425	Creatinine	An Y	Renal histologic changes and the outcome in patients with diabetic nephropathy.	Nephrology, dialysis, transplantation 	2015	17
25145934	Creatinine	Lai JY	MicroRNA-21 in glomerular injury.	Journal of the American Society of Nephrology 	2015	27
25272234	Creatinine	Pavkov ME	Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.	Kidney international	2015	19
25311702	Creatinine	Liu KD	Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2015	18
26180129	Creatinine	Peralta CA	APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.	Journal of the American Society of Nephrology 	2016	17
26242184	Creatinine	Jones AG	Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes.	Diabetes care	2016	11
26268910	Creatinine	de Zeeuw D	The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.	The lancet. Diabetes & endocrinology	2015	31
26362696	Creatinine	Inker LA	GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.	American journal of kidney diseases 	2016	15
26690912	Creatinine	Heung M	Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.	American journal of kidney diseases 	2016	11
27479614	Creatinine	Murphy D	Trends in Prevalence of Chronic Kidney Disease in the United States.	Annals of internal medicine	2016	18
27647855	Creatinine	Voelker J	Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy.	Journal of the American Society of Nephrology 	2017	7
27797925	Creatinine	Mosenzon O	Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.	Diabetes care	2017	12
28186566	Creatinine	Menne J	C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.	Nephrology, dialysis, transplantation 	2017	9
17492946	Aldosterone	Young WF	Primary aldosteronism: renaissance of a syndrome.	Clinical endocrinology	2007	63
20440277	Aldosterone	Ruggenenti P	The RAAS in the pathogenesis and treatment of diabetic nephropathy.	Nature reviews. Nephrology	2010	47
23932846	Aldosterone	Aroor AR	Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.	Metabolism	2013	47
24130346	Aldosterone	Dart AB	Earlier onset of complications in youth with type 2 diabetes.	Diabetes care	2014	22
25400162	Aldosterone	Kandzari DE	Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.	European heart journal	2015	48
26936907	Aldosterone	Lindhardt M	Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.	BMJ open	2016	14
8432214	Cholesterol	Stamler J	Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.	Diabetes care	1993	483
9186882	Cholesterol	Hunsicker LG	Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.	Kidney international	1997	122
9673301	Cholesterol	Haffner SM	Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.	The New England journal of medicine	1998	895
9987089	Cholesterol	Zimmermann J	Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.	Kidney international	1999	136
10333910	Cholesterol	-	Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.	Diabetes care	1999	172
10657556	Cholesterol	Yudkin JS	Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?	Atherosclerosis	2000	233
10722987	Cholesterol	Martin LM	Validation of self-reported chronic conditions and health services in a managed care population.	American journal of preventive medicine	2000	124
10802740	Cholesterol	Tsujishita Y	Structure and lipid transport mechanism of a StAR-related domain.	Nature structural biology	2000	103
11440984	Cholesterol	Vasa M	Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.	Circulation research	2001	431
11535564	Cholesterol	Sharrett AR	Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.	Circulation	2001	139
11692019	Cholesterol	Rost NS	Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study.	Stroke	2001	111
11738396	Cholesterol	Dobiásová M	The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).	Clinical biochemistry	2001	100
11882522	Cholesterol	Eichner JE	Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.	American journal of epidemiology	2002	159
12020339	Cholesterol	Beckman JA	Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.	JAMA	2002	364
12432042	Cholesterol	Ridker PM	Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.	The New England journal of medicine	2002	516
12479764	Cholesterol	ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.	Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).	JAMA	2002	184
14769624	Cholesterol	Wassertheil-Smoller S	Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).	Archives of internal medicine	2004	104
15142859	Cholesterol	Burke AP	Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study.	Arteriosclerosis, thrombosis, and vascular biology	2004	94
15173056	Cholesterol	Willerson JT	Inflammation as a cardiovascular risk factor.	Circulation	2004	170
15197153	Cholesterol	Ridker PM	Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?	Circulation	2004	84
15466496	Cholesterol	Nicklas BJ	Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study.	American journal of epidemiology	2004	73
15699278	Cholesterol	Desvarieux M	Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).	Circulation	2005	116
15802102	Cholesterol	Shaffer EA	Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?	Current gastroenterology reports	2005	73
16030277	Cholesterol	Ridker PM	Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.	JAMA	2005	141
16061755	Cholesterol	Dekker JM	Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.	Circulation	2005	94
16314544	Cholesterol	Ballantyne CM	Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.	Archives of internal medicine	2005	66
16344423	Cholesterol	Wannamethee SG	Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.	Archives of internal medicine	2005	129
16476102	Cholesterol	Barter PJ	Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.	Journal of internal medicine	2006	71
16629855	Cholesterol	Walldius G	The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.	Journal of internal medicine	2006	79
16773565	Cholesterol	Saxena R	Comprehensive association testing of common mitochondrial DNA variation in metabolic disease.	American journal of human genetics	2006	81
16832001	Cholesterol	Folsom AR	An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.	Archives of internal medicine	2006	84
16894037	Cholesterol	Sattar N	Adiponectin and coronary heart disease: a prospective study and meta-analysis.	Circulation	2006	86
17182639	Cholesterol	O'Neill MS	Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility.	Occupational and environmental medicine	2007	77
17192343	Cholesterol	Samaras K	Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and corrected hypoadiponectinemia.	Diabetes care	2007	62
17259501	Cholesterol	Bonora E	Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study.	Diabetes care	2007	57
17322482	Cholesterol	Williams CJ	Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes.	Diabetes care	2007	59
17339582	Cholesterol	Solomon A	Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.	Neurology	2007	55
17389279	Cholesterol	Xu A	Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.	Circulation	2007	80
17495599	Cholesterol	Lara-Castro C	Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.	Current opinion in lipidology	2007	63
17531663	Cholesterol	Ridker PM	C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.	Journal of the American College of Cardiology	2007	125
17827399	Cholesterol	Hamilton MT	Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease.	Diabetes	2007	317
18024853	Cholesterol	Risérus U	Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.	Diabetes	2008	62
18065585	Cholesterol	Kabir M	Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study.	The American journal of clinical nutrition	2007	62
18067118	Cholesterol	Mizrak D	CD133: molecule of the moment.	The Journal of pathology	2008	152
18193043	Cholesterol	Willer CJ	Newly identified loci that influence lipid concentrations and risk of coronary artery disease.	Nature genetics	2008	608
18193044	Cholesterol	Kathiresan S	Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.	Nature genetics	2008	496
18240558	Cholesterol	Ridker PM	Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity.	Nutrition reviews	2007	60
18265477	Cholesterol	Giovannucci E	Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.	The American journal of clinical nutrition	2007	134
18305138	Cholesterol	Love-Gregory L	Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol.	Human molecular genetics	2008	62
18317847	Cholesterol	Schmittdiel JA	Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.	Journal of general internal medicine	2008	78
18440684	Cholesterol	Foster MC	Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.	American journal of kidney diseases 	2008	62
18452784	Cholesterol	Bahrami H	Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.	Journal of the American College of Cardiology	2008	91
18462017	Cholesterol	Schadt EE	Mapping the genetic architecture of gene expression in human liver.	PLoS biology	2008	497
18480203	Cholesterol	Zethelius B	Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.	The New England journal of medicine	2008	186
18565848	Cholesterol	Adiels M	Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	135
18997196	Cholesterol	Ridker PM	Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.	The New England journal of medicine	2008	998
19060911	Cholesterol	Aulchenko YS	Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.	Nature genetics	2009	343
19073504	Cholesterol	Goodwin PJ	Insulin-lowering effects of metformin in women with early breast cancer.	Clinical breast cancer	2008	61
19203419	Cholesterol	Elahi MM	Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice.	The British journal of nutrition	2009	47
19221221	Cholesterol	McGillicuddy FC	Inflammation impairs reverse cholesterol transport in vivo.	Circulation	2009	118
19245965	Cholesterol	Frankel DS	Resistin, adiponectin, and risk of heart failure the Framingham offspring study.	Journal of the American College of Cardiology	2009	60
19273753	Cholesterol	Helzner EP	Contribution of vascular risk factors to the progression in Alzheimer disease.	Archives of neurology	2009	72
19281927	Cholesterol	Patel S	Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.	Journal of the American College of Cardiology	2009	57
19360495	Cholesterol	Esquirol Y	Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms.	Chronobiology international	2009	58
19424218	Cholesterol	Mozaffarian D	Health effects of trans-fatty acids: experimental and observational evidence.	European journal of clinical nutrition	2009	70
19470637	Cholesterol	Bozaoglu K	Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population.	The Journal of clinical endocrinology and metabolism	2009	52
19546386	Cholesterol	Waters DD	Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.	Circulation	2009	67
19667238	Cholesterol	Oh J	1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus.	Circulation	2009	82
19695853	Cholesterol	Balducci S	Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss.	Nutrition, metabolism, and cardiovascular diseases 	2010	85
19820018	Cholesterol	Smith J	Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity.	The Journal of clinical endocrinology and metabolism	2009	59
20421924	Cholesterol	Whincup PH	Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study).	PLoS medicine	2010	46
20921964	Cholesterol	Harvie MN	The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women.	International journal of obesity	2011	91
21151126	Cholesterol	Momozawa Y	Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease.	Nature genetics	2011	65
21195348	Cholesterol	Tang JJ	Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques.	Cell metabolism	2011	57
21232666	Cholesterol	Stamatakis E	Screen-based entertainment time, all-cause mortality, and cardiovascular events: population-based study with ongoing mortality and hospital events follow-up.	Journal of the American College of Cardiology	2011	82
21278760	Cholesterol	Tlaskalová-Hogenová H	The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.	Cellular & molecular immunology	2011	109
21298090	Cholesterol	Lee DH	Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes.	PloS one	2011	85
21347282	Cholesterol	Lettre G	Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.	PLoS genetics	2011	134
21386088	Cholesterol	Jones TH	Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).	Diabetes care	2011	76
21403038	Cholesterol	de Boer IH	Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.	Archives of internal medicine	2011	76
21474825	Cholesterol	Murphy AJ	Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2011	37
21572415	Cholesterol	Small KS	Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes.	Nature genetics	2011	118
21818333	Cholesterol	Shiels PG	Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort.	PloS one	2011	39
22005937	Cholesterol	Tenforde M	The association between personal health record use and diabetes quality measures.	Journal of general internal medicine	2012	37
22026577	Cholesterol	de Boer RA	The fibrosis marker galectin-3 and outcome in the general population.	Journal of internal medicine	2012	49
22041985	Cholesterol	Lloyd LJ	Childhood obesity and risk of the adult metabolic syndrome: a systematic review.	International journal of obesity	2012	42
22236411	Cholesterol	Vilsbøll T	Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.	BMJ	2012	128
22347441	Cholesterol	Pinto Pereira SM	Sedentary behaviour and biomarkers for cardiovascular disease and diabetes in mid-life: the role of television-viewing and sitting at work.	PloS one	2012	42
22356914	Cholesterol	Oh J	Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation.	The Journal of biological chemistry	2012	63
22412070	Cholesterol	de Koning L	Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men.	Circulation	2012	84
22414775	Cholesterol	Landi F	Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study.	Clinical nutrition	2012	78
22508708	Cholesterol	Hamer M	Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality.	The Journal of clinical endocrinology and metabolism	2012	90
22741595	Cholesterol	Liu CJ	Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.	Journal of gastroenterology and hepatology	2012	39
22751103	Cholesterol	Strong A	Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.	The Journal of clinical investigation	2012	59
22893714	Cholesterol	Benn M	Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.	The Journal of clinical endocrinology and metabolism	2012	61
23111762	Cholesterol	Buchacz K	Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.	Antiviral therapy	2013	39
23141484	Cholesterol	Yamamoto S	Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.	Journal of the American College of Cardiology	2012	43
23160641	Cholesterol	Albrechtsen A	Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes.	Diabetologia	2013	41
23234628	Cholesterol	Saylor PJ	Metabolic complications of androgen deprivation therapy for prostate cancer.	The Journal of urology	2013	25
23415864	Cholesterol	Zhang R	Emerging roles of Lipasin as a critical lipid regulator.	Biochemical and biophysical research communications	2013	30
23628621	Cholesterol	Stone MA	Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study.	Diabetes care	2013	26
23663738	Cholesterol	Nagareddy PR	Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.	Cell metabolism	2013	71
23727030	Cholesterol	Yamada H	Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.	Clinica chimica acta; international journal of clinical chemistry	2013	41
23801799	Cholesterol	Gerhard GS	A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.	Diabetes care	2013	40
23817481	Cholesterol	Egan BM	Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.	Circulation	2013	27
23829656	Cholesterol	Monami M	Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2014	26
23884353	Cholesterol	Desai NR	AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial.	Circulation	2013	37
23926208	Cholesterol	Varbo A	Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.	Circulation	2013	29
23965489	Cholesterol	Boekholdt SM	Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.	Circulation	2013	32
23981342	Cholesterol	Shen Y	Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.	Cardiovascular diabetology	2013	26
23995233	Cholesterol	Freigang S	Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.	Nature immunology	2013	56
24013058	Cholesterol	Thomas GS	Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.	Journal of the American College of Cardiology	2013	32
24013639	Cholesterol	Westra HJ	Systematic identification of trans eQTLs as putative drivers of known disease associations.	Nature genetics	2013	432
24097125	Cholesterol	Park S	The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	21
24366527	Cholesterol	McKee AC	The neuropathology of sport.	Acta neuropathologica	2014	56
24384645	Cholesterol	Breuer J	Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK.	Neurology	2014	27
24507774	Cholesterol	Peloso GM	Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.	American journal of human genetics	2014	80
24507775	Cholesterol	Lange LA	Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.	American journal of human genetics	2014	67
24558110	Cholesterol	Hoogeveen RC	Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.	Arteriosclerosis, thrombosis, and vascular biology	2014	36
24602293	Cholesterol	Gacci M	Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.	BJU international	2015	23
24663222	Cholesterol	Laakso M	Insulin resistance and hyperglycaemia in cardiovascular disease development.	Nature reviews. Endocrinology	2014	41
24832097	Cholesterol	Rahman M	Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.	Clinical journal of the American Society of Nephrology 	2014	22
24918789	Cholesterol	Usiskin K	Safety and tolerability of canagliflozin in patients with type 2 diabetes mellitus: pooled analysis of phase 3 study results.	Postgraduate medicine	2014	29
25014686	Cholesterol	HPS2-THRIVE Collaborative Group.	Effects of extended-release niacin with laropiprant in high-risk patients.	The New England journal of medicine	2014	159
25350695	Cholesterol	Postmus I	Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.	Nature communications	2014	38
25467842	Cholesterol	Chen L	Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis.	Metabolism	2015	24
25691689	Cholesterol	Soininen P	Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics.	Circulation. Cardiovascular genetics	2015	58
25725623	Cholesterol	Vergès B	Pathophysiology of diabetic dyslipidaemia: where are we?	Diabetologia	2015	20
25756439	Cholesterol	Besseling J	Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.	JAMA	2015	28
25961943	Cholesterol	Surakka I	The impact of low-frequency and rare variants on lipid levels.	Nature genetics	2015	47
25980762	Cholesterol	Dongiovanni P	Statin use and non-alcoholic steatohepatitis in at risk individuals.	Journal of hepatology	2015	25
26116691	Cholesterol	Lin X	Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.	Journal of the American Heart Association	2015	32
26131930	Cholesterol	Joshi PK	Directional dominance on stature and cognition in diverse human populations.	Nature	2015	29
26580236	Cholesterol	Wong PM	Social Jetlag, Chronotype, and Cardiometabolic Risk.	The Journal of clinical endocrinology and metabolism	2015	20
26817832	Cholesterol	Ortega Moreno L	Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes.	Cardiovascular diabetology	2016	10
26896437	Cholesterol	Leander K	Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.	Circulation	2016	14
27009502	Cholesterol	Vienberg S	MicroRNAs in metabolism.	Acta physiologica	2017	20
27040132	Cholesterol	Yusuf S	Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.	The New England journal of medicine	2016	45
27841877	Cholesterol	Lotta LA	Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.	Nature genetics	2017	27
27986651	Cholesterol	Reyes-Soffer G	Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.	Circulation	2017	12
28031477	Cholesterol	Lordén G	Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation.	The Journal of experimental medicine	2017	6
28199805	Cholesterol	Schauer PR	Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.	The New England journal of medicine	2017	40
28249988	Cholesterol	Wang J	Curcumin improves intestinal barrier function: modulation of intracellular signaling, and organization of tight junctions.	American journal of physiology. Cell physiology	2017	5
28304224	Cholesterol	Sabatine MS	Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.	The New England journal of medicine	2017	105
28334899	Cholesterol	Spracklen CN	Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels.	Human molecular genetics	2017	7
28399252	Cholesterol	Gottesman RF	Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.	JAMA	2017	16
28514624	Cholesterol	Lincoff AM	Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.	The New England journal of medicine	2017	21
20865240	Fluorescein	Broekhuizen LN	Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus.	Diabetologia	2010	54
24768239	Fluorescein	Campochiaro PA	Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema.	Ophthalmology	2014	22
26912261	Fluorescein	Zhang Q	Wide-field optical coherence tomography based microangiography for retinal imaging.	Scientific reports	2016	19
17605313	DG(14:0/14:0/0:0)	Holland WL	Lipid mediators of insulin resistance.	Nutrition reviews	2007	75
18062770	DG(14:0/14:0/0:0)	Mérida I	Diacylglycerol kinases: at the hub of cell signalling.	The Biochemical journal	2008	127
18757836	DG(14:0/14:0/0:0)	Yen CL	Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.	Journal of lipid research	2008	197
21297467	DG(14:0/14:0/0:0)	Boden G	Obesity, insulin resistance and free fatty acids.	Current opinion in endocrinology, diabetes, and obesity	2011	141
21930939	DG(14:0/14:0/0:0)	Kumashiro N	Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.	Proceedings of the National Academy of Sciences of the United States of America	2011	118
23929732	DG(14:0/14:0/0:0)	Birkenfeld AL	Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.	Hepatology	2014	87
24899308	DG(14:0/14:0/0:0)	Perry RJ	The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.	Nature	2014	130
16431339	25-Hydroxyvitamin D2	Kamen DL	Vitamin D deficiency in systemic lupus erythematosus.	Autoimmunity reviews	2006	82
16549493	25-Hydroxyvitamin D2	Harris SS	Vitamin D and African Americans.	The Journal of nutrition	2006	76
19443637	25-Hydroxyvitamin D2	de Boer IH	25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification.	Journal of the American Society of Nephrology 	2009	69
19781131	25-Hydroxyvitamin D2	von Hurst PR	Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial.	The British journal of nutrition	2010	127
21441443	25-Hydroxyvitamin D2	Cooper JD	Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes.	Diabetes	2011	56
22399511	25-Hydroxyvitamin D2	Gennari L	Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2012	37
25775274	25-Hydroxyvitamin D2	Beveridge LA	Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data.	JAMA internal medicine	2015	46
16460677	Somatostatin	Timper K	Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells.	Biochemical and biophysical research communications	2006	74
17329620	Somatostatin	Krebs M	The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man.	Diabetes	2007	59
17409288	Somatostatin	Dunning BE	The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.	Endocrine reviews	2007	84
22745242	Somatostatin	Gregg BE	Formation of a human β-cell population within pancreatic islets is set early in life.	The Journal of clinical endocrinology and metabolism	2012	84
23064014	Somatostatin	Egerod KL	A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin.	Endocrinology	2012	43
27941241	Somatostatin	Swisa A	PAX6 maintains β cell identity by repressing genes of alternative islet cell types.	The Journal of clinical investigation	2017	7
24722248	Pioglitazone	Kurtz CL	MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes.	Diabetes	2014	29
11423483	TG(16:0/16:0/18:0)	Boden G	Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects.	Diabetes	2001	93
11856796	TG(16:0/16:0/18:0)	Oral EA	Leptin-replacement therapy for lipodystrophy.	The New England journal of medicine	2002	203
11967537	TG(16:0/16:0/18:0)	Agarwal AK	AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.	Nature genetics	2002	104
12483461	TG(16:0/16:0/18:0)	Mead JR	Lipoprotein lipase: structure, function, regulation, and role in disease.	Journal of molecular medicine	2002	116
14683737	TG(16:0/16:0/18:0)	Hanefeld M	Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.	European heart journal	2004	80
15033247	TG(16:0/16:0/18:0)	Sajadieh A	Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease.	European heart journal	2004	71
18008060	TG(16:0/16:0/18:0)	Sparsø T	The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.	Diabetologia	2008	61
18775362	TG(16:0/16:0/18:0)	Halberg N	The adipocyte as an endocrine cell.	Endocrinology and metabolism clinics of North America	2008	96
19800867	TG(16:0/16:0/18:0)	Karbiener M	microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma.	Biochemical and biophysical research communications	2009	90
20335584	TG(16:0/16:0/18:0)	Petersen KF	Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.	The New England journal of medicine	2010	98
20648472	TG(16:0/16:0/18:0)	Speliotes EK	PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.	Hepatology	2010	77
20713683	TG(16:0/16:0/18:0)	Divoux A	Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss.	Diabetes	2010	96
21345103	TG(16:0/16:0/18:0)	Gandotra S	Perilipin deficiency and autosomal dominant partial lipodystrophy.	The New England journal of medicine	2011	41
21636801	TG(16:0/16:0/18:0)	Lassenius MI	Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation.	Diabetes care	2011	74
21843325	TG(16:0/16:0/18:0)	Innala L	Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.	Arthritis research & therapy	2011	44
22302940	TG(16:0/16:0/18:0)	Hugo SE	A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.	Genes & development	2012	34
22569073	TG(16:0/16:0/18:0)	Ren G	Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism.	American journal of physiology. Endocrinology and metabolism	2012	63
23542898	TG(16:0/16:0/18:0)	Graham MJ	Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.	Circulation research	2013	54
24172179	TG(16:0/16:0/18:0)	Scherer J	Issues in hypertriglyceridemic pancreatitis: an update.	Journal of clinical gastroenterology	2014	31
24390345	TG(16:0/16:0/18:0)	SIGMA Type 2 Diabetes Consortium.	Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.	Nature	2014	84
24716628	TG(16:0/16:0/18:0)	Abu-Farha M	Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.	Cardiovascular diabetology	2014	20
24978903	TG(16:0/16:0/18:0)	Liu YL	TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.	Nature communications	2014	58
25555214	TG(16:0/16:0/18:0)	Fabbrini E	Metabolically normal obese people are protected from adverse effects following weight gain.	The Journal of clinical investigation	2015	39
26100857	TG(16:0/16:0/18:0)	Xu Y	A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.	Nature communications	2015	21
26239609	TG(16:0/16:0/18:0)	Patni N	Congenital generalized lipodystrophies--new insights into metabolic dysfunction.	Nature reviews. Endocrinology	2015	22
15504954	1-Phosphatidyl-D-myo-inositol	Kim JE	regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis.	Diabetes	2004	106
16847462	1-Phosphatidyl-D-myo-inositol	Engelman JA	The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.	Nature reviews. Genetics	2006	829
20212113	1-Phosphatidyl-D-myo-inositol	Chagpar RB	Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2010	61
22936542	1-Phosphatidyl-D-myo-inositol	Rose DP	The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression.	Endocrine-related cancer	2012	33
23838428	1-Phosphatidyl-D-myo-inositol	Beazley-Long N	VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.	The American journal of pathology	2013	25
